<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="other">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">TPX</journal-id>
<journal-id journal-id-type="hwp">sptpx</journal-id>
<journal-id journal-id-type="nlm-ta">Toxicol Pathol</journal-id>
<journal-title>Toxicologic Pathology</journal-title>
<issn pub-type="ppub">0192-6233</issn>
<issn pub-type="epub">1533-1601</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0192623312444471</article-id>
<article-id pub-id-type="publisher-id">10.1177_0192623312444471</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Invited Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A Comprehensive Review of the Carcinogenic and Anticarcinogenic Potential of Capsaicin</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Bley</surname>
<given-names>Keith</given-names>
</name>
<xref ref-type="aff" rid="aff1-0192623312444471">1</xref>
<xref ref-type="corresp" rid="corresp1-0192623312444471"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boorman</surname>
<given-names>Gary</given-names>
</name>
<xref ref-type="aff" rid="aff2-0192623312444471">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mohammad</surname>
<given-names>Bashir</given-names>
</name>
<xref ref-type="aff" rid="aff3-0192623312444471">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McKenzie</surname>
<given-names>Donald</given-names>
</name>
<xref ref-type="aff" rid="aff3-0192623312444471">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Babbar</surname>
<given-names>Sunita</given-names>
</name>
<xref ref-type="aff" rid="aff1-0192623312444471">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0192623312444471">
<label>1</label>NeurogesX, Inc., San Mateo, California, USA</aff>
<aff id="aff2-0192623312444471">
<label>2</label>Covance Laboratories Inc., Chantilly, Virginia, USA</aff>
<aff id="aff3-0192623312444471">
<label>3</label>Covance Laboratories Inc., Madison, Wisconsin, USA</aff>
<author-notes>
<corresp id="corresp1-0192623312444471">Keith Bley, Solimar Therapeutics, Inc., 1134 Crane Street, Suite 216, Menlo Park, CA 94025, USA; e-mail: <email>kbley@solimarthera.com</email>.</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>8</month>
<year>2012</year>
</pub-date>
<volume>40</volume>
<issue>6</issue>
<fpage>847</fpage>
<lpage>873</lpage>
<permissions>
<copyright-statement>© 2012 by The Author(s)</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">Society of Toxicologic Pathology</copyright-holder>
</permissions>
<abstract>
<p>Human exposure to capsaicin, the most abundant pungent chili pepper component, is ubiquitous. Evaluation of capsaicin’s carcinogenic potential has produced variable results in <italic>in vitro </italic>and <italic>in vivo</italic> genotoxicity and carcinogenicity assays. The capsaicin tested in older studies was often from pepper plant extracts and included other capsaicinoids and diverse impurities. Recent studies utilizing high-purity capsaicin and standardized protocols provide evidence that the genotoxic and carcinogenic potential of capsaicin is quite low and that the purity of capsaicin is important. Several small epidemiological studies suggest a link between capsaicin consumption and stomach or gall bladder cancer, but contamination of capsaicin-containing foods with known carcinogens renders their interpretation problematic. The postulated ability of capsaicin metabolites to damage DNA and promote carcinogenesis remains unsupported. Anticancer activities of capsaicin have been widely reported, as it inhibits the activity of carcinogens and induces apoptosis in numerous cancer cell lines <italic>in vitro</italic> and explanted into rodents. Diverse mechanisms have been postulated for capsaicin’s anticancer properties. One hypothesis is that inhibition of cytochrome P450 enzymes—particularly CYP2E1—retards carcinogen activation but is contradicted by the low potency of capsaicin for CYP inhibition. The potential for dietary capsaicin to act as a chemopreventative is now widely postulated.</p>
</abstract>
<kwd-group>
<kwd>capsaicin</kwd>
<kwd>cancer</kwd>
<kwd>carcinogenicity</kwd>
<kwd>neoplasm</kwd>
<kwd>cytochrome P450</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0192623312444471">
<title>Introduction</title>
<p>Capsaicin, the most abundant pungent molecule produced by pepper plants, represents an important ingredient in spicy foods consumed throughout the world (<xref ref-type="bibr" rid="bibr56-0192623312444471">European Commission Scientific Committee on Food, 2002</xref>). The capsaicin content of chili peppers ranges from 0.1 to 1% w/w (<xref ref-type="bibr" rid="bibr65-0192623312444471">Govindarajan and Sathyanarayana 1991</xref>). Substantial human exposure to capsaicin in the form of prescription or nonprescription topical analgesics, self-defense products (e.g., pepper spray), cosmetics, and oral herbal supplements also occurs.</p>
<p>Capsaicin is a highly selective agonist for the transient receptor potential cation channel, subfamily V, member 1 (TRPV1), a ligand-gated, nonselective cation channel, preferentially expressed on small-diameter sensory neurons (C-fibers and to a lesser extent Aδ-fibers; <xref ref-type="bibr" rid="bibr3-0192623312444471">Alawi and Keeble 2010</xref>). Initially, activation of TRPV1-expressing nociceptors by capsaicin results in burning and itching sensations, hyperalgesia, and allodynia. The transient erythema produced by capsaicin is due to a neurovascular response stemming from the release of vasoactive neuropeptides from nociceptors (<xref ref-type="bibr" rid="bibr61-0192623312444471">Geppetti et al. 2008</xref>). These acute effects are followed by a reversible defunctionalization of nociceptive sensory axons. Defunctionalization of hyperactive nociceptors is thought to underlie the pain relief that follows topical application or intra-articular injections of capsaicin (<xref ref-type="bibr" rid="bibr7-0192623312444471">Anand and Bley 2011</xref>). For instance, Qutenza<sup>®</sup>, a cutaneous patch containing a high concentration (8%) of synthetic capsaicin, has been approved recently in the European Union and United States for the management of peripheral neuropathic pain syndromes (<xref ref-type="bibr" rid="bibr120-0192623312444471">McCormack 2010</xref>).</p>
<p>Much of the published toxicological literature on capsaicin relates to extracts of capsaicin derived from peppers; these extracts are typically a mixture of capsaicin, norhydrocapsaicin, dihydrocapsaicin, homocapsaicin, homodihydrocapsaicin, and nonivamide. The actual percentage of capsaicin and other capsaicinoids varies depending on the pepper source and method of extraction (<xref ref-type="bibr" rid="bibr82-0192623312444471">Johnson 2007</xref>). The capsaicin concentration can range (on a by weight basis) from about 65% (USP grade natural capsaicin) to &gt;99% (in the case of synthetically pure capsaicin) in medical and cosmetic products. Pepper extracts may also contain chemical entities other than capsaicinoid compounds. Toxicology results with pure capsaicin may differ from results obtained with extracts because of variable contents and potentially toxic impurities in the extracts.</p>
<p>The relationship of capsaicin to genotoxicity, carcinogenicity, and cancer prevention and treatment has been widely explored. A PubMed search using the terms “capsaicin” and “cancer” or “carcinogenicity” or “neoplasm” returns nearly 400 references. We have attempted to include all directly relevant references in this review, as well as some publications which clearly pertain to the subject matter but were not captured by the above PubMed search. Publications reviewed range from <italic>in vitro</italic> and <italic>in vivo</italic> studies, chemoprevention and metabolic inhibition, to apoptosis of cancer cell lines and epidemiological studies. The carcinogenic potential of capsaicin, other capsaicinoids, and capsaicin extracts has been reviewed previously (e.g., <xref ref-type="bibr" rid="bibr167-0192623312444471">Surh and Lee 1995</xref>; <xref ref-type="bibr" rid="bibr82-0192623312444471">Johnson 2007</xref>). Although comprehensive and very thorough, the most recent reference cited in <xref ref-type="bibr" rid="bibr82-0192623312444471">Johnson (2007</xref>) is from 2003, and roughly half of the publications on capsaicin and carcinogenicity have appeared since 2003.</p>
<p>This review focuses on carcinogenic and anticarcinogenic potential of capsaicin and not on pepper extracts or other capsaicinoid molecules. When interpreting toxicological evidence, weight was given to data from nonclinical studies for which protocols were consistent with drug regulatory agency guidelines and/or utilized high-purity capsaicin. Interpretation of metabolism studies was based upon available human pharmacokinetic information, with particular attention paid to the physiological relevance of capsaicin concentrations and exposures. Data regarding the numerous mechanisms postulated to underlie capsaicin’s anticancer activities were summarized. Finally, human epidemiological studies were examined for completeness with respect to accounting for known dietary carcinogens.</p>
</sec>
<sec id="section2-0192623312444471">
<title>
<italic>In Vitro</italic> Genotoxicity</title>
<p>Published information on the potential genotoxicity of capsaicin has been inconsistent, as both positive and negative effects have been found in classical genetic toxicology assays. Brief summaries of eighteen <italic>in vitro</italic> genotoxicity studies are provided in <xref ref-type="table" rid="table1-0192623312444471">Table 1</xref>.</p>
<table-wrap id="table1-0192623312444471" position="float">
<label>Table 1.</label>
<caption>
<p>
<italic>In vitro</italic> genotoxicity assays with capsaicin.</p>
</caption>
<graphic alternate-form-of="table1-0192623312444471" xlink:href="10.1177_0192623312444471-table1.tif"/>
<table>
<thead>
<tr>
<th>Assay</th>
<th>Cell type/source</th>
<th>Conditions</th>
<th>Results</th>
<th>References</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ames</td>
<td>
<italic>S. typhimurium </italic>TA98, TA100, TA1535, and TA1538</td>
<td>Capsaicin in DMSO at 0.5 to 5000 µg/plate</td>
<td>Non-genotoxic </td>
<td>
<xref ref-type="bibr" rid="bibr33-0192623312444471">Buchanan et al. 1981</xref>
</td>
</tr>
<tr>
<td>Ames</td>
<td>
<italic>S. typhimurium </italic>TA97, TA98, TA100, and TA102</td>
<td>Capsaicin in DMSO at 10 mg/mL </td>
<td>Weakly genotoxic in TA98 after metabolic activation </td>
<td>
<xref ref-type="bibr" rid="bibr174-0192623312444471">Toth et al. 1984</xref> </td>
</tr>
<tr>
<td>Ames</td>
<td>
<italic>S. typhimurium </italic>TA98, TA100, TA1535, TA1537, and TA1538</td>
<td>Capsaicin in DMSO at 40 µg/plate </td>
<td>Mutagenic with metabolic activation in TA98, TA100, and TA1535; not mutagenic without metabolic activation for all strains </td>
<td>
<xref ref-type="bibr" rid="bibr133-0192623312444471">Nagabhushan and Bhide 1985</xref> </td>
</tr>
<tr>
<td>Ames</td>
<td>
<italic>S. typhimurium</italic> TA 98 and TA1535</td>
<td>Capsaicin up to 1000 µg/plate</td>
<td>Non-genotoxic</td>
<td>
<xref ref-type="bibr" rid="bibr59-0192623312444471">Gannett et al. 1988</xref>
</td>
</tr>
<tr>
<td>Ames</td>
<td>
<italic>S. typhimurium </italic>TA98, TA100, TA1535, TA1537, and TA1538</td>
<td>Capsaicin (no solvent indicated) at 19.5 to 2500 μg/plate </td>
<td>Non-genotoxic</td>
<td>
<xref ref-type="bibr" rid="bibr69-0192623312444471">Hamid et al. 1989</xref> </td>
</tr>
<tr>
<td>Ames</td>
<td>
<italic>S. typhimurium</italic> TA98, and TA100, TA1535 </td>
<td>Capsaicin – commercial source (no concentrations or solvent specified)</td>
<td>Non-genotoxic</td>
<td>
<xref ref-type="bibr" rid="bibr185-0192623312444471">Vinitketkumnuen et al. 1991</xref>
</td>
</tr>
<tr>
<td>Ames, modified</td>
<td>
<italic>S. typhimurium </italic>TA100</td>
<td>Capsaicin in DMSO at 20, 30, and 40 µg/plate or in acetone at 10 to 40 µg/plate </td>
<td>Weak mutagenic response with metabolic activation by 0.5 mL S9; not mutagenic with 0.25 mL S9; not mutagenic with vehicle or without metabolic activation</td>
<td>
<xref ref-type="bibr" rid="bibr19-0192623312444471">Azizan and Blevins 1995</xref> </td>
</tr>
<tr>
<td>Ames</td>
<td>
<italic>S. typhimurium</italic> TA1535, TA1537, TA98, TA100 and <italic>E. coli</italic> WP2 <italic>uvr</italic>A </td>
<td>Capsaicin in DMSO up to 5000 µg/plate</td>
<td>Non-genotoxic</td>
<td>Proudlock et al. <xref ref-type="bibr" rid="bibr145-0192623312444471">2004</xref>
</td>
</tr>
<tr>
<td>Ames</td>
<td>
<italic>S. typhimurium</italic> TA1535, TA1537, TA98, TA100 and <italic>E. coli</italic> WP2 <italic>uvr</italic>A </td>
<td>Capsaicin in DMSO up to 5000 µg/plate</td>
<td>Non-genotoxic</td>
<td>Chanda et al. <xref ref-type="bibr" rid="bibr38-0192623312444471">2004</xref>
</td>
</tr>
<tr>
<td>Ames</td>
<td>
<italic>S. typhimurium</italic> TA1535, TA1537, TA98, TA100</td>
<td>Capsaicin in DMSO up to 2,000 µg/plate</td>
<td>Non-genotoxic</td>
<td>
<xref ref-type="bibr" rid="bibr177-0192623312444471">Tsuchiya et al. 2011</xref>
</td>
</tr>
<tr>
<td>Sister-chromatid exchange assay </td>
<td>Lymphocytes from human blood</td>
<td>Capsaicin in DMSO at 10 to 200 µM </td>
<td>Genotoxic </td>
<td>
<xref ref-type="bibr" rid="bibr119-0192623312444471">Marques et al. 2002</xref> </td>
</tr>
<tr>
<td>Induction of 8-azaguanine-resistant mutations </td>
<td>V79 Chinese hamster cells</td>
<td>Capsaicin in DMSO at 40 µg/mL</td>
<td>No induction of resistant colonies </td>
<td>
<xref ref-type="bibr" rid="bibr133-0192623312444471">Nagabhushan and Bhide 1985</xref>
</td>
</tr>
<tr>
<td>Ouabain- and 6-thioguanine-resistant mutagenicity</td>
<td>V79 Chinese hamster cells</td>
<td>Capsaicin at 1 to 10 µg/mL</td>
<td>Genotoxic</td>
<td>Lawson and Gannett <xref ref-type="bibr" rid="bibr98-0192623312444471">1989</xref>
</td>
</tr>
<tr>
<td>Mammalian cell mutation</td>
<td>L5178Y  mouse lymphoma cells</td>
<td>Capsaicin in DMSO Without activation: Up to 90 and 60 µg/mL for 4- and 24-hr exposures, respectively;  With activation: up to 24 µg/mL for 4-hr exposure </td>
<td>Weakly mutagenic with activation</td>
<td>Chanda et al. <xref ref-type="bibr" rid="bibr38-0192623312444471">2004</xref>
</td>
</tr>
<tr>
<td>
<italic>In vitro</italic> chromosomal aberration</td>
<td>Human peripheral blood lymphocytes</td>
<td>Capsaicin in DMSO Up to 128 µg/mL with/without activation</td>
<td>Non-genotoxic</td>
<td>
<xref ref-type="bibr" rid="bibr145-0192623312444471">Proudlock et al. 2004</xref>
</td>
</tr>
<tr>
<td>
<italic>In vitro</italic> chromosomal aberration</td>
<td>Human peripheral blood lymphocytes</td>
<td>Capsaicin in DMSO Up to123 µg/mL without activation, up to 192 µg/mL with activation</td>
<td>Non-genotoxic</td>
<td>Chanda et al. <xref ref-type="bibr" rid="bibr38-0192623312444471">2004</xref>
</td>
</tr>
<tr>
<td>DNA damage</td>
<td>Calf thymus and plasma DNA </td>
<td>Capsaicin (1 mM) </td>
<td>Strand breaks in presence Cu<sup>2+</sup>. After 6 hr, DNA degradation &lt;2%. DNA strand breakage mediated by reactive oxygen species</td>
<td>
<xref ref-type="bibr" rid="bibr162-0192623312444471">Singh et al. 2001</xref> </td>
</tr>
<tr>
<td>Cytokinesis-block <italic>in vitro</italic> micronucleus</td>
<td>Lymphocytes from human blood </td>
<td>Capsaicin in DMSO at 10 to 200 µM </td>
<td>Genotoxic</td>
<td>
<xref ref-type="bibr" rid="bibr119-0192623312444471">Marques et al. 2002</xref>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Bacterial point mutation tests (Ames assays; <xref ref-type="bibr" rid="bibr6-0192623312444471">Ames et al. 1975</xref>) were performed with and without metabolic activation using various strains of <italic>Salmonella typhimurium</italic>; seven of these tests resulted in negative responses and three in positive or weakly positive responses. Importantly, two most recently completed studies were conducted in compliance with Good Laboratory Practices and International Committee on Harmonization Guidelines (<xref ref-type="bibr" rid="bibr131-0192623312444471">Mueller et al. 1999</xref>) and used either highly pure synthetic capsaicin (Chanda et al. <xref ref-type="bibr" rid="bibr38-0192623312444471">2004</xref>) or highly purified capsaicin extracted from chili peppers (<xref ref-type="bibr" rid="bibr145-0192623312444471">Proudlock et al. 2004</xref>); data from these two studies appear to be of high quality and quite consistent. Chanda and colleagues (<xref ref-type="bibr" rid="bibr38-0192623312444471">2004</xref>) performed the Ames test with <italic>S. typhimurium</italic> TA1535, TA1537, TA98, and TA100, and <italic>Escherichia coli</italic> WP2<italic>uvr</italic>A, both in the absence and presence of metabolic activation, by both preincubation and plate incorporation methods. No mutagenic activity was observed in any of the five bacterial strains, in any of the activation conditions. Essentially identical results were reported by <xref ref-type="bibr" rid="bibr145-0192623312444471">Proudlock et al. (2004</xref>). <xref ref-type="bibr" rid="bibr177-0192623312444471">Tsuchiya et al. (2011</xref>) demonstrated mutagenicity of chili pepper extract in strain TA98, while pure capsaicin was inactive in the same assay; subsequent analysis of the chili pepper samples identified the presence of carcinogenic aflatoxins B1 and G1.</p>
<p>
<italic>In vitro </italic>chromosomal aberration assays using human peripheral blood lymphocytes (HBPLcs) were conducted twice using pure capsaicin. No significant increases in chromosomal aberrations, polyploidy, or endoreduplication were observed, with or without metabolic activation (Chanda et al. <xref ref-type="bibr" rid="bibr38-0192623312444471">2004</xref>; <xref ref-type="bibr" rid="bibr145-0192623312444471">Proudlock et al. 2004</xref>). Previously, capsaicin had been studied using HBPLcs in the cytokinesis-block micronucleus (CBMN) assay and the sister chromatid exchange (SCE) assay in the presence or absence of external metabolic activation (<xref ref-type="bibr" rid="bibr119-0192623312444471">Marques et al. 2002</xref>). Capsaicin induced the formation of micronuclei in a concentration-dependent manner in the CBMN assay; this increase was more evident in the absence of metabolic activation, with a maximum of 3.4-fold increase above the background. These results were interpreted by Marques et al. (<xref ref-type="bibr" rid="bibr119-0192623312444471">2002</xref>) to indicate that capsaicin is genotoxic.</p>
<p>Chanda and colleagues (<xref ref-type="bibr" rid="bibr38-0192623312444471">2004</xref>) found a positive result in the mouse lymphoma assay conducted with L5178Y tk<sup>+</sup>/tk<sup>−</sup> mouse lymphoma cells, in the absence and presence of metabolic activation. Capsaicin was found to be weakly mutagenic in the presence of S9, when tested at concentrations extending into the toxic range. Limited evidence of very weak activity was also noted in the absence of S9. However, the clinical significance of the weak positive result in the mouse lymphoma assay is unclear: the capsaicin molecule contains a catechol moiety, and other naturally occurring catechol compounds such as <sc>l</sc>-DOPA, dopamine, epinephrine, etc., have shown positive responses in mouse lymphoma assays despite the absence of carcinogenic potential (<xref ref-type="bibr" rid="bibr121-0192623312444471">McGregor et al. 1988</xref>).</p>
<p>Capsaicin was also reported to induce DNA strand breaks in human neuroblastoma cells SHSY-5Y (<xref ref-type="bibr" rid="bibr149-0192623312444471">Richeux et al. 1999</xref>). However, because of the established ability of capsaicin to selectively induce apoptosis in cancerous cells (discussed below), this study should not be considered as evidence for mutagenic potential and is not included in <xref ref-type="table" rid="table1-0192623312444471">Table 1</xref>. Point mutation tests in Chinese hamster V79 cells were conducted, resulting in positive (<xref ref-type="bibr" rid="bibr59-0192623312444471">Gannett et al. 1988</xref>; <xref ref-type="bibr" rid="bibr98-0192623312444471">Lawson and Gannett 1989</xref>) and negative (<xref ref-type="bibr" rid="bibr133-0192623312444471">Nagabhushan and Bhide 1985</xref>) responses. While a positive finding was reported for V79 mammalian cells by <xref ref-type="bibr" rid="bibr59-0192623312444471">Gannett et al. (1988</xref>), it was noted that a greater response was observed for red pepper extract as compared to pure capsaicin. Although V79 cells have been used in studies of DNA damage and repair and are not classified as cancerous cells, they share several properties with cancer cells (<xref ref-type="bibr" rid="bibr41-0192623312444471">Chaung et al. 1997</xref>). Therefore, data derived from V79 cells should be interpreted with caution for molecules such as capsaicin which can induce apoptosis in cancerous cells.</p>
</sec>
<sec id="section3-0192623312444471">
<title>
<italic>In Vivo </italic>Genotoxicity</title>
<p>Non-mutagenicity of capsaicin in albino mice was first shown by <xref ref-type="bibr" rid="bibr132-0192623312444471">Muralidhara (1988</xref>) upon intraperitoneal administration of pure capsaicin at doses up to 1.6 mg/kg (one-fifth of the LD<sub>50</sub> ). At least five <italic>in vivo</italic> micronucleus tests have been conducted with capsaicin in bone marrow cells from different strains of mice, yielding three negative and two positive results. <xref ref-type="bibr" rid="bibr133-0192623312444471">Nagabhushan and Bhide (1985</xref>) showed a positive result at a dose near the LD<sub>50</sub> but not at a lower dose (one quarter of the LD<sub>50</sub> ), but the capsaicin used was only 80% pure. <xref ref-type="bibr" rid="bibr16-0192623312444471">Arceo et al. (1995</xref>) also showed a significant increase in number of peripheral blood cells with micronuclei. The micronucleus assay was repeated by groups with &gt;98% pure capsaicin, both times yielding negative results: Chanda et al. (<xref ref-type="bibr" rid="bibr38-0192623312444471">2004</xref>) administered capsaicin orally to male mice at dose levels up to 800 mg/kg and females received 200 mg/kg; <xref ref-type="bibr" rid="bibr145-0192623312444471">Proudlock et al. (2004</xref>) administered capsaicin subcutaneously using an escalating dosing regime up to 500 mg/kg. Earlier, <xref ref-type="bibr" rid="bibr184-0192623312444471">Villaseñor et al. (1993</xref>) had also shown that capsaicin at a maximum tolerable dose of 1.22 mg/kg (intraperitoneally) was not mutagenic in the same assay. In another study, <xref ref-type="bibr" rid="bibr50-0192623312444471">De et al. (1995</xref>) showed that capsaicin significantly inhibited cyclophosphamide-induced chromosomal aberrations and DNA strand breakages in bone marrow cells of Swiss albino mice. These groups concluded that capsaicin was non-clastogenic. The results for nine <italic>in vivo</italic> genotoxicity studies are briefly summarized in <xref ref-type="table" rid="table2-0192623312444471">Table 2</xref>.</p>
<table-wrap id="table2-0192623312444471" position="float">
<label>Table 2.</label>
<caption>
<p>
<italic>In vivo</italic> genotoxicity assays with capsaicin.</p>
</caption>
<graphic alternate-form-of="table2-0192623312444471" xlink:href="10.1177_0192623312444471-table2.tif"/>
<table>
<thead>
<tr>
<th>Assay</th>
<th>Cell type/source</th>
<th>Dosing conditions</th>
<th>Results</th>
<th>References</th>
</tr>
</thead>
<tbody>
<tr>
<td>
<italic>In vivo</italic> chromosomal aberrations</td>
<td>Bone marrow cells from Swiss albino inbred mice</td>
<td>Capsaicin in Tween 80/ethanol/saline, at 0.42, 1.68, or  3.36 mg/kg, i.p. followed by cyclophosphamide </td>
<td>Inhibited cyclophosphamide-induced chromosomal aberrations and DNA strand breakages</td>
<td>
<xref ref-type="bibr" rid="bibr50-0192623312444471">De et al. 1995</xref>
</td>
</tr>
<tr>
<td>
<italic>In vivo</italic> DNA damage</td>
<td>Bone marrow cells from Swiss albino inbred mice</td>
<td>Capsaicin in Tween 80/ethanol/saline, at 0.42, 1.68, or  3.36 mg/kg, i.p. followed by cyclophosphamide</td>
<td>No significant effect on DNA breakage. DNA breakage increased with cyclophosphamide exposure </td>
<td>
<xref ref-type="bibr" rid="bibr50-0192623312444471">De et al. 1995</xref> </td>
</tr>
<tr>
<td>Sister chromatid exchange assay </td>
<td>Bone marrow cells from male NIH mice</td>
<td>Capsaicin in DMSO at 1.46 and 1.94 mg/kg, i.p. (latter was 1/15 of LD<sub>50</sub> )</td>
<td>Moderate but significant increase in frequency of sister-chromatid exchanges in 1.94 mg/kg dose group, but within control range at 1.46 mg/kg </td>
<td>
<xref ref-type="bibr" rid="bibr16-0192623312444471">Arceo et al. 1995</xref>
</td>
</tr>
<tr>
<td>
<italic>In vivo</italic> micronucleus</td>
<td>Bone marrow cells from male Swiss mice</td>
<td>Capsaicin in DMSO at 1.8 and 7.5 mg/kg, i.p.</td>
<td>Significant increase in incidence micronuclei at 7.5 but not 1.8 mg/kg</td>
<td>Nagabushan and Bhide 1985</td>
</tr>
<tr>
<td>
<italic>In vivo</italic> Micronucleus</td>
<td>Bone marrow cells from male NIH mice</td>
<td>Capsaicin in DMSO at i.p. doses of 1.46 and 1.94 mg/kg, i.p. (latter was 1/15 of LD<sub>50</sub> )</td>
<td>At 1.46 mg/kg, statistically significant  increase in micronuclei only at last day of sampling.  Significant, constant increase micro-nucleated cells at 1.94 mg/kg</td>
<td>
<xref ref-type="bibr" rid="bibr16-0192623312444471">Arceo et al. 1995</xref>
</td>
</tr>
<tr>
<td>
<italic>In vivo</italic> micronucleus</td>
<td>Bone marrow cells from Swiss Webster albino mice</td>
<td>Capsaicin in DMSO at 1.22 mg/kg, i.p.</td>
<td>Not mutagenic</td>
<td>Villaseñor  et al. 1993  </td>
</tr>
<tr>
<td>
<italic>In vivo</italic> micronucleus</td>
<td>Bone marrow cells from adult CD outbred albino Sprague-Dawley rats</td>
<td>Capsaicin in ethanol/Tween 80/saline, dosed up to 500 mg/kg, s.c.</td>
<td>Non-genotoxic</td>
<td>
<xref ref-type="bibr" rid="bibr145-0192623312444471">Proudlock et al. 2004</xref>
</td>
</tr>
<tr>
<td>
<italic>In vivo</italic> micronucleus</td>
<td>Bone marrow cells from CD-1 mice</td>
<td>Capsaicin in 0.5% carboxymethylcellulose (CMC) using a 0 hr + 24 hr oral dosing</td>
<td>Non-genotoxic at 800 mg/kg/day in male and 200 mg/kg/day in female</td>
<td>Chanda et al. <xref ref-type="bibr" rid="bibr38-0192623312444471">2004</xref>
</td>
</tr>
<tr>
<td>
<italic>In vivo</italic> sperm morphology assay and dominant-lethal test</td>
<td>Adult male Swiss albino mice</td>
<td>Capsaicin in DMSO, i.p. doses up to 1.6 mg/kg/day (1/5 LD<sub>50</sub> )<sub>  </sub> </td>
<td>No effect on epididymal sperm count and sperm-head abnormalities. Pregnancy index, number of implants or live embryos per male, number of postimplantation deaths per male unaffected</td>
<td>Muralidhara and Narasimhamurthy 1988</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>These <italic>in vitro</italic> and <italic>in vivo</italic> results point to the absence of genotoxic activity of high-purity capsaicin, even with metabolic activation. It is possible that the genotoxic activity observed in some of the studies was associated with other compounds or mutagenic impurities in the test articles, as is suggested by the results of <xref ref-type="bibr" rid="bibr177-0192623312444471">Tsuchiya et al. (2011</xref>). Moreover, at the high concentrations used in some of these assays, capsaicin itself displays antimicrobial activities and induces cytotoxicity—properties which are shared with many other naturally occurring phenolic and flavonoid compounds (<xref ref-type="bibr" rid="bibr136-0192623312444471">Ozçelik et al. 2011</xref>).</p>
</sec>
<sec id="section4-0192623312444471">
<title>
<italic>In Vivo </italic>Carcinogenicity</title>
<p>Fewer investigations of the carcinogenic potential of capsaicin in <italic>in vivo </italic>animal models (<xref ref-type="table" rid="table3-0192623312444471">Table 3</xref>) are reported, in contrast to the numerous genotoxicity studies. Capsaicin-containing materials tested in these studies were always natural extracts and never highly pure capsaicin, with exception of the Tg.AC mouse study (<xref ref-type="bibr" rid="bibr39-0192623312444471">Chanda et al. 2007</xref>).</p>
<table-wrap id="table3-0192623312444471" position="float">
<label>Table 3.</label>
<caption>
<p>Studies evaluating capsaicin in <italic>in vivo</italic> carcinogenicity models.</p>
</caption>
<graphic alternate-form-of="table3-0192623312444471" xlink:href="10.1177_0192623312444471-table3.tif"/>
<table>
<thead>
<tr>
<th>Test Species</th>
<th>Capsaicin dose and duration</th>
<th>Results</th>
<th>Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td>Swiss albino mice</td>
<td>0.0625, 0.125, 0.25, 0.5 and 1% in diet for 35 days and held for life</td>
<td>One female at 0.0625%, one male at 0.125%, one male at 0.25%, and one male at 0.5% developed adenocarcinomas of the duodenum Duodenal tumors were not found at the highest dose level and control results were not provided Results were not statistically significant</td>
<td>
<xref ref-type="bibr" rid="bibr174-0192623312444471">Toth et al. 1984</xref>
</td>
</tr>
<tr>
<td>Swiss albino mice</td>
<td>0.03125% in diet (contained 65% capsaicin) for life</td>
<td>Polypoid adenomas of the cecum were found in 11/50 females and 7/50 males versus 4/50 in untreated females and 4/50 untreated males. They were not reported as statistically significantly different. The few duodenal tumors found were not attributed to capsaicin exposure Tumors classified as benign polypoid adenomas</td>
<td><xref ref-type="bibr" rid="bibr172-0192623312444471">Toth and Gannett 1992</xref></td>
</tr>
<tr>
<td>B6C3F1 mice</td>
<td>64.5% capsaicin and 32.6% dihydrocapsaicin, in diet at 0.0025, 0.083 or 0.25% for 79 weeks</td>
<td>Number of females in the high-dose groups with tumors were significantly lower than in controls Incidence of hepatocellular neoplasms negatively correlated with capsaicinoid dose in both males and females</td>
<td>
<xref ref-type="bibr" rid="bibr2-0192623312444471">Akagi et al. 1998</xref>
</td>
</tr>
<tr>
<td>Tg.AC mice</td>
<td>Pure capsaicin solubilized, applied topically, up to 102 mg/kg, at 25.6 mg/cm<sup>2</sup>/kg/week for 26 weeks</td>
<td>No increase in the number of tumors per animal or number of tumor-bearing mice in capsaicin-treated mice relative to concurrent vehicle or untreated controls No increase in pre-neoplastic skin lesions or in neoplasms at other sites</td>
<td>
<xref ref-type="bibr" rid="bibr39-0192623312444471">Chanda et al. 2007</xref>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Capsaicin was administered at concentrations of 1, 0.5, 0.25, 0.125, and 0.0625% in powdered diet for 35 days to five groups (four/sex/group) of Swiss albino mice (<xref ref-type="bibr" rid="bibr174-0192623312444471">Toth et al. 1984</xref>). Capsaicin had no effect on survival. Three males and one female developed adenocarcinomas of the duodenum (one tumor in each of the four lowest capsaicin dose level groups), while no such tumors occurred in the highest dose level group. No direct comparison with capsaicin-treated controls was possible, as data for control groups were presented in another report (<xref ref-type="bibr" rid="bibr173-0192623312444471">Toth et al. 1980</xref>). Pathological descriptions of the tumors were not provided. In a subsequent study using fifty animals/sex/group, capsaicin was administered in a semisynthetic powdered diet at 0.03125% level (the capsaicin extract contained 65% capsaicin) for the lifespan of Swiss albino mice, starting from 6 weeks of age (Toth and Gannett 1992). Again, capsaicin had no effect on survival. Adenocarcinomas of the duodenum were not seen in females and the one tumor in the males was not considered related to capsaicin. The authors also noted that duodenal tumors were not significantly increased in their previous (<xref ref-type="bibr" rid="bibr174-0192623312444471">Toth et al. 1984</xref>) study. Instead, benign polypoid adenomas of the cecum were considered to be increased, with 7/50 in treated males versus 4/50 in the control males and 11/50 in treated females versus 4/40 in the control females.</p>
<p>
<xref ref-type="bibr" rid="bibr132-0192623312444471">Muralidhara (1988</xref>) administered intraperitoneally capsaicin to adult male mice at 0.4, 0.8, or 1.6 mg/kg body weight/day (1/20, 1/10, or 1/5 of the LD<sub>50</sub> ) on five consecutive days; these doses did not induce any clinical signs of toxicity. No significant alterations were observed in epididymal weights, caudal sperm counts, testicular weights, or testicular histology. In the sperm morphology assay, sperms at 1, 3, 5, and 7 weeks did not reveal any treatment-related increase in the incidence of sperm head abnormalities. Capsaicin also failed to induce dominant lethal mutations during an 8-week sequential mating schedule of males treated at the highest dose level.</p>
<p>
<xref ref-type="bibr" rid="bibr2-0192623312444471">Akagi et al. (1998</xref>) evaluated the carcinogenicity of a mixture of 64.5% capsaicin and 32.6% dihydrocapsaicin using groups of fifty male and female B6C3F1 mice fed 0.025%, 0.083%, and 0.25% capsaicinoids for 79 weeks, and then a standard diet for 4 weeks. No effect on survival was seen and body weights were lower in females in a dose-related fashion. The numbers of tumor-bearing females in the high-dose groups were significantly lower than the controls, and the incidences of hepatocellular neoplasms in both sexes were negatively correlated with the dose of capsaicinoids. The authors concluded that a mixture of capsaicinoids was not carcinogenic in B6C3F1 mice.</p>
<p>The dermal carcinogenic potential of pure synthetic capsaicin was evaluated in the Tg.AC transgenic mouse model (<xref ref-type="bibr" rid="bibr39-0192623312444471">Chanda et al. 2007</xref>). Capsaicin was administered weekly via topical application to the dorsal skin of 25/group of male and female Tg.AC mice for 26 weeks. The positive control tetradecanoylphorbol-13-acetate (TPA), was dosed twice per week. Analysis of the macroscopic observations after the final sacrifice revealed no noteworthy treatment-related findings. The frequency of dermal masses in the capsaicin-treated groups (at dose levels of up to 102.4 mg/kg and an application rate of 25.6 mg/cm<sup>2</sup>/kg/week) was not elevated in comparison to either concurrent vehicle or untreated controls. Increased incidence of dermal masses was observed in the TPA-treated mice compared to both control groups. Topical application of capsaicin resulted in no increased incidence of pre-neoplastic or neoplastic skin lesions. Spontaneously occurring neoplasms were also not increased in capsaicin-treated animals. Capsaicin-related non-neoplastic microscopic findings were seen sporadically in males and females and included acanthosis, hyperkeratosis/parakeratosis, epidermal crusts, subepidermal fibrosis, epidermal ulcerations/erosions, and chronic-active inflammation. No evidence of a dose response in either the incidence or severity of these findings was found and the authors concluded that capsaicin was non-oncogenic in the Tg.AC dermal mouse model.</p>
</sec>
<sec id="section5-0192623312444471">
<title>Co-Carcinogenicity, Multiple-Stage, and Anticarcinogenicity Models</title>
<p>Studies on the activity of capsaicin in <italic>in vivo</italic> co-carcinogenicity, multiple-stage, and anticarcinogenicity models are summarized briefly in <xref ref-type="table" rid="table4-0192623312444471">Table 4</xref>, and selected publications are discussed below. Studies with chili pepper extracts have generally been excluded. For instance, Agrawal conducted a large study in BALB/c mice (<xref ref-type="bibr" rid="bibr1-0192623312444471">Agrawal et al. 1986</xref>). However, the source of the capsaicin extract was dried chilies purchased from a local market in India. As discussed below in context of human epidemiological studies, known carcinogens have been found in chilies from India (<xref ref-type="bibr" rid="bibr161-0192623312444471">Siddiqi et al. 1988</xref>) and Chile (<xref ref-type="bibr" rid="bibr177-0192623312444471">Tsuchiya et al. 2011</xref>).</p>
<table-wrap id="table4-0192623312444471" position="float">
<label>Table 4.</label>
<caption>
<p>Studies on capsaicin in <italic>in vivo</italic> co-carcinogenicity, multiple-stage, and anticarcinogenicity models.</p>
</caption>
<graphic alternate-form-of="table4-0192623312444471" xlink:href="10.1177_0192623312444471-table4.tif"/>
<table>
<thead>
<tr>
<th>Test species</th>
<th>Key methods and results</th>
<th>Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td>Female CD-1 mice</td>
<td>Following initiation by DMBA for 1 week, no inhibition by topical capsaicin (2%) on incidence or rate of TPA-induced tumor formation Photographs suggested enhancement of TPA-induced tumor development rate</td>
<td>
<xref ref-type="bibr" rid="bibr97-0192623312444471">LaHann 1986</xref>
</td>
</tr>
<tr>
<td>NIH (GP) mice</td>
<td>Single dose 1 mg BP or 40 µg DMBA (s.c.) after birth and then 0.01% capsaicin in diet for 6 weeks after weaning At 9 weeks, capsaicin significantly inhibited frequency of tumor-bearing mice (BP-treated) and mean number of tumors (DMBA-treated)</td>
<td>
<xref ref-type="bibr" rid="bibr80-0192623312444471">Jang et al. 1989</xref>
</td>
</tr>
<tr>
<td>Male Fisher-344 rats</td>
<td>Sequential pretreatment with DEN (100 mg/kg, i.p.), MNU (20 mg/kg, i.p.) then DBN (0.05% in drinking water) Diet containing 0.01% capsaicin for 20 weeks inhibited GST-P+ hepatic foci, decreased incidence adenoma of the lung, and increased incidence of papillary or nodular hyperplasia in urinary bladder</td>
<td>
<xref ref-type="bibr" rid="bibr79-0192623312444471">Jang et al. 1991</xref>
</td>
</tr>
<tr>
<td>Female ICR mice Female CD-1 mice</td>
<td>Topical pretreatment with 2.5 µmol reduced VC-induced (5.8 mol) and TPA-promoted tumor incidence (by 62%) at 22 weeks (ICR) 1 µmol topical capsaicin 24 and 1 hr before, also significantly inhibited tumors induced by topical BP (0.3 µmol) then promoted with TPA (CD-1)</td>
<td><xref ref-type="bibr" rid="bibr166-0192623312444471">Surh, Lee, et al. 1995</xref></td>
</tr>
<tr>
<td>Female ICR mice</td>
<td>No significant increase in skin tumors with either single topical application of 10 µmol capsaicin followed by twice-weekly applications of TPA for 22 weeks or twice weekly application for 22 weeks following initiation by 0.2 µmol of DMBA Capsaicin 30 min prior to each DMBA treatment lowered incidence of tumors by 22% at Week 15</td>
<td><xref ref-type="bibr" rid="bibr140-0192623312444471">Park and Surh 1997</xref></td>
</tr>
<tr>
<td>Female ICR mice</td>
<td>Repeated applications (10 µmol) following a single initiating dose of DMBA No increase in papilloma formation and abnormal hyperplastic or inflammatory skin lesions Did not induce the epidermal ornithine decarboxylase activity, suggesting lacks tumor-promotional activity Ameliorated mouse skin carcinogenesis when given simultaneously with the tumor promoter TPA</td>
<td>
<xref ref-type="bibr" rid="bibr139-0192623312444471">Park et al. 1998</xref>
</td>
</tr>
<tr>
<td>Female A/J mice</td>
<td>21 weeks of 5 mg/kg oral not significantly reduce number NNK-induced lung tumors Capsaicin alone not affect spontaneous formation lung tumors</td>
<td>
<xref ref-type="bibr" rid="bibr170-0192623312444471">Teel and Huynh 1999</xref>
</td>
</tr>
<tr>
<td>Male Fisher-344 rats</td>
<td>20 ppm in food and 1 ppm in water modulated MNNG-stimulated <italic>c-jun</italic> induction in liver spleen heart and lung, but not kidney, stomach and intestine</td>
<td>
<xref ref-type="bibr" rid="bibr92-0192623312444471">Kim et al. 1999</xref>
</td>
</tr>
<tr>
<td>Male Fisher-344 rats</td>
<td>Gavage with capsaicin significantly elevated phase II enzymes in liver and colon Oral capsaicin at 500 ppm for 4 weeks significantly inhibited ACF formation induced by AOM (20 mg/kg body weight, once a week for 2 weeks) In a 38-week study, 500 ppm capsaicin during the 4-week initiation phase significantly reduced (60%) incidence of colonic adenocarcinoma</td>
<td>
<xref ref-type="bibr" rid="bibr191-0192623312444471">Yoshitani et al. 2001</xref>
</td>
</tr>
<tr>
<td>Male Fisher-344 rats</td>
<td>10 weeks of 500 ppm capsaicin in food with 4-NQO exposure inhibited tongue dysplasia In 38-week study, 20 ppm 4-NQO in water for 8 weeks followed by 4-NQO plus 500 ppm capsaicin, trend toward reduction of frequency of tongue carcinoma and apoptotic index of tongue carcinoma increased</td>
<td>
<xref ref-type="bibr" rid="bibr169-0192623312444471">Tanaka et al. 2002</xref>
</td>
</tr>
<tr>
<td>Swiss albino mice</td>
<td>BP (50 mg/kg, p.o.) twice weekly for 4 weeks increased lysosomal enzyme activities and oxidative stress, altered phase I and II enzymes, increased serum tumor markers, changed body weight, and tumor incidences Capsaicin (10 mg/kg, i.p.) 1 week prior to first BP dose for 14 weeks generally reversed all reported BP-induced changes, attenuated abnormalities and restored normal values</td>
<td>
<xref ref-type="bibr" rid="bibr8-0192623312444471">Anandakumar et al. 2008</xref>; Anandakumar et al. <xref ref-type="bibr" rid="bibr9-0192623312444471">2008a</xref>, 2008b; Anandakumar et al.2009a, 2009b; Anandakumar, Jagan, Kamaraj, et al. <xref ref-type="bibr" rid="bibr14-0192623312444471">2009</xref>; Anandakumar, Kamaraj, Ramakrishnan, et al. <xref ref-type="bibr" rid="bibr15-0192623312444471">2009</xref>; Anandakumar, P., Kamaraj, S., Jagan, S., Ramakrishnan, G., Naveenkumar, et al. 2009</td>
</tr>
<tr>
<td>B6 mice</td>
<td>DMBA-initiated and TPA-promoted TRPV1 WT mice showed more tumors than KO mice DMBA-initiated mice showed no tumors with topical capsaicin applications Capsaicin co-administration enhanced TPA-promoted tumors</td>
<td>
<xref ref-type="bibr" rid="bibr29-0192623312444471">Bode et al. 2009</xref>; <xref ref-type="bibr" rid="bibr74-0192623312444471">Hwang et al. 2010</xref>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0192623312444471">
<p>Abbreviations: ACF, aberrant crypt foci; AOM, azoxymethane; BP, benzo(a)pyrene; DBN, <italic>N,N</italic>-dibutylnitrosamine; DEN, diethylnitrosamine; DMBA, 9,10-demethyl-1,2-benzanthracene; HCAs, heterocyclic amines; KO, knock-out; MNNG, <italic>N</italic>-Methyl-<italic>N'</italic>-nitro-N-nitrosoguanidine; MNU, N-methylnitrosourea, NDMA, <italic>N</italic>-nitrosodimethylamine; NNK, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; 4-NQO, 4-nitroquinoline 1-oxide; TPA, 12-<italic>O</italic>-tetradecanoylphorbol-13-acetate; VC, vinyl carbamates; WT, wild-type.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>
<xref ref-type="bibr" rid="bibr97-0192623312444471">LaHann (1986</xref>) evaluated the effect of capsaicin on TPA-induced tumorigenesis in the skin of CD-1 mice in which 25 nmol 7,12-dimethylbez(a)-arthracene (DMBA) was applied for 7 days during the initiation phase. Mice were then treated twice weekly with 10 nmol TPA or vehicle, and one group was also treated with capsaicin (13.5 µmol) 0.5, 1.5, and 24 hr prior to each TPA dose. The rate and incidence of papillomas were recorded weekly for 20 weeks. Capsaicin did not reduce the incidence or rate of TPA-induced tumor formation but may have reduced the time required for tumor development.</p>
<p>Newborn Swiss Webster mice were injected subcutaneously with 1 mg of benzo(a)pyrene BP or 40 µg of DMBA to study lung carcinogenesis (<xref ref-type="bibr" rid="bibr80-0192623312444471">Jang et al. 1989</xref>). Capsaicin was dissolved in dimethyl sulfoxide (DMSO) and included in food pellets at 0.01% for 6 weeks after weaning, with an average daily intake of about 13–18 mg/kg. Capsaicin had reduced significantly the mean number of lung tumors in both BP- and DMBA-treated animals at 9 weeks after birth. The same author (<xref ref-type="bibr" rid="bibr79-0192623312444471">Jang et al. 1991</xref>) evaluated the effect of capsaicin on F344 rats pretreated with three carcinogens (diethylnitrosamine [DEN], <italic>N,N</italic>-dibutylnitrosamine [DBN] and <italic>N</italic>-methylnitrosourea [MNU]). The rats were initially administered a single dose of DEN (100 mg/kg, i.p.), then MNU (20 mg/kg, i.p.) on days 2, 5, 8, and 11, and then DBN was at 0.05% in drinking water during weeks 3 and 4. A diet containing capsaicin (0.01%) until week 20 significantly inhibited the induction of glutathione S-transferase π hepatic foci, significantly decreased the incidence of lung adenoma (from 56% to 13%), but enhanced the incidence of papillary or nodular hyperplasia of the urinary bladder. Incidences of carcinogen-induced lesions of the thyroid and kidney were not significantly altered by capsaicin.</p>
<p>Surh, Lee, and colleagues have been key contributors to the examination of the pro- and anticarcinogenic potential of capsaicin. <xref ref-type="bibr" rid="bibr166-0192623312444471">Surh, Lee, et al. (1995)</xref> studied the antitumorigenicity of capsaicin using Imprinting control region (ICR) mice. Capsaicin (2.5 µmol) in 0.2 ml acetone was applied 10 min prior to topical application of vinyl carbamate (VC; 5.8 µmol), which was followed by promotion with TPA. Pretreatment with capsaicin lowered tumor multiplicity by 62%. One µmol topical capsaicin 24 and 1 hr before initiation by topical BP (0.3 µmol) and then promoted with TPA also significantly reduced the number of tumors. <xref ref-type="bibr" rid="bibr140-0192623312444471">Park and Surh (1997)</xref> evaluated the tumor initiating and promotional effects of capsaicin using female ICR mice. Topical capsaicin (10 µmol) followed by treatment with TPA for 22 weeks did not produce an increase in the incidence and multiplicity of skin papillomas. In the same paper, after initiation with DMBA, capsaicin was applied topically twice weekly for 22 weeks, again with no significant enhancement of skin tumor formation. In another experiment, treatment with capsaicin 30 min prior to each topical application of TPA lowered the incidence of DMBA-initiated mouse skin tumors by 22% at week 15 (the multiplicity of skin tumors was only slightly affected). In a study by the same group under similar conditions in female ICR mice (<xref ref-type="bibr" rid="bibr139-0192623312444471">Park et al. 1998</xref>), a single topical application of DMBA was used for initiation. At 1 week after initiation, controls or capsaicin (10 µmol) were applied twice weekly for 22 weeks. One group received simultaneously TPA and capsaicin during the promotion stage. In addition to tumor counts, induction of epidermal ornithine decarboxylase (ODC) activity was evaluated as a marker of tumor promotion. Neither capsaicin alone nor combined with DMBA resulted in increased papillomas. Compared to the DMBA-TPA group, simultaneous application of capsaicin and TPA after DMBA initiation resulted in a slightly higher tumor incidence and multiplicity during the first 12 weeks of tumor promotion (no statistics provided), but then the tumor count was clearly reduced after the first 12 weeks. Microscopic examination indicated that capsaicin did not alter the morphological features of untreated skin, while TPA resulted in striking changes, including epithelial hyperplasia and chronic dermal inflammation. Application of capsaicin did not cause any increase in ODC activity, while TPA caused a dramatic increase which was not reversed with capsaicin.</p>
<p>Female A/J mice were dosed intragastrically with capsaicin (5 mg/kg, in 0.2 mL corn oil or corn oil alone) for 3 consecutive days (<xref ref-type="bibr" rid="bibr170-0192623312444471">Teel and Huynh 1999</xref>). In both groups, the last dose was followed by a single i.p. injection of 10 µmol NNK. A small but not statistically significant decrease in lung tumors in the capsaicin-dosed animals was observed after 21 weeks.</p>
<p>
<xref ref-type="bibr" rid="bibr92-0192623312444471">Kim et al. (1999</xref>) evaluated the effects of capsaicin on <italic>N</italic>-methyl-<italic>N’</italic>-nitro-<italic>N</italic>-nitrosoguanidine (MNNG)-induced c-<italic>jun </italic>proto-oncogene expression in male Fisher-344 rats. Rats were fed a capsaicin-containing (20 ppm) diet for 13-weeks. After 6 weeks, some rats were dosed orally with MNNG (200 mg/kg) via gavage. In another 6-week study presented in the same paper, rats were given a single oral dose of MNNG (200 mg/kg) via gavage, and then at 1 week post-dosing, capsaicin (20 ppm) was given to half the animals. MNNG enhanced c-<italic>jun </italic>expression 1.5- to 3.0-fold in tissues of the spleen, heart, and intestine; however, c-<italic>jun </italic>transcripts were reduced in the liver, kidney, stomach, and lung. Capsaicin decreased c-<italic>jun </italic>mRNA levels in most organs, except for the spleen and intestine, with the most significant transcription reductions in the stomach and liver. <xref ref-type="bibr" rid="bibr92-0192623312444471">Kim et al. (1999</xref>) suggested that capsaicin uptake in the diet could play a role in inhibition of tumorigenesis induced by MNNG.</p>
<p>
<xref ref-type="bibr" rid="bibr29-0192623312444471">Bode et al. (2009</xref>) reported a striking increase in skin carcinogenesis in TRPV1 knock-out (TRPV1<sup>-/-</sup>) mice in a two-stage carcinogenesis experiment. When TRPV1<sup>-/-</sup> mice were initiated with DMBA and then promoted with TPA over 21 weeks, a significant enhancement of tumor development relative to wild-type controls was found. Subsequently, the same group (<xref ref-type="bibr" rid="bibr74-0192623312444471">Hwang et al. 2010</xref>) showed that capsaicin did not induce tumors when applied topically to DMBA-initiated mice twice a week for 21 weeks, as treatment with only capsaicin or vehicle did not induce any skin tumors in either wild-type or TRPV1-knockout mice. Tumors appeared only following treatment with TPA, with the combination of TPA and capsaicin producing even more tumors than TPA alone. Unfortunately for the interpretation of these data, the potential effects of variable skin pharmacokinetics of TPA were not evaluated. Capsaicin is known to enhance delivery of compounds into skin, with efficacy similar to the widely used skin penetration enhancer Azone<sup>®</sup> (<xref ref-type="bibr" rid="bibr51-0192623312444471">Degim et al. 1999</xref>; <xref ref-type="bibr" rid="bibr137-0192623312444471">Parhi et al. 2011</xref>). Hence it is possible that the putative tumor promotion by capsaicin was due to increased delivery of TPA and not a direct effect of capsaicin. Regarding the ability of TRPV1 to make mouse skin more susceptible to the effect of either TPA or TPA plus capsaicin, it must be remembered that activation of TRPV1 produces a neurovascular response associated with increased skin blood flow (<xref ref-type="bibr" rid="bibr61-0192623312444471">Geppetti et al. 2008</xref>). TPRV1 knock-out mice do not respond to capsaicin (<xref ref-type="bibr" rid="bibr35-0192623312444471">Caterina et al. 2000</xref>) and in consequence may be missing enhancement of drug clearance from skin due to capsaicin-mediated blood flow increases. It is possible that TPA remains longer in the skin of TRPV1 knockout mice, resulting in increased tumor formation. None of these pharmacokinetic complexities were considered in a recent review of these data (<xref ref-type="bibr" rid="bibr30-0192623312444471">Bode and Dong 2011</xref>).</p>
<p>The effects of dietary capsaicin on azoxymethane (AOM)-induced colon tumorigenesis were investigated in male F344 rats (<xref ref-type="bibr" rid="bibr191-0192623312444471">Yoshitani et al. 2001</xref>). Gavage with capsaicin significantly elevated phase II enzymes (glutathione <italic>S</italic>-transferase and quinone reductase) in the liver and colon. In an aberrant crypt foci (ACF) bioassay, feeding of capsaicin at 500 ppm for 4 weeks significantly inhibited ACF formation induced by AOM (20 mg/kg body weight, once a week for 2 weeks). In a subsequent long-term study designed to examine possible protective effects on ACF development, groups were treated with AOM alone or AOM plus 500 ppm capsaicin for 4 weeks (initiation phase) and for 34 weeks (post-initiation phase). Capsaicin during the initiation phase was found to significantly reduce (by 60%, relative to controls) the incidence of colonic adenocarcinoma. The same group next studied the effects of dietary capsaicin on 4-nitroquinoline 1-oxide (4-NQO)-induced tongue tumorigenesis in male F344 rats (<xref ref-type="bibr" rid="bibr169-0192623312444471">Tanaka et al. 2002</xref>). Ten weeks of feeding 500 ppm capsaicin together with 4-NQO inhibited the occurrence of tongue dysplasia. In a subsequent long-term study, groups were treated with 4-NQO alone (20 ppm in drinking water for 8 weeks) or 4-NQO plus 500 ppm capsaicin in diet for 10 weeks (initiation phase) or for 28 weeks (post-initiation phase). At the termination of the study (38 weeks), capsaicin feeding during either the initiation or promotion phase reduced the frequency of tongue squamous cell papillomas and squamous cell carcinomas (NQO alone, 9/15 rats with tongue tumors; NQO plus 10 weeks capsaicin, 5/17 rats with tongue tumors [not significant]; NQO plus 28 weeks of capsaicin, 3/14 rats with tongue tumors [p&lt;0.05]).</p>
<p>In a series of closely related experiments using Swiss albino mice, capsaicin was shown to exert its chemoprotective effects via several different mechanisms against benzo(a)pyrene (BP)-induced lung cancer (<xref ref-type="bibr" rid="bibr8-0192623312444471">Anandakumar et al. 2008</xref>; Anandakumar et al. <xref ref-type="bibr" rid="bibr9-0192623312444471">2008a</xref>, <xref ref-type="bibr" rid="bibr10-0192623312444471">2008b</xref>; Anandakumar et al.<xref ref-type="bibr" rid="bibr11-0192623312444471">2009a</xref>, <xref ref-type="bibr" rid="bibr12-0192623312444471">2009b</xref>; Anandakumar, Jagan, Kamaraj, et al. <xref ref-type="bibr" rid="bibr13-0192623312444471">2009</xref>; Anandakumar, Kamaraj, Ramakrishnan, et al. <xref ref-type="bibr" rid="bibr13-0192623312444471">2009</xref>; Anandakumar, P., Kamaraj, S., Jagan, S., Ramakrishnan, G., Naveenkumar, et al. 2009). Due to the closely related nature of methods and somewhat overlapping results, key results from all 8 publications are grouped into one entry in <xref ref-type="table" rid="table4-0192623312444471">Table 4</xref>. In this model, BP was administered orally (50 mg/kg) twice a week for 4 weeks. Capsaicin treatment (10 mg/kg, i.p.) was initiated one week prior to the first dose of BP and continued once a week for 14 weeks, with outcomes appearing in separate publications. Generally, capsaicin reversed all BP-induced changes. For instance, capsaicin prevented pronounced oxidative damage caused by BP to biomolecules, preserved lysosomal stability, restored the activities of phase I and II biotransformation enzymes and the levels of tumor markers to near normalcy. BP-induced lung cancer animals showed abnormal changes in body weight, tumor incidence, low blood glucose and alterations in lipid levels, all of which were significantly reversed by capsaicin (Anandakumar et al. 2008; Anandakumar et al. 2008a, 2008b; Anandakumar et al.2009a, 2009b; Anandakumar, Jagan, Kamaraj, et al. 2009; Anandakumar, Kamaraj, Ramakrishnan, et al. 2009; Anandakumar, P., Kamaraj, S., Jagan, S., Ramakrishnan, G., Naveenkumar, et al. 2009).</p>
<p>These studies in which rodents were exposed to multiple compounds support the conclusion that capsaicin alone produces little to no increase in tumor incidence or multiplicity. When administered in combination with known carcinogenic substances, in almost all cases, capsaicin either reduced tumors or did not potentiate them. The only exception to this conclusion is the study of <xref ref-type="bibr" rid="bibr74-0192623312444471">Hwang et al. (2010</xref>), which unfortunately fails to take into account indirect effects on dermal delivery and retention of the administered tumor promoter TPA. In order to substantiate a direct effect of capsaicin on tumor formation in this or in any other model, levels of carcinogens in the skin should be quantified and be comparable in the various treatment groups.</p>
</sec>
<sec id="section6-0192623312444471">
<title>Metabolism, cyp Inhibition and Antimutagenicity</title>
<p>The <italic>in vitro</italic> metabolism of capsaicin has been investigated extensively and a number of metabolites have been characterized. A compilation of potential capsaicin metabolites are shown in <xref ref-type="fig" rid="fig1-0192623312444471">Figure 1</xref>, based on figures which appeared in Surh and Lee (1995), <xref ref-type="bibr" rid="bibr148-0192623312444471">Reilly and Yost (2006</xref>), and Chanda et al. (<xref ref-type="bibr" rid="bibr37-0192623312444471">2008</xref>). It is important to note that while the metabolites depicted in <xref ref-type="fig" rid="fig1-0192623312444471">Figure 1</xref> have been reported under <italic>in vitro</italic> or <italic>ex vivo</italic> conditions, the <italic>in vivo</italic> metabolism of capsaicin in humans or animals following experimental, dietary, environmental or medical exposure has not been thoroughly investigated.</p>
<fig id="fig1-0192623312444471" position="float">
<label>Figure 1.</label>
<caption>
<p>Compilation of all reported potential capsaicin metabolites, based on Surh and Lee (1995), Reilly and Yost (2006), and Chanda et al. (<xref ref-type="bibr" rid="bibr37-0192623312444471">2008</xref>). No quantitative determination of relative abundance is available, although Chanda et al. found that 16-hydroxycapsaicin, 17-hydroxycapsaicin, and 16,17-dehydrocapsaicin were the major metabolites.</p>
</caption>
<graphic xlink:href="10.1177_0192623312444471-fig1.tif"/>
</fig>
<p>Capsaicin is metabolized by a number of cytochrome (CYP) P450 enzymes leading to aromatic and alkyl hydroxylation, <italic>O</italic>-demethylation and alkyl dehydrogenation (Surh, Ahn, et al. 1995; Reilly et al. <xref ref-type="bibr" rid="bibr147-0192623312444471">2003</xref>; <xref ref-type="bibr" rid="bibr148-0192623312444471">Reilly and Yost 2006</xref>). It has been further suggested that capsaicin is bioactivated through the formation of several electrophilic metabolites that have the potential to lead to hepatotoxic and/or mutagenic responses (Surh and Lee 1995; Reilly et al <xref ref-type="bibr" rid="bibr147-0192623312444471">2003</xref>; <xref ref-type="bibr" rid="bibr148-0192623312444471">Reilly and Yost 2006</xref>). However, the formation of reactive metabolites as identified through <italic>in vitro</italic> experiments such as glutathione trapping and covalent binding has not been directly linked to adverse drug reactions in the clinic (<xref ref-type="bibr" rid="bibr138-0192623312444471">Park et al. 2011</xref>). For example, a number of hepatotoxic and non-hepatotoxic compounds have been tested for covalent binding to liver microsomal protein, and the results indicated that prediction of toxicity through the use of <italic>in vitro</italic> covalent binding experiments was unreliable due to the number of false positive findings (<xref ref-type="bibr" rid="bibr134-0192623312444471">Obach et al. 2008</xref>). In fact, BEAS-2B and HepG2 cells displayed a greater sensitivity to cytotoxicity in the presence of capsaicin and 1-aminobenzotriazole (a nonspecific CYP450 inhibitor), indicating that capsaicin metabolism represented a detoxification mechanism, as opposed to bioactivation (Reilly et al. <xref ref-type="bibr" rid="bibr147-0192623312444471">2003</xref>).</p>
<p>Compounds can either directly inhibit CYP enzymes or be metabolized to compounds that can reversibly or irreversibly inhibit CYP enzymes (<xref ref-type="bibr" rid="bibr117-0192623312444471">Madan et al. 2002</xref>). Inhibition of CYP enzymes, particularly CPY2E1, has been evoked by several contributors to explain the antimutagenic and anticancer properties of capsaicin, which occur at the same time as the putative pro-carcinogenic activities of other metabolites (see <xref ref-type="fig" rid="fig2-0192623312444471">Figure 2</xref>). For instance, one recent review states that, “Capsaicin has been documented to modulate microsomal cytochrome P450-dependent monooxygenase activities with resultant alteration of metabolism of carcinogens and other xenobiotics, to [the] ultimate carcinogen” (<xref ref-type="bibr" rid="bibr135-0192623312444471">Oyagbemi et al. 2010</xref>). The general acceptance of the hypothesis, which focuses on the inhibition of CYP2E1 by capsaicin, appears to be due to the influence of reviews by Surh and Lee (1995) and <xref ref-type="bibr" rid="bibr148-0192623312444471">Reilly and Yost (2006</xref>).</p>
<fig id="fig2-0192623312444471" position="float">
<label>Figure 2.</label>
<caption>
<p>Conjectured roles of capsaicin metabolites in CYP-mediated carcinogenesis and anticarcinogenesis. Although often repeated in literature, little evidence suggests than any CYP-produced metabolite has either physiological or clinical relevance.</p>
</caption>
<graphic xlink:href="10.1177_0192623312444471-fig2.tif"/>
</fig>
<p>The origins of the hypothesis that capsaicin prevents cancer via the inhibition of CYP2E1 arose from studies with the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Metabolic activation is required for the mutagenicity and carcinogenicity of NNK and its metabolism occurs via three major pathways: (1) carbonyl reduction, (2) <italic>N</italic>-oxidation of the pyridine ring, and (3) α-methylene hydroxylation (Richter et al. <xref ref-type="bibr" rid="bibr150-0192623312444471">2009</xref>). <xref ref-type="bibr" rid="bibr194-0192623312444471">Zhang et al. (1993)</xref> evaluated the effect of capsaicin on the <italic>in vitro</italic> metabolism of NNK by hamster and rat liver microsomes. At each of the concentrations of capsaicin tested (250, 500, and 1000 µM), significant inhibition of all three major pathways for NNK metabolism was observed in hamster liver microsomes. Concentration-dependent inhibition of NNK reduction occurred in rat microsomes and 500 and 1,000 µM capsaicin also significantly inhibited α-hydroxylation of NNK. <xref ref-type="bibr" rid="bibr194-0192623312444471">Zhang et al. (1993)</xref> also evaluated the effect of capsaicin (500 µM) on the formation of metabolites of <sup>14</sup>C-testosterone by hamster and rat microsomes. As testosterone is hydroxylated by several CYP P450s, results indicated that capsaicin inhibited the activity of several enzymes. In a parallel <italic>in vitro</italic> study by the same group, capsaicin significantly inhibited the mutagenicity of NNK in <italic>S. typhimurium </italic>strain TA1535 at doses of 0.1, 0.2, and 0.4 µmol/plate (with metabolic activation; Miller et al. <xref ref-type="bibr" rid="bibr122-0192623312444471">1994</xref>). Therefore, it was suggested that the antimutagenic and anticarcinogenic properties of capsaicin are due to its inhibition of xenobiotic-metabolizing enzymes.</p>
<p>Dihydrocapsaicin, the saturated analog of capsaicin, was observed to inhibit CYP2E1 (<xref ref-type="bibr" rid="bibr60-0192623312444471">Gannett et al. 1990</xref>); the tested concentration of dihydrocapsaicin was not disclosed. Subsequently, Surh, Ahn, et al. (<xref ref-type="bibr" rid="bibr165-0192623312444471">1995</xref>) reported that capsaicin (420 µM) attenuated the mutagenicity of vinyl carbamate and <italic>N-</italic>nitrosodimethylamine (NDMA) in <italic>S. typhimurium</italic> TA100. The authors also suggested that capsaicin suppressed vinyl carbamate and NDMA-induced mutagenesis, in part, through inhibition of CYP2E1, which is responsible for the activation of these two carcinogens. Because inhibition of CYP2E1 is thought to prevent the metabolic activation of carcinogens such as NNK, it was inferred that capsaicin was a CYP2E1 inhibitor (Surh and Lee 1995).</p>
<p>A summarized listing of these antimutagenicity and anticancer (next section) activities of capsaicin—excluding the compound’s direct effects on cancerous cells <italic>in vitro</italic> and in xenograph mouse models—is provided in <xref ref-type="table" rid="table5-0192623312444471">Table 5</xref>. This listing includes <italic>in vivo</italic> studies in which capsaicin’s ability to protect from known carcinogens was evaluated.</p>
<table-wrap id="table5-0192623312444471" position="float">
<label>Table 5.</label>
<caption>
<p>Chronological listing of studies evaluating the direct effects of capsaicin on cancerous cells</p>
</caption>
<graphic alternate-form-of="table5-0192623312444471" xlink:href="10.1177_0192623312444471-table5.tif"/>
<graphic alternate-form-of="table5-0192623312444471" xlink:href="10.1177_0192623312444471-table5a.tif"/>
<graphic alternate-form-of="table5-0192623312444471" xlink:href="10.1177_0192623312444471-table5b.tif"/>
<graphic alternate-form-of="table5-0192623312444471" xlink:href="10.1177_0192623312444471-table5c.tif"/>
<graphic alternate-form-of="table5-0192623312444471" xlink:href="10.1177_0192623312444471-table5d.tif"/>
<graphic alternate-form-of="table5-0192623312444471" xlink:href="10.1177_0192623312444471-table5e.tif"/>
<table>
<thead>
<tr>
<th>Reference</th>
<th>Cell line/lines</th>
<th>Effects of capsaicin and key results</th>
</tr>
</thead>
<tbody>
<tr>
<td><xref ref-type="bibr" rid="bibr125-0192623312444471">Morré et al. 1995</xref>
</td>
<td>Human HeLa cervical carcinoma, BT-20 mammary adenocarcinoma carcinoma, HL-60 and Caov-3 ovarian adenocarcinoma</td>
<td>Inhibited constitutively activated plasma membrane NADPH oxidase selectively expressed in cancerous cells (IC<sub>50</sub> values: 5 nM HeLa and &lt;100 nM Caov-3) Selectively inhibited growth and induced apoptosis in cancerous cells (IC<sub>50</sub> &lt; 100 nM for HeLa)</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr126-0192623312444471">Morré et al. 1996</xref>
</td>
<td>Human melanoma A-375 and SK-MEL-28, mouse melanoma B16</td>
<td>Inhibited NADPH oxidase activity in human melanoma but not in melanocytes or mouse melanoma Selectively induced apoptosis in cancerous cells (IC<sub>50</sub> ∼6 µM for A-375) With xenographs in C57BL/6 mice, inhibited B16 tumors when co-administered at 5 µg/day with t-butyl hydroperoxide</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr91-0192623312444471">Kim et al. 1997</xref>
</td>
<td>Human Korean stomach tumor SNU-1</td>
<td>Induced apoptosis and cell death at &gt;1 mM Enhanced transcription of two proto-oncogenes and tumor suppressor gene p53</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr115-0192623312444471">Macho et al. 1998</xref>
</td>
<td>Human T cell lymphoblast Jurkat and CEM-9F3</td>
<td>DNA nuclear loss induced by 100 to 300 µM preceded by ΔΨ<sub>m</sub> dissipation ROS increases independent of mitochondrial respiration Overexpression of Bcl-2 in 9F3 cells or pretreatment with cyclosporin A or NAC in Jurkat cells blocked ΔΨ<sub>m</sub> disruption and apoptosis, but not generation ROS </td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr28-0192623312444471">Bíró et al. 1998</xref>
</td>
<td>Rat glioma C6</td>
<td>Inhibited proliferation (IC<sub>50</sub> = 2 µM), altered differentiation and produced apoptosis Capsazepine, instead of antagonizing capsaicin, acted as an agonist and produced the same effects, with higher potency</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr149-0192623312444471">Richeux et al. 1999</xref>
</td>
<td>Human neuroblastoma SHSY-5Y</td>
<td>Inhibited protein synthesis (IC<sub>50</sub> = 60 µM) Induced DNA strand breaks at ∼50 µM</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr116-0192623312444471">Macho et al. 1999</xref>
</td>
<td>Human T cell lymphoblast Jurkat, erythroleukemic K562, embryonic kidney 293T</td>
<td>250 µM induced rapid increase ROS followed by disruption ΔΨ<sub>m</sub> Blocking mitochondrial respiration not reduce ROS induction by capsaicin In resting T cells, capsaicin not initiate ROS production, apoptosis or Ca<sup>2+</sup> mobilization Preincubation of Jurkat cells with BAPTA-AM not prevent ROS generation or apoptosis </td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr168-0192623312444471">Takahata et al. 1999</xref>
</td>
<td>Human cervical carcinoma HeLa</td>
<td>Inhibited growth (IC<sub>50</sub> ∼30 µM) and increased intracellular calcium, with effect blocked by capsazepine but not BAPTA-AM</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr107-0192623312444471">Lee et al. 2000</xref>
</td>
<td>Human glioblastoma A172</td>
<td>Induced apoptosis at ≥200 µM, not inhibited by capsazepine or BAPTA/AM 250 µM reduced basal generation of ROS and lipid peroxidation H<sub>2</sub>O<sub>2</sub> reduced apoptosis, while NAC enhanced</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr31-0192623312444471">Brar et al. 2001</xref>
</td>
<td>Human melanoma CRL 1585 and CRL 1619</td>
<td>100 µM inhibited NADPH reductase and cell proliferation</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr85-0192623312444471">Jung et al. 2001</xref>
</td>
<td>Human hepatocellular carcinoma SK-Hep-1</td>
<td>Inhibited growth (IC<sub>50</sub> = 90 µM) and induced apoptosis (200 µM) Reduced ratio of anti-apoptotic Bcl-2 to pro-apoptotic Bax and increased caspase-3 activity</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr78-0192623312444471">Jacobsson et al. 2001</xref>
</td>
<td>Rat glioma C6</td>
<td>No significant inhibition of proliferation at up to 30 µM</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr151-0192623312444471">Roy et al. 2002</xref>
</td>
<td>Human leukemia HL-60, chronic myelogenic leukemia K-562, breast adenocarcinoma MCF-7 and cervical epithelial carcinoma HeLa</td>
<td>Less cytotoxic than other phenolic spice compounds for cancer cells (IC<sub>50</sub> values ≥75 µM) No cytoxicity for human lymphocytes</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr106-0192623312444471">Lee et al. 2002</xref>
</td>
<td>Human neuroblastoma SK-N-SH</td>
<td>200 µM induced apoptosis, reduced basal generation of ROS, and suppressed expression of COX-1 and COX-2 Pretreatment with COX inhibitors enhanced capsaicin-induced apoptosis, H<sub>2</sub> O<sub>2</sub> reduced</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr67-0192623312444471">Hail and Lotan, 2002</xref>
</td>
<td>Human squamous cell carcinoma COLO 16</td>
<td>Apoptosis induced in majority cells after 12-hr exposure to 100 µM Apoptosis associated with mitochondrial permeability transition, rapid increase hydroperoxide generation and decrease oxygen consumption</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr141-0192623312444471">Patel, Varney, et al. 2002</xref>; <xref ref-type="bibr" rid="bibr142-0192623312444471">Patel, Yang, et al. 2002</xref>
</td>
<td>Human melanoma A375P</td>
<td>300 µM inhibited constitutive and IL-1β-induced and TNFα-induced IL-8 expression Inhibited IL-1β-induced proliferation 200 µM maximally enhanced VEGF production and increased hypoxia-inducible factor-1α</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr87-0192623312444471">Kang et al. 2003</xref>
</td>
<td>Human H-<italic>ras</italic>-transformed breast epithelial MCF10A </td>
<td>Selectively induced apoptosis in H-<italic>ras</italic>-transformed cells (IC<sub>50</sub> = 56 µM) but not in normal cells (&gt;100 µM) Apoptosis involved caspase-3-like activity, and JNK-1 and p38 activation</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr192-0192623312444471">Zhang et al. 2003</xref>
</td>
<td>Human T-cell leukemia virus type 1 (HTLV-1)-and Jurkat</td>
<td>100 µM selectively inhibited growth in HTLV-1 positive and negative cells, but not in normal peripheral blood T cells, mainly due to induction cell cycle arrest and apoptosis IC<sub>50</sub> value for inhibition  DNA synthesis ∼60 µM</td>
</tr>
<tr>
<td>Galati and O’Brien <xref ref-type="bibr" rid="bibr58-0192623312444471">2003</xref></td>
<td>Human heptoma Hep G2</td>
<td>Induced apoptosis in Hep G2 cells with IC<sub>50</sub> of 50 μM, while LD<sub>50</sub> for hepatocytes was 400 µM &lt;70 µM inhibited ROS formation in hepatocytes and &lt;20 µM protected against rotenone-induced ΔΨ<sub>m</sub> collapse</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr46-0192623312444471">Chueh et al. 2004</xref>
</td>
<td>Monkey kidney fibroblast COS-1, human cervical carcinoma HeLa</td>
<td>Stable transfection with tNOX cDNA made COS cells more sensitive (IC<sub>50</sub>s decreased from 15 to 2.3 µM) tNOX antisense abrogated growth inhibition in HeLa cells (IC<sub>50</sub>s increased from 10 to 100 µM)</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr77-0192623312444471">Ito et al. 2004</xref>
</td>
<td>Human myeloid leukemia NB4 and Kasumi-1</td>
<td>Suppressed growth of leukemic cells (IC<sub>50</sub> ∼50 µM), but not normal bone marrow mononuclear cells, via induction of G<sub>0</sub> -G<sub>1</sub> phase cell cycle arrest and apoptosis Pretreatment with NAC and catalase completely inhibited capsaicin-induced apoptosis When injected at 50 mg/kg, inhibited NB4 tumor growth and induced apoptosis in NOD/SCID mice, with no toxic effects</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr186-0192623312444471">Vriens et al. 2004</xref>
</td>
<td>Human hepatoma HepG2</td>
<td>10 µM stimulated increases in [Ca<sup>2+</sup>]<sub>i</sub> within minutes, due to influx and release from intracellular stores, mediated by TRPV1</td>
</tr>
<tr>
<td>Lee JS et al. <xref ref-type="bibr" rid="bibr101-0192623312444471">2004</xref></td>
<td>Murine bladder MBT-2</td>
<td>250 µM induced apoptosis, blocked by pretreatment with caspase or caspase-3-selective inhibitors Caused cytochrome c release, decreased Bcl-2 protein expression, and reduced ROS levels and lipid peroxidation</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr95-0192623312444471">Kim and Moon 2004</xref>
</td>
<td>H-ras-transformed human breast epithelial MCF10A</td>
<td>100 µM selectively induced ROS generation in H-ras-transformed cells NAC pretreatment prevented growth reduction by 50 µM capsaicin</td>
</tr>
<tr>
<td>Kim et al. 2004</td>
<td>Human colon cancer HT-29</td>
<td>≥100 µM induced apoptosis Blocked by a PPARγ antagonist but not TRPV1 antagonist</td>
</tr>
<tr>
<td>Lee YS et al. 2004</td>
<td>Human hepatoma HepG2</td>
<td>≥200 µM induced significant apoptosis and increased levels of ROS, suppressed by antioxidants and inhibitors of NADPH oxidase 250 µM activated NF-κB</td>
</tr>
<tr>
<td>Kim et al. <xref ref-type="bibr" rid="bibr90-0192623312444471">2005</xref></td>
<td>Human hepatoma HepG2</td>
<td>250 µM induced apoptosis, which was associated with rapid and sustained increases in [Ca<sup>2+</sup>]<sub>i</sub> Ca<sup>2+</sup> chelation, blocking Ca<sup>2+</sup>
<sub>i</sub> release and inhibition of phospholipase C reduced</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr64-0192623312444471">Gong et al. 2005</xref>
</td>
<td>Human melanoma A375-S2</td>
<td>≥100 µM induced apoptosis, which increased over 48 hr Reduced expression of inhibitor of caspase-activated DNase</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr146-0192623312444471">Qiao et al. 2005</xref>
</td>
<td>Rat glioma C6</td>
<td>150 µM induced apotosis in C6 glioma cells, not inhibited by two TPRV1 antagonists ≥100 µM generated superoxides, promoted iNOS expression, and suppressed expression of SODs Pretreatment with peroxynitrite scavenger reduced apoptosis</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr109-0192623312444471">Lo et al. 2005</xref>
</td>
<td>Human gastric adenocarcinoma AGS</td>
<td>≥200 µM induced apoptosis and reduced expression anti-apoptotic protein Bcl-2</td>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr155-0192623312444471">Sánchez et al. 2005</xref></td>
<td>Human prostate PC-3 and lymph node (LNCaP) carcinomas</td>
<td>5 to 1,000 nM induced increases [Ca<sup>2+</sup>]<sub>i</sub>, blocked by capsazepine</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr176-0192623312444471">Tsou et al. 2006</xref>
</td>
<td>Human leukemia HL-60</td>
<td>≥50 µM induced G<sub>0</sub> /G<sub>1</sub> -phase cell cycle arrest and apoptosis Apoptosis associated elevation ROS and [Ca<sup>2+</sup>]<sub>i</sub>, decreased ΔΨ<sub>m</sub> , cytochrome c release and activation of caspase-3</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr124-0192623312444471">Mori et al. 2006</xref>
</td>
<td>Human prostate cancer LNCaP, PC-3 and DU-145</td>
<td>500 µM completely inhibited proliferation, with significant inhibition starting ∼10 µM Down-regulated expression of PSA, AR and NF-κB signaling pathway 5 mg/kg/day, s.c., for 4 weeks inhibited growth PC-3 xenograph tumors in nude mice without significant adverse effects</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr178-0192623312444471">Tuoya et al. 2006</xref>
</td>
<td>Human breast MCF-7 and leukemic U937 cancer</td>
<td>≥100 µM slightly inhibited growth MCF-7 cells, blocked by a broad-spectrum caspase inhibitor</td>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr154-0192623312444471">Sánchez et al. 2006</xref></td>
<td>Human prostate cancer PC-3 and LNCaP</td>
<td>Inhibited growth (IC<sub>50</sub>=20 µM) and induced apoptosis in PC-3 cells, with lower potency in LNCaP cells, no attenuation by capsazepine Mechanisms included ROS generation, dissipation ΔΨ<sub>m</sub> and activation caspase-3 With established PC-3 xenograft tumors in nude mice, s.c. injection of 5 mg/kg for 14 days suppressed tumor growth and induced apoptosis</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr189-0192623312444471">Wu et al. 2006</xref>
</td>
<td>Human esophageal epidermoid carcinoma CE 81T/VGH</td>
<td>≥100 µM induced apoptosis and G<sub>0</sub>-G<sub>1</sub> phase cell cycle arrest Mechanisms included activation caspase-3, elevation of ROS and [Ca<sup>2+</sup>]<sub>i</sub> and loss ΔΨ<sub>m</sub> </td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr26-0192623312444471">Beltran et al. 2007</xref>
</td>
<td>Mouse methylcholanthrene-induced and CMS5 fibrosarcomas, human colon carcinoma CT26</td>
<td>Two injections of 100 or 200 µg into established xenograph tumors in BALB/cJ mice retarded progression of injected (and even uninjected) tumors Induced significant apoptosis in fibrosarcoma cells but not mouse embryonic fibroblasts </td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr17-0192623312444471">Athanasiou et al. 2007</xref>
</td>
<td>Human non-small lung cancer H460</td>
<td>50 µM induced apoptosis in H460 cells, which do not express TRPV1 In isolated rat heart mitochondria, reduced oxygen consumption and dissipated ΔΨ<sub>m</sub> </td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr45-0192623312444471">Chow et al. 2007</xref>
</td>
<td>Human gastric cancer AGS</td>
<td>≥10 µM induced apoptosis in both gastric cancer, with normal gastric epithelial cells (GES-1) more resistant to 50 µM TRPV1 antagonist did not prevent apoptosis, and susceptibility seemed dependent on TRPV6 expression Increased mitochondrial permeability, and induction of Bax and p53</td>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr152-0192623312444471">Sánchez et al. 2007</xref>
</td>
<td>Human prostate epithelial PC-3</td>
<td>When incubated for 48 hr, ≥10 µM induced apoptosis through caspase-3 pathway activation and increased intracellular ceramide levels</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr96-0192623312444471">Kim et al. 2007</xref>
</td>
<td>Human colon cancer HT-29</td>
<td>≥25 µM induced apoptosis, activated adenosine monophosphate-activated protein kinase and increased expression of the inactive form of acetyl-CoA carboxylase</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr84-0192623312444471">Jun et al. 2007</xref>
</td>
<td>Mouse melanoma B16-F10</td>
<td>≥50 µM induced apoptosis in time-dependent manner Caused release of mitochondrial cytochrome c, activation of caspase-3, and cleavage of poly (ADP-ribose) polymerase and slight down-regulation of Bcl-2 expression</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr5-0192623312444471">Amantini et al. 2007</xref>
</td>
<td>Human glioma U373 and U87</td>
<td>≥50 µM triggered apoptosis of U373, but not U87 cells, involved Ca<sup>2+</sup> influx, dissipation of ΔΨm, and was antagonized by capsazepine</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr27-0192623312444471">Bhutani et al. 2007</xref>
</td>
<td>Human multiple myeloma U266 and MM.1S</td>
<td>≥5 µM inhibited cell proliferation, caused the accumulation of cells in G<sub>1</sub> phase, activated caspase-3, and suppressed phosphorylation of STAT3 and constitutive activation of Src kinase Administered i.p. at 1 mg/kg, twice a week for 3 weeks, inhibited growth of U266 xenograft tumors in male nude mice</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr83-0192623312444471">Joung et al. 2007</xref>
</td>
<td>Human hepatoma HepG2</td>
<td>200 µM induced expression heme oxygenase-1 and production ROS, which were prevented by pretreatment with N-acetyl-L-cysteine Decreased expression of NADPH oxidase</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr193-0192623312444471">Zhang et al. 2008</xref>
</td>
<td>Human pancreatic cancer AsPC-1 and BxPC-3</td>
<td>Inhibited prolifereation both cell lines (IC<sub>50</sub>=150 µM) Induced apoptosis, generated ROS, disrupted ΔΨms, increased expression of Bax, down-regulated bcl-2 and activated JNK Admininstered po to nude mice at 2/5 mg/kg for 5 days/week or 5 mg/kg 3 days/week, suppressed growth of AsPC-1 tumor xenografts, without adverse effects</td>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr153-0192623312444471">Sánchez et al. 2008</xref>
</td>
<td>Human prostate cancer PC-3</td>
<td>20 µM down-regulated 10 genes and induced 5 genes, including GADD153/CHOP, an endoplasmic reticulum stress-regulated gene Blockage of GADD153/CHOP expression by siRNA reduced capsaicin-induced apoptosis</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr63-0192623312444471">Gil and Kang 2008</xref>
</td>
<td>Human glioma A172</td>
<td>≥25 µM inhibited cell growth and induced apoptosis through down-regulation of Bcl-2 and activation of caspase-3 Stimulated terminal differentiation predominantly to astrocyte-like cells</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr22-0192623312444471">Baek et al. 2008</xref>
</td>
<td>Human hepatoma HepG2 and neuroblastoma SK-N-SH</td>
<td>During apoptosis induced by ≥50 µM, ROS increased in HepG2 and decreased in SK-N-SH cells 23 proteins were increased in HepG2 and 26 proteins were decreased in SK-N-SH cells</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr159-0192623312444471">Shin et al. 2008</xref>
</td>
<td>Mouse melanoma B16-F10</td>
<td>≥50 µM inhibited migration without showing obvious cellular cytotoxicity at ≤ 100 µM, which correlated with down-regulation of phosphatidylinositol 3-kinase and Akt signaling pathways ≥100 µM inhibited Rac1 activity</td>
</tr>
<tr>
<td>Amantini et al. <xref ref-type="bibr" rid="bibr4-0192623312444471">2009</xref></td>
<td>Human urothelial cancer RT4</td>
<td>Reduced growth (IC<sub>50</sub>=80 µM) via a TRPV1-dependent process, induced cell cycle arrest in G<sub>0</sub>/G<sub>1</sub> phase Apoptosis occurred via rapid coordinated transcription of pro-apoptotic genes, loss of ΔΨm and caspase activation </td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr44-0192623312444471">Chou et al. 2009</xref>
</td>
<td>Human breast cancer MCF-7</td>
<td>≥50 µM inhibited growth and induced apoptosis of MCF-7 cells (which do not express caspase-3) Induced elevation of [Ca<sup>2+</sup>]<sub>i</sub> but didn’t alter levels of ROS and only trend toward decrease ΔΨ<sub>m</sub> </td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr71-0192623312444471">Huang et al. 2009</xref>
</td>
<td>Human hepatoma HepG2</td>
<td>≥10 µM decrease cell viability, increased [Ca<sup>2+</sup>]<sub>I</sub>, generated ROS and activated caspase-3, with apoptosis prevented by BAPTA-AM Decreased Bcl-2 and increased Bax in mitochondrial fraction, while p53 and cytochrome c protein levels increased in cytosolic</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr73-0192623312444471">Hwang et al. 2009</xref>
</td>
<td>Human breast cancer MCF-7</td>
<td>In combination with genistein, 50 µM induced apoptosis and reduced COX-2 expression</td>
</tr>
<tr>
<td>Lee et al. <xref ref-type="bibr" rid="bibr102-0192623312444471">2009</xref></td>
<td>Human H-<italic>ras</italic>-transformed breast epithelial MCF10A</td>
<td>≥50 µM inhibited growth and induced apoptosis Induced degradation of p53, triggered ER stress, increased [Ca<sup>2+</sup>]<sub>i</sub>, activated calpain, dissipated ΔΨ<sub>m</sub>, released cytochrome c, and activated caspase-9 and -7</td>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr188-0192623312444471">Wang et al. 2009</xref></td>
<td>Human gastric carcinoma SCM-1</td>
<td>Induced apoptosis and PARP cleavage, and down-regulated tNOX protein</td>
</tr>
<tr>
<td>Kim et al. <xref ref-type="bibr" rid="bibr94-0192623312444471">2009</xref></td>
<td>Human HCT116 colon carcinoma</td>
<td>In wild-type p53 (p53-WT) and p53 knockout (p53-null) cells, inhibited cell growth and promoted apoptosis by the elevation of NO Reduction in anti-apoptotic Bcl-2 protein, cytochrome c loss from mitochondria and activation of caspases 9 and 3</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr190-0192623312444471">Yang et al. 2010</xref>
</td>
<td>Human bladder cancer T24</td>
<td>≥100 µM induced cell viability, ROS production and mitochondrial membrane depolarization (which was prevented by pretreatment with capsazepine) After 5 mg/kg s.c. every 3 days for 4 weeks, growth of xenograph tumors in nude mice slowed significantly</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr62-0192623312444471">Ghosh and Basu 2010</xref>
</td>
<td>Mouse methylcholanthrene-induced and CMS5 fibrosarcomas</td>
<td>100 µM induced apoptosis and ROS production, not inhibited by TRPV1 antagonist but by NAC Activated caspase-3 and degraded Fas-associated factor1 (FAF1), a TRPV1-associated protein</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr171-0192623312444471">Thoennissen et al. 2010</xref>
</td>
<td>Human breast cancer MCF-7, T47D, BT-474, SKBR-3 and MDA-MB231</td>
<td>Inhibited growth all (both ER-positive and –negative) cell lines, with IC<sub>50</sub> 50 to 200 μM Associated with G<sub>0</sub>/G<sub>1</sub> cell-cycle arrest, increased apoptosis and reduced expression EGFR, HER-2, activated extracellular–regulated kinase and cyclin D1 Blocked cell migration <italic>in vitro</italic> 5 mg/kg three times per week, p.o., decreased the size of MDA-MB231 tumors in mice by 50% without noticeable side effects</td>
</tr>
<tr>
<td>Lee et al. <xref ref-type="bibr" rid="bibr103-0192623312444471">2010</xref></td>
<td>Human colorectal HCT-SW480 and LoVo</td>
<td>Induced apoptosis, and up-regulated NAG-1 gene expression Knockdown of NAG-1 or C/EBPβ inhibited capsaicin-induced apoptosis</td>
</tr>
<tr>
<td>Kim et al. <xref ref-type="bibr" rid="bibr93-0192623312444471">2010</xref></td>
<td>Human gliomas</td>
<td>≤200 μM capsaicin induced &lt;20% cell death, but sensitized multiple cell lines to TRAIL-induced apoptosis Normal astrocytes resistant to combined capsaicin and TRAIL</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr118-0192623312444471">Maity et al. 2010</xref>
</td>
<td>Mouse neuro 2a</td>
<td>300 μM induced 50% cell death at 8 hr Mechanism involved concentration- and time-dependent inhibition proteasome activity, via generation of oxidative stress Triggered apoptosis via mitochondria and induced neurite outgrowth</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr43-0192623312444471">Choi et al. 2010</xref>
</td>
<td>Human breast MCF-7 and MDA-MB-231</td>
<td>250 μM caused non-apoptotic cell cycle arrest of MCF-7 and MDA-MB-231 cells but induced apoptosis in normal MCF10A cells In MCF-7 and MDA-MB-231 cells, induced endoplasmic reticulum stress and autophagy</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr32-0192623312444471">Brown et al. 2010</xref>
</td>
<td>Human small cell NCI-H69, NCI-H82, DMS53 and DMS114</td>
<td>50 μM suppressed growth all four human SCLC cell lines, with maximum effect at 72 hr; little effect on normal epithelial cell lines 10 mg/kg in diet suppressed H69 tumors in nude mice Anti-proliferative activity correlated with decrease in expression of E2F transcription factors</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr75-0192623312444471">Ip et al. 2010</xref>
</td>
<td>Human tongue SCC-4</td>
<td>Concentration- and time-dependent decreases viable cells, DNA fragmentation and G<sub>0</sub>/G<sub>1</sub> phase arrest Increased ROS and [Ca<sup>2+</sup>]<sub>i</sub>, reduced  ΔΨ<sub>m</sub> </td>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr112-0192623312444471">Lu et al. 2011</xref></td>
<td>Human colon colo 205</td>
<td>At  25 hr, 150 μM induced 50% cell death Increased ROS and [Ca<sup>2+</sup>]<sub>I</sub>, decreased ΔΨ<sub>m</sub>; decreased anti-apoptotic and increased pro-apoptotic proteins 1 or 3 mg/kg, i.p. inhibited xenograph tumors in nu/nu mice</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr54-0192623312444471">Dou et al. 2011</xref>
</td>
<td>Human breast MDA-MB-231 MCF-7 and leukemia Jurkat T</td>
<td>Extracts from 10 pepper varieties induced growth arrest and apoptosis in cancer cells with no significant effect on normal breast epithelial cells Inhibition and apoptosis correlated positively with pepper capsaicin content</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr40-0192623312444471">Chang et al. 2011</xref>
</td>
<td>Human breast MCF-7 and BT-20</td>
<td>Both cell lines expressed TRPV1 Concentration-dependent reduction of viability in both caspase-3-deficient (MCF-7) and non-deficient (BT-20) cell lines through apoptosis and arresting cell cycle in S phase Decreased ΔΨ<sub>m</sub>, induced cleavage PARP-1, and decreased procaspase-7</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr34-0192623312444471">Caprodossi et al. 2011</xref>
</td>
<td>Human 5637 urothelial</td>
<td>Induced more invasive and aggressive phenotype in TRPV1-null 5637 cells Up-regulated pro-angiogenetic and down-regulated apoptotic genes</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr144-0192623312444471">Pramanik et al. 2011</xref>
</td>
<td>Human BxPC-3 and AsPC-1 pancreatic</td>
<td>150 µM generated 4- to 6-fold more ROS but not in normal HPDE-6 cells; generation ROS was inhibited by catalase In pure mitochondria, inhibited mitochondrial complex-I and complex-III, but not in normal cells Tumors from mice fed orally 2.5 mg/kg capsaicin showed decreased SOD activity and increased ratio of oxidized glutathione to glutathione</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr187-0192623312444471">Wang et al. 2011</xref>
</td>
<td>Human SNU-1 and TMC-1 gastric</td>
<td>Capsaicin induced apoptosis, oxidative stress, PARP cleavage, down-regulation tNOX in SNU-1 cells at ≥100 µM; TMC-1 cells much less sensitive to capsaicin</td>
</tr>
<tr>
<td>Lee et al. <xref ref-type="bibr" rid="bibr104-0192623312444471">2011</xref></td>
<td>Human SW480, LoVo and HCT-116 colorectat</td>
<td>≥50 µM suppressed cell proliferation and β-catenin/T-cell factor transcriptional activity</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr76-0192623312444471">Ip et al. 2011</xref>
</td>
<td>Human NPC-TW 039 nasopharyngeal</td>
<td>Time- and concentration-dependent (≥200 µM) induction G<sub>0</sub>/G<sub>1</sub> phase arrest and apoptosis Increased ROS and [Ca<sup>2+</sup>]<sub>i</sub>, dissipated ΔΨ<sub>m</sub>, released cytochrome c and activated caspases</td>
</tr>
<tr>
<td>
<xref ref-type="bibr" rid="bibr72-0192623312444471">Huh et al. 2011</xref>
</td>
<td>Human SNU-668 gastric</td>
<td>In combination with cisplatin, induced higher apoptotic cell death than with either capsaicin or cisplatin alone Aurora-A protein increased in response to cisplatin and was degraded upon combined treatment with capsaicin and cisplatin</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0192623312444471">
<p>Abbreviations: AR, androgen receptor; BAPTA-AM, 1,2-bis(2-aminophenoxy)ethane-N, N,N',N'-tetraacetic acid tetrakis(acetoxymethyl ester); [Ca<sup>2+</sup>]<sub>i</sub>, intracellular calcium ions; C/EBPβ, CCAAT/enhancer binding protein beta; hEGFR, human epidermal growth factor receptor; ER, estrogen receptor; iNOS, inducible nitric oxide synthase; NAC, N-acetyl-L-cysteine; NADPH, nicotinamide adenine dinucleotide phosphate; NAG-1, nonsteroidal anti-inflammatory drug-activated gene-1, NF-κB, nuclear factor kappa B; PARP-1, polyADP-ribose polymerase 1; PPARγ, peroxisome proliferator-activated receptor gamma; PSA, prostate-specific antigen; ROS, reactive oxygen species; SODs, superoxide dismutases; STAT3, Signal transducer and activator of transcription 3; tNOX, tumor-associated NADPH oxidase; TRAIL, tumor necrosis factor-related apoptosis-inducing ligand; TRPV1, transient receptor potential vanilloid 1 receptor; ΔΨ<sub>m</sub>, mitochondrial membrane potential.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Protocols for the prediction of potential drug-drug interaction via <italic>in vitro</italic> experiments with CYPs have evolved and are now governed by guidance from drug regulatory agencies (<xref ref-type="bibr" rid="bibr163-0192623312444471">Singh 2006</xref>). Data derived from such protocols has recently appeared for capsaicin: capsaicin inhibits CYP1A2, CYP2C9, and CYP2C19, with IC<sub>50</sub> values of 2.1, 2.0, and 3.2 µM, respectively, and inhibits CYP2B6, CYP2D6, CYP3A4, and CYP3A5 with extrapolated IC<sub>5</sub>
<sub>0</sub> values of 24, 18, 38, and 12 µM, respectively (Babbar et al. <xref ref-type="bibr" rid="bibr20-0192623312444471">2010</xref>). Due to a lack of inhibition at the highest tested concentration (10 µM), an IC<sub>50</sub> value for CYP2E1 could not even be extrapolated. Drugs are predicted to lack drug–drug interactions when the [I]/K<sub>i</sub> ratio is less than 0.1, where [I] is the plasma C<sub>max</sub> value and K<sub>i</sub> is inhibition constant that defines the affinity of the inhibitor for the enzyme is estimated from the IC<sub>50</sub> values (<xref ref-type="bibr" rid="bibr180-0192623312444471">US FDA 2006</xref>). In the case of capsaicin, assuming a competitive mode of inhibition where K<sub>i</sub> ≈ IC<sub>50</sub> /2 for each of the enzymes evaluated and 58 nM for the highest plasma capsaicin concentration reported in any publication (<xref ref-type="bibr" rid="bibr21-0192623312444471">Babbar et al. 2009</xref>; <xref ref-type="bibr" rid="bibr36-0192623312444471">Chaiyasit et al. 2009</xref>), all values are calculated to be less than 0.1. With the exception of CYP2B6 and CYP2D6, the IC<sub>50</sub> values for metabolism-dependent CYP inhibition <italic>increased</italic> upon preincubation of capsaicin with each CYP (Babbar et al. 2010). Even for CYP2B6 and CYP2D6, they were still in the micromolar range and outside of concentrations considered relevant based on potential ingestion or medical use.</p>
<p>In summary, standard safety calculations indicate that capsaicin is unlikely to inhibit directly or even indirectly the metabolism of compounds or drugs by CYPs based on the pharmacokinetic values for the dietary and medical product exposure discussed above. Recent data suggest that concentrations of capsaicin outside of those readily generated in human tissues may be required to produce either substantial inhibition of CYP2E1 or inhibit metabolic activation of carcinogens such as NNK. In the study on capsaicin-mediated CYP inhibition by <xref ref-type="bibr" rid="bibr148-0192623312444471">Reilly and Yost (2006</xref>), the lowest capsaicin concentration tested was 10 µM, which is already about 10,000-fold higher than required to activate TRPV1 (Alawi and Keeble <xref ref-type="bibr" rid="bibr3-0192623312444471">2010</xref>). We question the physiological relevance of millimolar capsaicin concentrations. Alternative possible mechanisms for protection by capsaicin against carcinogens, which require metabolic activation are discussed below.</p>
</sec>
<sec id="section7-0192623312444471">
<title>Direct Effects on Cancerous Cells</title>
<p>Capsaicin has been recognized to inhibit the growth of or induce apoptosis in a wide variety of tumor and cancer cell lines (<xref ref-type="bibr" rid="bibr164-0192623312444471">Surh 2002</xref>; <xref ref-type="bibr" rid="bibr135-0192623312444471">Oyagbemi et al. 2010</xref>). More recent studies have confirmed and extended these observations to additional cell lines and to rodent <italic>in vivo</italic> xenograph tumor models. <xref ref-type="table" rid="table5-0192623312444471">Table 5</xref> briefly captures some key observations, in these studies, in approximate order of their publication. Note that this table excludes data generated from heterologous systems, such as cell lines stably transfected with TRPV1. Overall, capsaicin appears to inhibit the growth of or induce apoptosis in over forty distinct cancer cell lines, the vast majority of which are human in origin. Due to the preponderance of data from human cell lines, it is not possible to conclude whether cancers from rodents or other species display differential sensitivity to capsaicin.</p>
<p>The anticancer effects of capsaicin <italic>in vitro</italic> are both concentration- and time-dependent, as illustrated in <xref ref-type="fig" rid="fig3-0192623312444471">Figure 3</xref>. In most publications, the effects of capsaicin appear in the low micromolar range and become maximal at approximately 200–300 µM. Duration of exposure enhances the potency of capsaicin, and the stability of capsaicin under specific experimental conditions may vary, so rigorous comparisons of IC<sub>50</sub> values across studies is not possible. Most studies are limited to measurements of cell viability, growth rates or apoptosis within 48–72 hr of treatment. The only information about long-term or continuous exposure is provided by <xref ref-type="bibr" rid="bibr116-0192623312444471">Macho et al. (1999</xref>), who found that incubation with 300 µM capsaicin for 5 days did not induce apoptosis in resting T cells.</p>
<fig id="fig3-0192623312444471" position="float">
<label>Figure 3.</label>
<caption>
<p>Representative concentration- and time-dependency (at 100 µM) of capsaicin for induction of apoptosis in cancerous cells. Study on human esophageal epidermoid carcinonama CE 81T/VGH cells. Taken from Wu et al. (2006).</p>
</caption>
<graphic xlink:href="10.1177_0192623312444471-fig3.tif"/>
</fig>
<p>Corresponding antitumor activity has been observed in <italic>in vivo</italic> mouse xenograph models in eleven publications in which capsaicin was administered orally, subcutaneously, and intraperitoneally, as well as directly into tumors. Source cells included mouse melanoma (<xref ref-type="bibr" rid="bibr126-0192623312444471">Morré et al. 1996</xref>), human leukemia (<xref ref-type="bibr" rid="bibr77-0192623312444471">Ito et al. 2004</xref>), human prostate (<xref ref-type="bibr" rid="bibr124-0192623312444471">Mori et al. 2006</xref>; <xref ref-type="bibr" rid="bibr154-0192623312444471">Sánchez et al. 2006</xref>; <xref ref-type="bibr" rid="bibr52-0192623312444471">Díaz-Laviada 2010</xref>), human multiple myeloma (<xref ref-type="bibr" rid="bibr27-0192623312444471">Bhutani et al. 2007</xref>), human pancreatic (<xref ref-type="bibr" rid="bibr193-0192623312444471">Zhang et al. 2008</xref>; <xref ref-type="bibr" rid="bibr144-0192623312444471">Pramanik et al. 2011</xref>), and human bladder (<xref ref-type="bibr" rid="bibr190-0192623312444471">Yang et al. 2010</xref>) cancers. With the exception of skin ulceration and irritability noted by <xref ref-type="bibr" rid="bibr154-0192623312444471">Sánchez et al. (2006)</xref>, no appreciable toxic effects on mice by capsaicin administration were reported.</p>
<p>Normal or noncancerous cells appear to be significantly less sensitive to the apoptotic or growth inhibitory effects of capsaicin than cancerous cells (as described in fourteen studies listed in <xref ref-type="table" rid="table5-0192623312444471">Table 5</xref>); the potential bases for this selective action will be discussed below. One important implication of this general observation is that mutagenicity or genotoxicity studies with capsaicin using cancer cells may have limited relevance for normal cells. For instance, <xref ref-type="bibr" rid="bibr149-0192623312444471">Richeux et al. (1999</xref>) reported that cytotoxicty and DNA fragmentation was induced in human neuroblastoma SHSY-5Y cells by 25–100 µM capsaicin, with an IC<sub>50</sub> of 60 µM for the inhibition of protein synthesis. The authors concluded that this finding could have, “important implications for the possible health threats of capsaicin, especially in the case of misuse of capsaicin preparations in pathological situations.” Similarly, Lawson and Gannett (<xref ref-type="bibr" rid="bibr98-0192623312444471">1989</xref>) reported that oxidative metabolism of capsaicin by hepatic microsomes produced a metabolite that was mutagenic for Chinese hamster lung fibroblast V79 cells, even though capsaicin itself was not mutagenic. This study by Lawson and Gannett seems to have provided additional impetus for research into whether metabolic activation of capsaicin could yield mutagens or carcinogens (discussed above). Although V79 cells are widely used in studies of DNA damage and repair and are not classified as cancerous cells, they share several properties with cancer cells, including being immortal, not expressing functional p53 protein, failing to show induction of the <italic>mdm2</italic> gene product in response to DNA damage, and being readily mutagenized to make stable mutant lines deficient in DNA repair enzymes (Chaung et al. <xref ref-type="bibr" rid="bibr41-0192623312444471">1997</xref>). Therefore, it seems prudent to interpret with caution DNA damage results derived from capsaicin exposure to cells, which display properties typical of cancerous cells. We have excluded the study of Richeux et al. (<xref ref-type="bibr" rid="bibr149-0192623312444471">1999</xref>) in the listing of mutagenicity or genotoxicity studies in <xref ref-type="table" rid="table1-0192623312444471">Table 1</xref>, but to be conservative, have included the two studies based on V79 cells.</p>
<p>A comprehensive review of the potential pro-apoptotic cascades initiated by capsaicin in cancerous cells is beyond the scope of this review, so the following constitutes a survey of possible explanations for the selective action of capsaicin. Reviews with more details regarding apoptotic pathways in cancerous cells have been assembled by others (<xref ref-type="bibr" rid="bibr164-0192623312444471">Surh 2002</xref>; <xref ref-type="bibr" rid="bibr68-0192623312444471">Hail and Lotan 2009</xref>; <xref ref-type="bibr" rid="bibr195-0192623312444471">Ziglioli et al. 2009</xref>).</p>
<p>The first report on the selective action of capsaicin against cancer cells was published by <xref ref-type="bibr" rid="bibr128-0192623312444471">Morré and colleagues (1995)</xref>, and this group has continued to investigate the potential to use capsaicin and similarly acting molecules as cancer chemotherapeutic agents. Initially, they observed that capsaicin inhibited the growth of human HeLa, ovarian carcinoma, mammary adenocarcinoma, and HL-60 leukemia cells (<xref ref-type="bibr" rid="bibr128-0192623312444471">Morré et al. 1995</xref>). Without added epidermal growth factor (EGF), 50% growth inhibition of HeLa cells was noted at 1 µM capsaicin, and with the addition of EGF, complete growth inhibition occurred at 1 µM. Capsaicin was largely without effect in mammary epithelial cells, rat kidney cells, or HL-60 cells induced to differentiate with DMSO. In a subsequent study, <xref ref-type="bibr" rid="bibr126-0192623312444471">Morré et al. (1996</xref>) reported that capsaicin inhibited the growth of human A-375 melanoma cells with an EC<sub>50</sub> value of ∼6 µM (but human melanoma cell line SK-MEL-28 was resistant to capsaicin). However, growth of primary melanocytes was not inhibited with 10 µM capsaicin and only ∼20% by 1 mM capsaicin.</p>
<p>One important early observation was that the NADPH oxidase activity in plasma membranes was inhibited by capsaicin in HeLa, ovarian carcinoma, mammary adenocarcinoma, and HL-60 cells (with an ED<sub>50</sub> value of 5 nM in HeLa cells). In contrast, the NADPH oxidase activity in plasma membranes of normal human mammary epithelial, rat liver, normal rat kidney cells, or HL-60 cells induced to differentiate with DMSO was not inhibited by capsaicin (Morré et al. <xref ref-type="bibr" rid="bibr125-0192623312444471">1995</xref>). Subsequently, this group claimed that a cancer-specific form of NADPH oxidase modulated by capsaicin is present in sera from cancer patients, but absent from the sera of individuals free of cancer (<xref ref-type="bibr" rid="bibr127-0192623312444471">Morré et al. 1997</xref>). Additional studies of plasma membrane NADPH oxidase by Morré and colleagues led to the designation of the cancer-specific and growth-related cell surface protein with both oxidative (hydroquinone) and protein disulfide-thiol interchange activity as tNOX (<xref ref-type="bibr" rid="bibr130-0192623312444471">Morré et al. 1998</xref>; the official full name of tNOX is ecto-NOX disulfide-thiol exchanger). Chueh et al. (<xref ref-type="bibr" rid="bibr46-0192623312444471">2004</xref>) found that vector-forced overexpression of tNOX in MCF-10A mammary epithelia or COS cells that lack tNOX or in COS cells that underexpress tNOX enhanced the susceptibility of apoptosis induction by capsaicin. Moreover, antisense tNOX DNA abrogated growth inhibition by capsaicin and reduced anchorage-dependent growth of HeLa cells. The authors concluded that cell surface expression of tNOX is both necessary and sufficient for the anticancer activities attributed to capsaicin. Subsequently, tNOX has been cloned (<xref ref-type="bibr" rid="bibr81-0192623312444471">Jiang et al. 2008</xref>), but the existence of more than twenty different isoforms dependent on parental tissue and cancer type led to the conclusion that a single, highly effective treatment for all types of cancer is unlikely (Morré et al. 2009).</p>
<p>There are NADPH oxidases that are distinct from cell-surface tNOX enzymes and the plasma membrane electron transport system. NADPH oxidase also constitutes part of complex I of the mitochondrial electron transport chain, which is involved in oxidative metabolism (<xref ref-type="bibr" rid="bibr86-0192623312444471">Kamata 2009</xref>). Capsaicin directly inhibits mitochondrial NADPH oxidase activity by binding competitively to the ubiquinone/coenzyme Q site on this enzyme and has been termed an “antagonist” to ubiquinone (<xref ref-type="bibr" rid="bibr158-0192623312444471">Shimomura et al. 1989</xref>; <xref ref-type="bibr" rid="bibr156-0192623312444471">Satoh et al. 1996</xref>). Capsaicin even more strongly inhibited activity of mitochondrial complex III in pancreatic cancer cells (<xref ref-type="bibr" rid="bibr144-0192623312444471">Pramanik et al. 2011</xref>). Therefore, if capsaicin blocks electron transport in mitochondria, dissipation of transmembrane mitochondrial potential (ΔΨ<sub>m</sub>) should follow. Indeed, capsaicin is widely reported to cause the dissipation of ΔΨ<sub>m</sub> in cancerous cells, as is summarized in <xref ref-type="table" rid="table5-0192623312444471">Table 5</xref>. Loss of ΔΨ<sub>m</sub> is widely understood to initiate apoptosis through causing mitochondrial permeability, which leads to the release of cytochrome c and subsequent activation of pro-apoptotic pathways. ΔΨ<sub>m</sub> dissipation is associated with hyperproduction of reactive oxygen species (ROS), although it is unclear whether this hyperproduction initiates or follows ΔΨ<sub>m</sub> dissipation (see discussion below).</p>
<p>Several lines of evidence suggest that the selective action of capsaicin against some cancerous cells may be via convergence on mitochondrial pathways. Not only does capsaicin cause the dissipation of ΔΨ<sub>m</sub> , but at least in some cancerous cells, it also induces large increases in intracellular calcium, mediated by activation of TRPV1, which is expressed both in plasma and in intracellular membranes (<xref ref-type="bibr" rid="bibr70-0192623312444471">Han et al. 2007</xref>). Together, these multiple sources of calcium provide a substantial load for intracellular buffering capacity. Mitochondria are important buffers for high intracellular calcium, and it is widely appreciated that they can be overwhelmed by excessively high calcium loads (<xref ref-type="bibr" rid="bibr42-0192623312444471">Chinopoulos and Adam-Vizi 2010</xref>). At this time, in cancerous cells that express TRPV1, there are scant data regarding the relative contributions of the inhibition of mitochondrial electron transport and excessive TRPV1-mediated calcium load to mitochondrial permeability, which leads to release of cytochrome c and subsequent activation of pro-apoptotic pathways. <xref ref-type="fig" rid="fig4-0192623312444471">Figure 4</xref> depicts the key elements of these pathways. The existence of multiple sites of action (inhibition of NADPH oxidases, mitochondrial electron chain transport, etc.) may make it difficult to determine whether one mechanism is generally more important for capsaicin’s anticancer actions. Given the heterogeneity between types of cancerous cells and the possible differential sensitivity to capsaicin, such a generalization may not even be possible.</p>
<fig id="fig4-0192623312444471" position="float">
<label>Figure 4.</label>
<caption>
<p>Schema showing pro-apoptotic pathways activated potentially by capsaicin in some cancerous cells.</p>
</caption>
<graphic xlink:href="10.1177_0192623312444471-fig4.tif"/>
</fig>
<p>The relationship between capsaicin exposure and generation of ROS is also quite complex. In normal cells, ROS are conventionally thought as cytotoxic and mutagenic, and at high levels they can induce cell death, apoptosis, and senescence (<xref ref-type="bibr" rid="bibr68-0192623312444471">Hail and Lotan 2009</xref>). In contrast, ROS at low levels are understood to function as signaling molecules involved in cell growth, migration, differentiation, and gene expression. Relative to normal cells, tumors contain higher levels of ROS (<xref ref-type="bibr" rid="bibr68-0192623312444471">Hail and Lotan 2009</xref>). Many groups have suggested that capsaicin induces apoptosis in cancerous cells via the generation of even higher levels of intracellular ROS (<xref ref-type="table" rid="table5-0192623312444471">Table 5</xref>). For instance, Macho and coworkers addressed the relationship between capsaicin-induced apoptosis and ROS, generation by studying human T cell lymphoblast Jurkat cells. In these rigorous studies, they found that DNA disruption induced by 100–300 µM is preceded by ΔΨ<sub>m</sub> dissipation, with ROS increases being independent of mitochondrial respiration, as pretreatment with cyclosporin A or <italic>N</italic>-acetylcysteine blocked ΔΨ<sub>m</sub> disruption and apoptosis, but not the generation of ROS (<xref ref-type="bibr" rid="bibr115-0192623312444471">Macho et al. 1998</xref>). In the second study, 250 µM capsaicin induced rapid increases of ROS, which were followed by a disruption of ΔΨ<sub>m</sub> (Macho et al. <xref ref-type="bibr" rid="bibr116-0192623312444471">1999</xref>); blocking mitochondrial respiration did not reduce ROS induction by capsaicin. Consistent with the relative insensitivity of normal cells, which do not express TRPV1 to capsaicin, capsaicin (even at 300 µM for 5 days) failed to initiate ROS production, apoptosis or Ca<sup>2+</sup> mobilization in resting T cells. In contrast, other laboratories have reported that the anticancer activities of capsaicin are due to a reduction of ROS levels (<xref ref-type="bibr" rid="bibr141-0192623312444471">Patel, Varney, et al. 2002</xref>; Y. S. <xref ref-type="bibr" rid="bibr105-0192623312444471">Lee et al. 2004</xref>; <xref ref-type="bibr" rid="bibr146-0192623312444471">Qiao et al. 2005</xref>). For instance, <xref ref-type="bibr" rid="bibr31-0192623312444471">Brar et al. (2001</xref>) found that capsaicin inhibited the growth of melanoma and other malignant cell lines. In these cells, O<sub>2</sub>
<sup>−</sup> generation was reduced by capsaicin, suggesting that electron transfer from NADPH oxidase may be an important source of endogenous ROS in tumor cells, which could constitutively activate NF-κB (nuclear factor κ-light-chain-enhancer of activated B cells) in an autocrine fashion. Therefore, the relationship between intracellular ROS levels and apoptosis of cancer cells may be dependent upon the differentiated phenotype of cancer cell, and despite the numerous studies in this area, the roles which the regulation of ROS play in the initiation and progression of cancer and the induction of apoptosis are not well understood.</p>
<p>NF-κB is a ubiquitous and evolutionarily conserved transcription factor that regulates the expression of genes involved in the transformation, survival, proliferation, invasion, angiogenesis, metastasis, and drug resistance of tumor cells (<xref ref-type="bibr" rid="bibr66-0192623312444471">Gupta et al. 2010</xref>; <xref ref-type="bibr" rid="bibr114-0192623312444471">Luqman and Pezzuto 2010</xref>). Constitutively, active NF-κB has now been identified in tissues from most cancer patients. A consistent observation is that capsaicin inhibits expression of the pro-inflammatory NF-κB in both normal cells exposed to stressors (Lee et al. <xref ref-type="bibr" rid="bibr99-0192623312444471">2007</xref>; <xref ref-type="bibr" rid="bibr88-0192623312444471">Kang et al. 2007</xref>; <xref ref-type="bibr" rid="bibr113-0192623312444471">Luqman et al. 2011</xref>) and cancerous cells (e.g., <xref ref-type="bibr" rid="bibr124-0192623312444471">Mori et al. 2006</xref>). Capsaicin concentration dependently blocked TNFα-induced NFκB activation in stably transfected 293/NFκB-Luc human embryonic kidney cells with an IC<sub>50</sub> value of 0.68 µM, while no cytotoxicity was observed at 65.5 µM (Luqman et al. 2011).</p>
<p>Another unresolved issue is to what degree the anticancer activity of capsaicin is mediated by TRPV1 receptors. In the studies listed in <xref ref-type="table" rid="table5-0192623312444471">Table 5</xref>, some cancer cell lines were shown to express TRPV1, while many others show either no receptor mRNA and/or protein. Block of effects by receptor antagonists is an obvious way to suggest TRPV1 involvement, and several reports show that capsazepine or other TRPV1 antagonists block the pro-apoptotic effects of capsaicin. However, the interpretation of these data is clouded by the limited selectivity of the early antagonists (e.g., Ruthenium Red) and substantial species differences reported for the commonly used capsazepine (Valenzano and Sun <xref ref-type="bibr" rid="bibr183-0192623312444471">2004</xref>). Notably, unlike the TRP channels TRPM8, TRPV6 and TRPM1, there is little data to suggest either a causative role for TRPV1 in cancer pathogenesis or even increased expression with cancer (<xref ref-type="bibr" rid="bibr108-0192623312444471">Lehen’kyi and Prevarskaya 2011</xref>).</p>
<p>Adding more complexity to the issue of TRPV1 involvement in capsaicin’s anticancer activities, multiple laboratories have reported that capsazepine actually mimics the effects of capsaicin on cancer cell viability (e.g., <xref ref-type="bibr" rid="bibr89-0192623312444471">Kim et al. 2004</xref>). In a revealing set of experiments, <xref ref-type="bibr" rid="bibr17-0192623312444471">Athanasiou et al. (2007</xref>) showed that capsazepine and one of the new highly selective antagonists (SB366791) were both able to induce apoptosis in the human non-small cell lung cancer line H460 and disrupt ΔΨ<sub>m</sub>. Strikingly, capsaicin caused a decrease in mitochondrial OH<sup>-</sup> production, while capsazepine increased it. The authors concluded that, for apopotosis induction, whether vanilloid ligands increase or decrease ROS production is less important than the disruption of ΔΨ<sub>m</sub> and the consequent increase in mitochondrial permeability and release of cytochrome c. Therefore, inhibition of any step in the mitochondrial electron transport chain — whether at complex I and/or III — is sufficient to make cancerous cells prone to apoptosis. They suggest that cancerous cells that express TRPV1 channels are even more susceptible to capsaicin-induced apoptosis, as the increased cytosolic calcium load further compromises the integrity of mitochondria.</p>
<p>In summary, the mechanisms of capsaicin’s anticancer activities are complex and require additional elucidation. <xref ref-type="fig" rid="fig4-0192623312444471">Figure 4</xref> briefly summarizes some of the TRPV1-dependent and -independent pro-apoptotic mechanisms described in this section. Because of the phenotypic and genotypic diversity intrinsic to cancer, it is quite unlikely that these potential pathways are generalizable to all cancerous cells. Moreover, as a pleitrophic molecule with potentially multiple mechanisms of action at high concentrations, it is quite likely that capsaicin works through multiple pathways, and several of these do not involve activation of the TRPV1 receptor. Other than inhibition of metabolic activation of carcinogens and induction of apoptosis in a wide variety of cancer cells, mechanisms suggested to account for capsaicin’s anticancer activities include antioxidant activity (<xref ref-type="bibr" rid="bibr49-0192623312444471">Dairam et al. 2008</xref>), activation of peroxisome proliferator-activated receptor gamma (C. S. <xref ref-type="bibr" rid="bibr89-0192623312444471">Kim et al. 2004</xref>), inhibition of angiogenesis (<xref ref-type="bibr" rid="bibr123-0192623312444471">Min et al. 2004</xref>), modulation of lipid metabolism due to cancer (<xref ref-type="bibr" rid="bibr13-0192623312444471">Anandakumar, Jagan, Kamaraj, et al. 2009</xref>) and inhibition of aromatase activity (Luqman et al. 2011).</p>
</sec>
<sec id="section8-0192623312444471">
<title>Human Exposure and Epidemiological Studies</title>
<p>The relevancy of the dose levels administered to rodents in <italic>in vivo</italic> toxicology studies is provided context by reports on levels of actual human consumption and exposure. For instance, the maximum daily intake of capsaicin in the United States and Europe from chilies and paprika was calculated to be 1.5 mg/person/day (<xref ref-type="bibr" rid="bibr65-0192623312444471">Govindarajan and Sathyanarayana 1991</xref>). Alternately, the mean and maximum intake of capsaicin from industrially prepared food products containing the recommended general limit of 5 ppm would be 0.77 and 2.64 mg/day, respectively (CREDOC/OCA <xref ref-type="bibr" rid="bibr48-0192623312444471">1998</xref>); this would translate into a maximum of about 0.05 mg/kg for a 60 kg person. Finally, in countries such as Thailand and Mexico, which consume relatively large quantities of capsaicin-containing peppers, the daily intake of total capsaicinoids for a 50 kg body person was estimated to be 0.5 to 4 mg/kg per day (<xref ref-type="bibr" rid="bibr47-0192623312444471">Council of Europe 2001</xref>). Assuming capsaicin constitutes 60% of the total capsaicinoids, and using 60 kg as average body weight, the maximum intake would be about 2.9 mg/kg per day.</p>
<p>There is only one publication on plasma concentrations following the ingestion of peppers. In a study conducted in Thailand, the maximum average plasma concentration of capsaicin observed following oral administration of 5 g of standardized chili peppers was 8.1 nM (<xref ref-type="bibr" rid="bibr36-0192623312444471">Chaiyasit et al. 2009</xref>). Similarly, there is very limited data on systemic exposure following topical administration of capsaicin-containing medical products. In the only published study, following a 60-min administration of cutaneous high-concentration (8% w/w) capsaicin patch for pain management, the mean population C<sub>max</sub> was 1.38 ng/mL and the highest plasma concentration measured in any patient at any time point was 17.8 ng/mL, or 58 nM (<xref ref-type="bibr" rid="bibr21-0192623312444471">Babbar et al. 2009</xref>). In addition to low maximal levels, the plasma half life of capsaicin was quite short: about 25 min following oral administration (<xref ref-type="bibr" rid="bibr36-0192623312444471">Chaiyasit et al. 2009</xref>) and about 98 min when delivered through the skin (<xref ref-type="bibr" rid="bibr21-0192623312444471">Babbar et al. 2009</xref>). The rapid clearance of capsaicin is likely related to significant first-pass hepatic metabolism (<xref ref-type="bibr" rid="bibr53-0192623312444471">Donnerer et al. 1990</xref>; Chanda et al. 2008). Adding to the expectation of very modest systemic exposure, the water solubility of capsaicin is very low, in the range of ∼60 ng/mL under saturated conditions (<xref ref-type="bibr" rid="bibr179-0192623312444471">Turgut et al. 2004</xref>). As is generally the case with water-insoluble drugs, an assessment of protein binding of capsaicin in human plasma indicates that capsaicin is highly protein bound (∼93%; <xref ref-type="bibr" rid="bibr181-0192623312444471">US FDA 2009</xref>). Therefore, it is likely that circulating levels of free capsaicin are quite low.</p>
<p>Several epidemiological studies pertain to the potential carcinogenic effects of capsaicin. A significantly increased incidence of gastric cancer amongst high chili pepper consumers in Mexico who were estimated to consume 90–250 mg of capsaicin per day (the equivalent maximum of about 4.2 mg/kg per day) has been reported (<xref ref-type="bibr" rid="bibr110-0192623312444471">López-Carrillo et al. 1994</xref>; <xref ref-type="bibr" rid="bibr111-0192623312444471">López-Carrillo et al. 2003</xref>). Interestingly, López-Carrillo and colleagues suggested that a previous report from Korea (<xref ref-type="bibr" rid="bibr100-0192623312444471">Lee et al. 1995</xref>) corroborated the finding from Mexico. However, <xref ref-type="bibr" rid="bibr100-0192623312444471">Lee et al. (1995</xref>) described only a positive relationship between stomach cancer and consumption of hot pepper-soybean paste stew based on a questionnaire administered to hospitalized patients in Seoul and the capsaicin content of this stew was not estimated. In a hospital-based study conducted in India, cases of stomach cancer were matched to control; food group analysis suggested that consumption of chilies was a significant risk factor (<xref ref-type="bibr" rid="bibr57-0192623312444471">Gajalakshmi and Shanta 1996</xref>). More recently, two groups (<xref ref-type="bibr" rid="bibr157-0192623312444471">Serra et al. 2002</xref>; <xref ref-type="bibr" rid="bibr23-0192623312444471">Báez et al. 2010</xref>) have reported that gall bladder cancer patients in Chile consume significantly higher amounts of red chili pepper relative to controls. In an attempt to determine a causal relationship, <xref ref-type="bibr" rid="bibr177-0192623312444471">Tsuchiya et al. (2011</xref>) not only failed to detect capsaicin-induced genotoxicity (discussed above) but also confirmed the presence of the carcinogenic aflatoxins B1 and G1 in chili pepper samples from the region. Finally, in an analysis of U.S. population and mortality data, significantly higher rates for stomach and liver cancer were found in counties inhabited by four ethnic-cultural groups that were conjectured to consume more black pepper and chili peppers (Archer and Jones <xref ref-type="bibr" rid="bibr18-0192623312444471">2002</xref>); this conjecture was unsupported by data, as there was no attempt to quantify capsaicin consumption.</p>
<p>Chili pepper plants and their fruits may be contaminated with pesticides, insecticides, fertilizers, herbicides, microbiocides, or heavy metals. For instance, an assessment of pesticide content of chili peppers in the United States found that 55% of samples contained pesticide residues, with an average amount of 0.290 ppm; fifty-one different pesticides were identified (<xref ref-type="bibr" rid="bibr55-0192623312444471">Environmental Working Group, 2010</xref>). In California alone, 37,642 pounds of at least ten different classes of pesticides were applied to chili pepper crops in 2009 (<xref ref-type="bibr" rid="bibr143-0192623312444471">Pesticides Action Network Pesticides Database, 2009</xref>). Many countries outside the United States appear to have much less stringent standards regarding the types of pesticides in use. There can be little doubt that some pesticides are human carcinogens (e.g., there is a clear relationship between cumulative exposure and lymphoma in farmworkers), although the extent of the public health issue remains controversial (<xref ref-type="bibr" rid="bibr25-0192623312444471">Bassil et al. 2007</xref>).</p>
<p>Other non-pesticide carcinogens have also been found in chilies. When twenty chili samples from different suppliers obtained in Germany were analyzed for volatile <italic>N</italic>-nitroso compounds, over 75% of both dried, whole chilies and chili powder samples analyzed contained <italic>N</italic>-nitrosodimethylamine and <italic>N</italic>-nitrosopyrrolidine, at levels up to 6 µg/kg (<xref ref-type="bibr" rid="bibr175-0192623312444471">Tricker et al. 1988</xref>). The same group also found in a small survey of foodstuffs from an area in India with high esophageal cancer rates that chilies purchased in that area contained <italic>N</italic>-nitrosopyrrolidine (<xref ref-type="bibr" rid="bibr161-0192623312444471">Siddiqi et al. 1988</xref>). Subsequent analyses by the same research group found that consumption of chilies led to exposure to the amines dimethylamine, pyrrolide, and methylbenzylamine; nitrosamine may be formed from these compounds, which is genotoxic (<xref ref-type="bibr" rid="bibr160-0192623312444471">Siddiqi et al. 1992</xref>). Directly relevant to the increased incidence of gallbladder cancer, chili peppers in Chile were contaminated with the genotoxic aflatoxins B1 and G1 at 4.4 ng/g and 0.5 ng/g, respectively (<xref ref-type="bibr" rid="bibr177-0192623312444471">Tsuchiya et al. 2011</xref>).</p>
<p>Therefore, the modest epidemiological evidence suggesting an increased incidence of gastric or gallbladder cancer among high chili pepper consumers should allow for the possibility that contaminants that are carcinogens could have given rise to the putative signal. These studies should be considered inconclusive until additional larger studies exclude potential contributions from carcinogenic contaminants sometimes present in chili peppers.</p>
</sec>
<sec id="section9-0192623312444471">
<title>Discussion</title>
<p>In their frequently cited 1995 review in that capsaicin was referred to as a “double-edged sword,” Surh and Lee (1995) proposed mechanistic bases for the putative carcinogenicity, co-carcinogenicity, and anticarcinogenicity effects of capsaicin. They suggested that although minute amounts of capsaicin display few or no deleterious effects, heavy ingestion of the compound had been associated with carcinogenesis. The presumed underlying basis was that capsaicin is metabolized by CYP P450s to electrophilic compounds, that may subsequently interact with DNA in an irreversible manner, thereby triggering mutagenicity and malignant transformation. For the anticancer mechanism, it was suggested that the ability of capsaicin to alter carcinogen metabolism via CYP inhibition (especially CYP2E1) provided the primary rationale for application of this compound to cancer chemoprevention and inhibitory effects on the metabolism, DNA binding, mutagenicity and tumorigenicity of various carcinogens.</p>
<p>Our literature review suggests that there is very limited evidence for the pro- and anticancer mechanisms described by Surh and Lee (1995) and subsequently <xref ref-type="bibr" rid="bibr148-0192623312444471">Reilly and Yost (2006</xref>). We conclude that the <italic>in vitro</italic> data supporting the putative reactive metabolite genotoxic mechanism are weak: assumptions that formation of reactive metabolites inevitably lead to carcinogenicity are questionable, as the propensity for covalent binding of metabolites does not even predict hepatotoxicity, and the liver should be the organ most susceptible to damage by reactive metabolites (Park et al. 2011). Moreover, the presence of these putative highly reactive capsaicin metabolites has never been demonstrated <italic>in vivo</italic>, only in experimental situations that did not provide for quantification of the relative amounts of metabolites.</p>
<p>Regarding the putative anticancer mechanisms involving inhibition of carcinogen activation, based on recent human pharmacokinetic and <italic>in vitro</italic> metabolism data, no significant inhibition of any CYP—especially CYP2E1—is likely to occur following either ingestion of chili peppers or topical administration of a capsaicin-containing pain medicine. Given the very low levels of systemic exposure that are reported in humans, coupled with the low potency of capsaicin to inhibit CYPs, systemic inhibition of metabolic activation of carcinogens is unlikely to contribute significantly to the anticancer properties of capsaicin.</p>
<p>Very few of the studies summarized here were intended to define the activity of concentrations of capsaicin available to humans through diet, environment or medical products. Rather, the intention seems to have been to employ either a capsaicin concentration or a dose that would generate measurable and reproducible effects. For a number or reasons—not least of that is the low aqueous solubility of capsaicin—it seems quite unlikely that the high concentrations and dose levels administered to rodents or <italic>in vitro</italic> systems could be readily achieved in humans.</p>
<p>Ultimately, the ability of capsaicin or its putative reactive metabolites to induce pro-cancer effects would most likely depend upon a substantial local accumulation of those compounds in organs or tissues. At this time, there is no published data pointing to the accumulation of capsaicin or any of its metabolites in the liver, stomach, skin, or other organs. Clearly, much more information about capsaicin’s pharmacokinetic profile would be needed to render credible either the previously postulated pro- or anticancer mechanisms, for any potential target organ. Therefore, other explanations for capsaicin’s anticancer properties may be more important, such as the ability to inhibit selectively mitochondrial function in cancerous cells, modulate changes in lipid metabolism due to carcinogens, or serve as an antioxidant. Still, the absence of evidence for high levels of systemic exposure has not prevented speculation regarding usefulness as a cancer treatment or in chemoprevention and the subsequent inclusion of capsaicin in anticancer nutritional supplements. Recently, the US FDA warned a nutritional supplement manufacturer that a product that contains 55 mg of purified capsaicin could not be promoted to prevent or slow the development of cancer cells (<xref ref-type="bibr" rid="bibr182-0192623312444471">US FDA 2011</xref>). At this time, the only data-driven recommendation is that a diet rich in vegetables, fruits, seeds, and spices, that will contain capsaicin and a variety of similar phenolic compounds, may be effective for the prevention of some types of cancer (<xref ref-type="bibr" rid="bibr66-0192623312444471">Gupta et al. 2010</xref>).</p>
<p>Much remains to be learned about the relationship of capsaicin to carcinogenesis, despite the appearance of new information at an increasingly greater rate. Mechanistic or safety conclusions based on older studies that used capsaicin concentrations of questionable physiological relevance or capsaicin of unknown purity should be modified to give weight to more recent data that are based on capsaicin of known purity and concentrations more reflective of potential real-world human exposure. Small epidemiological studies in which capsaicin-containing foods were associated with increased cancer provide little basis for human health concerns because of potential contamination by known carcinogens. Of great interest would be carefully controlled studies comprehensively monitoring other dietary and environmental carcinogens sufficiently powered to detect capsaicin’s potential carcinogenic or cancer-protective effects.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict" id="fn1-0192623312444471">
<p>The authors declared the following potential conflict of interest with respect to the research, authorship, and/or publication of this article: Keith Bley and Sunita Bubbar were formerly employees of NeurogesX, Inc., which markets Qutenza®, a prescription capsaicin pain medicine.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-0192623312444471">
<p>The authors received the following financial support with respect to the research, authorship, and/or publication of this article: Keith Bley and Sunita Bubbar were employees of NeurogesX during the time that this article was prepared.</p>
</fn>
</fn-group>
<glossary content-type="abbr">
<title>Abbreviations</title>
<def-list>
<def-item>
<term id="term1-0192623312444471">CBMN</term>
<def>
<p>cytokinesis-block micronucleus</p>
</def>
</def-item>
<def-item>
<term id="term2-0192623312444471">DBN</term>
<def>
<p>
<italic>N,N</italic>-dibutylnitrosamine</p>
</def>
</def-item>
<def-item>
<term id="term3-0192623312444471">DEN</term>
<def>
<p>diethylnitrosamine</p>
</def>
</def-item>
<def-item>
<term id="term4-0192623312444471">DMBA</term>
<def>
<p>dimethylbez(a)-arthracene</p>
</def>
</def-item>
<def-item>
<term id="term5-0192623312444471">EGF</term>
<def>
<p>epidermal growth factor</p>
</def>
</def-item>
<def-item>
<term id="term6-0192623312444471">HBPLcs</term>
<def>
<p>human peripheral blood lymphocytes</p>
</def>
</def-item>
<def-item>
<term id="term7-0192623312444471">MNNG</term>
<def>
<p>
<italic>N</italic>-methyl-<italic>N’</italic>-nitro-<italic>N</italic>-nitrosoguanidine</p>
</def>
</def-item>
<def-item>
<term id="term8-0192623312444471">MNU</term>
<def>
<p>
<italic>N</italic>-methylnitrosourea</p>
</def>
</def-item>
<def-item>
<term id="term9-0192623312444471">NDMA</term>
<def>
<p>
<italic>N-</italic>nitrosodimethylamine</p>
</def>
</def-item>
<def-item>
<term id="term10-0192623312444471">SCE</term>
<def>
<p>sister chromatid exchange</p>
</def>
</def-item>
<def-item>
<term id="term11-0192623312444471">TPA</term>
<def>
<p>tetradecanoylphorbol-13-acetate</p>
</def>
</def-item>
<def-item>
<term id="term12-0192623312444471">VC</term>
<def>
<p>vinyl carbamate</p>
</def>
</def-item>
</def-list>
</glossary>
<ref-list>
<title>References</title>
<ref id="bibr1-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agrawal</surname>
<given-names>R. C.</given-names>
</name>
<name>
<surname>Wiessler</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hecker</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bhide</surname>
<given-names>S. V.</given-names>
</name>
</person-group> (<year>1986</year>). <article-title>Tumour-promoting effect of chilli extra in BALB/c mice</article-title>. <source>Int J Cancer</source> <volume>38</volume>, <fpage>689</fpage>–<lpage>95</lpage>.</citation>
</ref>
<ref id="bibr2-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akagi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sano</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Uehara</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Minami</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Otsuka</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Izumi</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Non-carcinogenicity of capsaicinoids in B6C3F1 mice</article-title>. <source>Food Chem Toxicol</source> <volume>36</volume>, <fpage>1065</fpage>–<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr3-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alawi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Keeble</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation</article-title>. <source>Pharmacol Ther</source> <volume>125</volume>, <fpage>181</fpage>–<lpage>95</lpage>.</citation>
</ref>
<ref id="bibr4-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amantini</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ballarini</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Caprodossi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nabissi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Morelli</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Lucciarini</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Cardarelli</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Mammana</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Santoni</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Triggering of transient receptor potential vanilloid type 1 (TRPV1) by capsaicin induces Fas/CD95-mediated apoptosis of urothelial cancer cells in an ATM-dependent manner</article-title>. <source>Carcinogenesis</source> <volume>30</volume>, <fpage>1320</fpage>–<lpage>29</lpage>.</citation>
</ref>
<ref id="bibr5-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amantini</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mosca</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nabissi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lucciarini</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Caprodossi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Arcella</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Giangaspero</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Santoni</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Capsaicin-induced apoptosis of glioma cells is mediated by TRPV1 vanilloid receptor and requires p38 MAPK activation</article-title>. <source>J Neurochem</source> <volume>102</volume>, <fpage>977</fpage>–<lpage>90</lpage>.</citation>
</ref>
<ref id="bibr6-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ames</surname>
<given-names>B. N.</given-names>
</name>
<name>
<surname>McCann</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yamasaki</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>1975</year>). <article-title>Methods for detecting carcinogens and mutagens with the <italic>Salmonella</italic>/microsome test: Assay of 300 chemicals</article-title>. <source>Mutat Res</source> <volume>31</volume>, <fpage>347</fpage>–<lpage>64</lpage>.</citation>
</ref>
<ref id="bibr7-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anand</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bley</surname>
<given-names>K. R.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Topical capsaicin for pain management: Therapeutic potential and mechanism of action of the new high-concentration 8% patch</article-title>. <source>Brit J Anaesth</source> <volume>107</volume>, <fpage>490</fpage>–<lpage>502</lpage>.</citation>
</ref>
<ref id="bibr8-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anandakumar</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Jagan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kamaraj</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ramakrishnan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Titto</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Devaki</surname>
<given-names>T</given-names>
</name>
</person-group>. (<year>2008</year>). <article-title>Beneficial influence of capsaicin on lipid peroxidation, membrane-bound enzymes and glycoprotein profile during experimental lung carcinogenesis</article-title>. <source>J Pharm Pharmacol</source> <volume>60</volume> <fpage>803</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr9-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anandakumar</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kamaraj</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jagan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ramakrishnan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Vinodhkumar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Devaki</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2008a</year>). <article-title>Stabilization of pulmonary mitochondrial enzyme system by capsaicin during benzo(a)pyrene induced experimental lung cancer</article-title>. <source>Biomed Pharmacother</source> <volume>62</volume>, <fpage>390</fpage>–<lpage>94</lpage>.</citation>
</ref>
<ref id="bibr10-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anandakumar</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kamaraj</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jagan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ramakrishnan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Vinodhkumar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Devaki</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2008b</year>). <article-title>Capsaicin modulates pulmonary antioxidant defense system during benzo(a)pyrene-induced lung cancer in Swiss albino mice</article-title>. <source>Phytother Res</source> <volume>22</volume>, <fpage>529</fpage>–<lpage>33</lpage>.</citation>
</ref>
<ref id="bibr11-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anandakumar</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kamaraj</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jagan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ramakrishnan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Devaki</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2009a</year>). <article-title>Effect of capsaicin on glucose metabolism studied in experimental lung carcinogenesis</article-title>. <source>Nat Prod Res</source> <volume>23</volume>, <fpage>763</fpage>–<lpage>74</lpage>.</citation>
</ref>
<ref id="bibr12-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anandakumar</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kamaraj</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jagan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ramakrishnan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Devaki</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2009b</year>). <article-title>Lysosomal abnormalities during benzo(a)pyrene-induced experimental lung carcinogenesis--defensive role of capsaicin</article-title>. <source>Fundam Clin Pharmacol</source> <volume>23</volume>, <fpage>97</fpage>–<lpage>103</lpage>.</citation>
</ref>
<ref id="bibr13-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anandakumar</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Jagan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kamaraj</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ramakrishnan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Clara</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>Pathitha</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kavitha</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Devaki</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Ameliorating effect of capsaicin on alterations in lipid metabolism during mice lung carcinoma</article-title>. <source>Arch Pharm Res</source> <volume>32</volume>, <fpage>229</fpage>–<lpage>34</lpage>.</citation>
</ref>
<ref id="bibr14-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anandakumar</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kamaraj</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ramakrishnan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Jagan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Devaki</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Chemopreventive task of capsaicin against benzo(a)pyrene-induced lung cancer in Swiss albino mice</article-title>. <source>Basic Clin Pharmacol Toxicol</source> <volume>104</volume>, <fpage>360</fpage>–<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr15-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anandakumar</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kamaraj</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jagan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ramakrishnan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Naveenkumar</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Asokkumar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Devaki</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Capsaicin alleviates the imbalance in xenobiotic metabolizing enzymes and tumor markers during experimental lung tumorigenesis</article-title>. <source>Mol Cell Biochem</source> <volume>331</volume>, <fpage>135</fpage>–<lpage>43</lpage>.</citation>
</ref>
<ref id="bibr16-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arceo</surname>
<given-names>S. D. B.</given-names>
</name>
<name>
<surname>Madrigal-Bujaidar</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Montellano</surname>
<given-names>E. C.</given-names>
</name>
<name>
<surname>Herrera</surname>
<given-names>L. R.</given-names>
</name>
<name>
<surname>Garcıa</surname>
<given-names>B. D. D.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Genotoxic effects produced by capsaicin in mouse during subchronic treatment</article-title>. <source>Mutat Res</source> <volume>345</volume>, <fpage>105</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr17-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Athanasiou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Vakilpour</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kumaran</surname>
<given-names>N. M.</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>Bagiokou</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Layfield</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ray</surname>
<given-names>D. E.</given-names>
</name>
<name>
<surname>Westwell</surname>
<given-names>A. D.</given-names>
</name>
<name>
<surname>Alexander</surname>
<given-names>S. P.</given-names>
</name>
<name>
<surname>Kendall</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Lobo</surname>
<given-names>D. N.</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Lophatanon</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Muir</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Bates</surname>
<given-names>T. E.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Vanilloid receptor agonists and antagonists are mitochondrial inhibitors: How vanilloids cause non-vanilloid receptor mediated cell death</article-title>. <source>Biochem Biophys Res Commun</source> <volume>354</volume>, <fpage>50</fpage>–<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr18-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Archer</surname>
<given-names>V. E.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>D. W.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Capsaicin pepper, cancer and ethnicity</article-title>. <source>Med Hypotheses</source> <volume>59</volume>, <fpage>450</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr19-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Azizan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Blevins</surname>
<given-names>R. D.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Mutagenicity and antimutagenicity testing of six chemicals associated with the pungent properties of specific spices as revealed by the Ames Salmonella/Microsomal Assay</article-title>. <source>Arch Environ Contam Toxicol</source> <volume>28</volume>, <fpage>248</fpage>–<lpage>58</lpage>.</citation>
</ref>
<ref id="bibr20-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Babbar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chanda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bley</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Inhibition and induction of human cytochrome P450 enzymes <italic>in vitro</italic> by capsaicin</article-title>. <source>Xenobiotica</source> <volume>40</volume>, <fpage>807</fpage>–<lpage>16</lpage>.</citation>
</ref>
<ref id="bibr21-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Babbar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Marier</surname>
<given-names>J. F.</given-names>
</name>
<name>
<surname>Mouksassi</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Beliveau</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vanhove</surname>
<given-names>G. F.</given-names>
</name>
<name>
<surname>Chanda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bley</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Pharmacokinetic analysis of capsaicin after topical administration of a high-concentration capsaicin patch to patients with peripheral neuropathic pain</article-title>. <source>Ther Drug Monit</source> <volume>31</volume>, <fpage>502</fpage>–<lpage>10</lpage>.</citation>
</ref>
<ref id="bibr22-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baek</surname>
<given-names>Y. M.</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S. W.</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Yun</surname>
<given-names>J. W.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>A comparative proteomic analysis for capsaicin-induced apoptosis between human hepatocarcinoma (HepG2) and human neuroblastoma (SK-N-SH) cells</article-title>. <source>Proteomics</source> <volume>8</volume>, <fpage>4748</fpage>–<lpage>67</lpage>.</citation>
</ref>
<ref id="bibr23-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Báez</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tsuchiya</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Calvo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pruyas</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kiyohara</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Oyama</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Genetic variants involved in gallstone formation and capsaicin metabolism, and the risk of gallbladder cancer in Chilean women</article-title>. <source>World J Gastroenterol</source> <volume>16</volume>, <fpage>372</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr25-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bassil</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Vakil</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sanborn</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cole</surname>
<given-names>D. C.</given-names>
</name>
<name>
<surname>Kaur</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Kerr</surname>
<given-names>K. J.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Cancer health effects of pesticides: Systematic review</article-title>. <source>Can Fam Physician</source> <volume>53</volume>, <fpage>1704</fpage>–<lpage>11</lpage>.</citation>
</ref>
<ref id="bibr26-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beltran</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Basu</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Immunotherapy of tumors with neuroimmune ligand capsaicin</article-title>. <source>J Immunol</source> <volume>178</volume>, <fpage>3260</fpage>–<lpage>4</lpage>.</citation>
</ref>
<ref id="bibr27-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhutani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pathak</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Nair</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Kunnumakkara</surname>
<given-names>A. B.</given-names>
</name>
<name>
<surname>Guha</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sethi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Aggarwal</surname>
<given-names>B. B.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Capsaicin is a novel blocker of constitutive and interleukin-6-inducible STAT3 activation</article-title>. <source>Clin Cancer Res</source> <volume>13</volume>, <fpage>3024</fpage>–<lpage>32</lpage>.</citation>
</ref>
<ref id="bibr28-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bíró</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Brodie</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Modarres</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lewin</surname>
<given-names>N. E.</given-names>
</name>
<name>
<surname>Acs</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Blumberg</surname>
<given-names>P. M.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Specific vanilloid responses in C6 rat glioma cells</article-title>. <source>Brain Res Mol Brain Res</source> <volume>56</volume>, <fpage>89</fpage>–<lpage>98</lpage>.</citation>
</ref>
<ref id="bibr29-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bode</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>Y. Y.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ericson</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>W. Y.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Transient receptor potential type vanilloid 1 suppresses skin carcinogenesis</article-title>. <source>Cancer Res</source> <volume>69</volume>, <fpage>905</fpage>–<lpage>13</lpage>.</citation>
</ref>
<ref id="bibr30-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bode</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>The two faces of capsaicin</article-title>. <source>Cancer Res</source> <volume>71</volume>, <fpage>2809</fpage>–<lpage>14</lpage>.</citation>
</ref>
<ref id="bibr31-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brar</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>T. P.</given-names>
</name>
<name>
<surname>Whorton</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Sturrock</surname>
<given-names>A. B.</given-names>
</name>
<name>
<surname>Huecksteadt</surname>
<given-names>T. P.</given-names>
</name>
<name>
<surname>Ghio</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Hoidal</surname>
<given-names>J. R.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Reactive oxygen species from NAD(P)H: Quinone oxidoreductase constitutively activate NF-kappaB in malignant melanoma cells</article-title>. <source>Am J Physiol Cell Physiol</source> <volume>280</volume>, <fpage>C659</fpage>–<lpage>76</lpage>.</citation>
</ref>
<ref id="bibr32-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>K. C.</given-names>
</name>
<name>
<surname>Witte</surname>
<given-names>T. R.</given-names>
</name>
<name>
<surname>Hardman</surname>
<given-names>W. E.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y. C.</given-names>
</name>
<name>
<surname>Carpenter</surname>
<given-names>A. B.</given-names>
</name>
<name>
<surname>Lau</surname>
<given-names>J. K.</given-names>
</name>
<name>
<surname>Dasgupta</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Capsaicin displays anti-proliferative activity against human small cell lung cancer in cell culture and nude mice models via the E2F pathway</article-title>. <source>PLoS One</source> <volume>5</volume>, <fpage>e10243</fpage>.</citation>
</ref>
<ref id="bibr33-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buchanan</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Budroe</surname>
<given-names>J. D.</given-names>
</name>
</person-group> (<year>1981</year>). <article-title>Examination of chili pepper and nutmeg oleoresins using the <italic>Salmonella</italic>/mammalian microsome mutagenicity assay</article-title>. <source>J Food Sci</source> <volume>47</volume>, <fpage>330</fpage>–<lpage>3</lpage>.</citation>
</ref>
<ref id="bibr34-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caprodossi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Amantini</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Nabissi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Morelli</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Farfariello</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Santoni</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gismondi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Santoni</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Capsaicin (CPS) promotes a more aggressive gene expression phenotype and invasiveness in null-TRPV1 urothelial cancer cells</article-title>. <source>Carcinogenesis</source> <volume>32</volume>, <fpage>686</fpage>–<lpage>94</lpage>.</citation>
</ref>
<ref id="bibr35-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caterina</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Leffler</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Malmberg</surname>
<given-names>A. B.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>W. J.</given-names>
</name>
<name>
<surname>Trafton</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Petersen-Zeitz</surname>
<given-names>K. R.</given-names>
</name>
<name>
<surname>Koltzenburg</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Basbaum</surname>
<given-names>A. I.</given-names>
</name>
<name>
<surname>Julius</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Impaired nociception and pain sensation in mice lacking the capsaicin receptor</article-title>. <source>Science</source> <volume>288</volume>, <fpage>306</fpage>–<lpage>13</lpage>.</citation>
</ref>
<ref id="bibr36-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaiyasit</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Khovidhunkit</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wittayalertpanya</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Pharmacokinetic and the effect of capsaicin in Capsicum frutescens on decreasing plasma glucose level</article-title>. <source>J Med Assoc Thai</source> <volume>92</volume>, <fpage>108</fpage>–<lpage>13</lpage>.</citation>
</ref>
<ref id="bibr37-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chanda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bashir</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Babbar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Koganti</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bley</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>
<italic>In vitro</italic> hepatic and skin metabolism of capsaicin</article-title>. <source>Drug Metab Dispos</source> <volume>36</volume>, <fpage>670</fpage>–<lpage>75</lpage>.</citation>
</ref>
<ref id="bibr38-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chanda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Erexson</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Riach</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Innes</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Stevenson</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Murli</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bley</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Genotoxicity studies with pure <italic>trans</italic>-capsaicin</article-title>. <source>Mutat Res</source> <volume>557</volume>, <fpage>85</fpage>–<lpage>97</lpage>.</citation>
</ref>
<ref id="bibr39-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chanda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Erexson</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Frost</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Babbar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Burlew</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Bley</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>26-Week dermal oncogenicity study evaluating pure trans-capsaicin in Tg.AC hemizygous mice (FBV/N)</article-title>. <source>Int J Toxicol</source> <volume>26</volume>, <fpage>123</fpage>–<lpage>33</lpage>.</citation>
</ref>
<ref id="bibr40-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>H. C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S. T.</given-names>
</name>
<name>
<surname>Chien</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>H. T.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>D. R.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Capsaicin may induce breast cancer cell death through apoptosis-inducing factor involving mitochondrial dysfunction</article-title>. <source>Hum Exp Toxicol</source> <volume>30</volume>, <fpage>1657</fpage>–<lpage>65</lpage>.</citation>
</ref>
<ref id="bibr41-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaung</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Mi</surname>
<given-names>L. J.</given-names>
</name>
<name>
<surname>Boorstein</surname>
<given-names>R. J.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>The p53 status of Chinese hamster V79 cells frequently used for studies on DNA damage and DNA repair</article-title>. <source>Nucleic Acids Res</source> <volume>25</volume>, <fpage>992</fpage>–<lpage>4</lpage>.</citation>
</ref>
<ref id="bibr42-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chinopoulos</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Adam-Vizi</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Mitochondrial Ca<sup>2+</sup> sequestration and precipitation revisited</article-title>. <source>FEBS J</source> <volume>277</volume>, <fpage>3637</fpage>–<lpage>51</lpage>.</citation>
</ref>
<ref id="bibr43-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>Y. K.</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>S. H.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Autophagy induction by capsaicin in malignant human breast cells is modulated by p38 and extracellular signal-regulated mitogen-activated protein kinases and retards cell death by suppressing endoplasmic reticulum stress-mediated apoptosis</article-title>. <source>Mol Pharmacol</source> <volume>78</volume>, <fpage>114</fpage>–<lpage>25</lpage>.</citation>
</ref>
<ref id="bibr44-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chou</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y. C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y. F.</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>D. R.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Capsaicin-induced apoptosis in human breast cancer MCF-7 cells through caspase-independent pathway</article-title>. <source>Oncol Rep</source> <volume>21</volume>, <fpage>665</fpage>–<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr45-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chow</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Norng</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chai</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>TRPV6 mediates capsaicin-induced apoptosis in gastric cancer cells—mechanisms behind a possible new "hot" cancer treatment</article-title>. <source>Biochim Biophys Acta</source> <volume>1773</volume>, <fpage>565</fpage>–<lpage>76</lpage>.</citation>
</ref>
<ref id="bibr46-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chueh</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>L. Y.</given-names>
</name>
<name>
<surname>Morré</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Morré</surname>
<given-names>D. J.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>tNOX is both necessary and sufficient as a cellular target for the anticancer actions of capsaicin and the green tea catechin (-)-epigallocatechin-3-gallate</article-title>. <source>Biofactors</source> <volume>20</volume>, <fpage>235</fpage>–<lpage>49</lpage>.</citation>
</ref>
<ref id="bibr47-0192623312444471">
<citation citation-type="journal">
<collab collab-type="author">Council of Europe</collab>. (<year>2001</year>). <article-title>Committee of experts on flavouring substances. Datasheet on capsaicin. Cited in: European Commission Scientific Committee on Food</article-title>.</citation>
</ref>
<ref id="bibr48-0192623312444471">
<citation citation-type="journal">
<collab collab-type="author">CREDOC/OCA (Observatoire des Consommations Alimentaires)</collab>. (<year>1998</year>). <source>Estimation des niveaux d’ingestion de substances aromatisantes Safrole, Estragole, Coumarine et Capsaicine</source>. <comment>Note technique No. 98.25. Cited in</comment>: <comment>European Commission Scientific Committee on Food. (2002)</comment>.</citation>
</ref>
<ref id="bibr49-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dairam</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fogel</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Daya</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Limson</surname>
<given-names>J. L.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Antioxidant and iron-binding properties of curcumin, capsaicin, and <italic>S</italic>-allylcysteine reduce oxidative stress in rat brain homogenate</article-title>. <source>J Agric Food Chem</source> <volume>56</volume>, <fpage>3350</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr50-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Agrawal</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sengupta</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Inhibition by capsaicin against cyclophosphamide-induced clastogenicity and DNA damage in mice</article-title>. <source>Mutat Res</source> <volume>335</volume>, <fpage>253</fpage>–<lpage>58</lpage>.</citation>
</ref>
<ref id="bibr51-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author"><name><surname>Degim</surname><given-names>I. T.</given-names></name><name><surname>Uslu</surname><given-names>A.</given-names></name><name><surname>Hadgraft</surname><given-names>J.</given-names></name><name><surname>Atay</surname><given-names>T.</given-names></name><name><surname>Akay</surname><given-names>C.</given-names></name><name><surname>Cevheroglu</surname><given-names>S.</given-names></name></person-group> (<year>1999</year>). <article-title>The effects of Azone and capsaicin on the permeation of naproxen through human skin</article-title>. <source>Int J Pharm</source> <volume>179</volume>, <fpage>21</fpage>–<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr52-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Díaz-Laviada</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Effect of capsaicin on prostate cancer cells</article-title>. <source>Future Oncol</source> <volume>6</volume>, <fpage>1545</fpage>–<lpage>50</lpage>.</citation>
</ref>
<ref id="bibr53-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donnerer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Amann</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Schuligoi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lembeck</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>1990</year>). <article-title>Absorption and metabolism of capsaicinoids following intragastric administration in rats</article-title>. <source>Naunyn Schmiedebergs Arch Pharmacol</source> <volume>342</volume>, <fpage>357</fpage>–<lpage>61</lpage>.</citation>
</ref>
<ref id="bibr54-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dou</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sarkar</surname>
<given-names>F. H.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Tumor cell growth inhibition is correlated with levels of capsaicin present in hot peppers</article-title>. <source>Nutr Cancer</source> <volume>63</volume>, <fpage>272</fpage>–<lpage>81</lpage>.</citation>
</ref>
<ref id="bibr55-0192623312444471">
<citation citation-type="web">
<collab collab-type="author">Environmental Working Group</collab>. <article-title>EWG's Shopper's Guide to Pesticides Compiled from USDA (Pesticide Data Program) and FDA (Pesticide Monitoring Database) Data from 2000 – 2008</article-title>. <ext-link ext-link-type="uri" xlink:href="http://static.foodnews.org/pdf/2010-foodnews-data.pdf">http://static.foodnews.org/pdf/2010-foodnews-data.pdf</ext-link>.</citation>
</ref>
<ref id="bibr56-0192623312444471">
<citation citation-type="web">
<collab collab-type="author">European Commission Scientific Committee on Food</collab>. (<year>2002</year>). <article-title>Opinion of the Scientific Committee on Food on Capsaicin. SCF/CS/FLAVour/8 Add1 Final; 28 Feb 2002</article-title>. <ext-link ext-link-type="uri" xlink:href="http://ec.europa.eu/food/fs/sc/scf/out120_en.pdf">http://ec.europa.eu/food/fs/sc/scf/out120_en.pdf</ext-link>.</citation>
</ref>
<ref id="bibr57-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gajalakshmi</surname>
<given-names>C. K.</given-names>
</name>
<name>
<surname>Shanta</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Lifestyle and risk of stomach cancer: A hospital-based case-control study</article-title>. <source>Int J Epidemiol</source> <volume>25</volume>, <fpage>1146</fpage>–<lpage>53</lpage>.</citation>
</ref>
<ref id="bibr58-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galati</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>O'Brien</surname>
<given-names>P. J.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Cytoprotective and anticancer properties of coenzyme Q versus capsaicin</article-title>. <source>Biofactors</source> <volume>18</volume>, <fpage>195</fpage>–<lpage>205</lpage>.</citation>
</ref>
<ref id="bibr59-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gannett</surname>
<given-names>P. M.</given-names>
</name>
<name>
<surname>Nagel</surname>
<given-names>D. L.</given-names>
</name>
<name>
<surname>Reilly</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Lawson</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sharpe</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Toth</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>1988</year>). <article-title>The capsaicinoids: Their separation, synthesis, and mutagenicity</article-title>. <source>J Org Chem</source> <volume>53</volume>, <fpage>1064</fpage>–<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr60-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gannett</surname>
<given-names>P. M.</given-names>
</name>
<name>
<surname>Iversen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lawson</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>1990</year>). <article-title>The mechanism of inhibition of cytochrome P450IIE1 by dihydrocapsaicin</article-title>. <source>Bioorg Chem</source> <volume>18</volume>, <fpage>185</fpage>–<lpage>98</lpage>.</citation>
</ref>
<ref id="bibr61-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geppetti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Nassini</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Materazzi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Benemei</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>The concept of neurogenic inflammation</article-title>. <source>BJU Int</source> <volume>101</volume>, <fpage>2</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr62-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghosh</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Basu</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Fas-associated factor 1 is a negative regulator in capsaicin induced cancer cell apoptosis</article-title>. <source>Cancer Lett</source> <volume>287</volume>, <fpage>142</fpage>–<lpage>49</lpage>.</citation>
</ref>
<ref id="bibr63-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gil</surname>
<given-names>Y. G.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>M. K.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Capsaicin induces apoptosis and terminal differentiation in human glioma A172 cells</article-title>. <source>Life Sci</source> <volume>82</volume>, <fpage>997</fpage>–<lpage>1003</lpage>.</citation>
</ref>
<ref id="bibr64-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gong</surname>
<given-names>X. F.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M. W.</given-names>
</name>
<name>
<surname>Ikejima</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Mechanisms of capsaicin-induced apoptosis of human melanoma A375-S2 cells. [Article in Chinese]</article-title>. <source>Zhonghua Zhong Liu Za Zhi</source> <volume>27</volume>, <fpage>401</fpage>–<lpage>3</lpage>.</citation>
</ref>
<ref id="bibr65-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Govindarajan</surname>
<given-names>V. S.</given-names>
</name>
<name>
<surname>Sathyanarayana</surname>
<given-names>M. N.</given-names>
</name>
</person-group> (<year>1991</year>). <article-title>Capsicum—production, technology, chemistry, and quality. Part V. Impact on physiology, pharmacology, nutrition, and metabolism; structure, pungency, pain, and desensitization sequences</article-title>. <source>Crit Rev Food Sci Nutr</source> <volume>29</volume>, <fpage>435</fpage>–<lpage>74</lpage>.</citation>
</ref>
<ref id="bibr66-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Prasad</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Aggarwal</surname>
<given-names>B. B.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals</article-title>. <source>Cancer Metastasis Rev</source> <year>2010</year> <volume>29</volume>, <fpage>405</fpage>–<lpage>34</lpage>.</citation>
</ref>
<ref id="bibr67-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hail</surname>
<given-names>N.</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Lotan</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Examining the role of mitochondrial respiration in vanilloid-induced apoptosis</article-title>. <source>J Natl Cancer Inst</source> <volume>94</volume>, <fpage>1281</fpage>–<lpage>92</lpage>.</citation>
</ref>
<ref id="bibr68-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hail</surname>
<given-names>N.</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Lotan</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Cancer chemoprevention and mitochondria: Targeting apoptosis in transformed cells via the disruption of mitochondrial bioenergetics/redox state</article-title>. <source>Mol Nutr Food Res</source> <volume>53</volume>, <fpage>49</fpage>–<lpage>67</lpage>.</citation>
</ref>
<ref id="bibr69-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamid</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Friedich</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Zbinden</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>1989</year>). <article-title>Evaluation of capsaicin mutagenicity by the Salmonella/mammalian-microsome testing system</article-title>. <source>J Drug Res</source> <volume>18</volume>, <fpage>153</fpage>–<lpage>60</lpage>.</citation>
</ref>
<ref id="bibr70-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>McDonald</surname>
<given-names>H. A.</given-names>
</name>
<name>
<surname>Bianchi</surname>
<given-names>B. R.</given-names>
</name>
<name>
<surname>Kouhen</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>Vos</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Jarvis</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Faltynek</surname>
<given-names>C. R.</given-names>
</name>
<name>
<surname>Moreland</surname>
<given-names>R. B.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Capsaicin causes protein synthesis inhibition and microtubule disassembly through TRPV1 activities both on the plasma membrane and intracellular membranes</article-title>. <source>Biochem Pharmacol</source> <volume>73</volume>, <fpage>1635</fpage>–<lpage>45</lpage>.</citation>
</ref>
<ref id="bibr71-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>S. P.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C. T.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>N. Y.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>Y. T.</given-names>
</name>
<name>
<surname>Lo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>J. G.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>J. G.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Capsaicin-induced apoptosis in human hepatoma HepG2 cells</article-title>. <source>Anticancer Res</source> <volume>29</volume>, <fpage>165</fpage>–<lpage>74</lpage>.</citation>
</ref>
<ref id="bibr72-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huh</surname>
<given-names>H. C.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>N. H.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>I. S.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Capsaicin induces apoptosis of cisplatin-resistant stomach cancer cells by causing degradation of cisplatin-inducible Aurora-A protein</article-title>. <source>Nutr Cancer</source> <volume>63</volume>, <fpage>1095</fpage>–<lpage>103</lpage>.</citation>
</ref>
<ref id="bibr73-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hwang</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y. K.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>J. I.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>O. J.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Anti-inflammatory and anticarcinogenic effect of genistein alone or in combination with capsaicin in TPA-treated rat mammary glands or mammary cancer cell line</article-title>. <source>Ann N Y Acad Sci</source> <volume>1171</volume>, <fpage>415</fpage>–<lpage>20</lpage>.</citation>
</ref>
<ref id="bibr74-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hwang</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Bode</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Byun</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>N. R.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>K. W.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Cocarcinogenic effect of capsaicin involves activation of EGFR signaling but not TRPV1</article-title>. <source>Cancer Res</source> <volume>70</volume>, <fpage>6859</fpage>–<lpage>69</lpage>.</citation>
</ref>
<ref id="bibr75-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ip</surname>
<given-names>S. W.</given-names>
</name>
<name>
<surname>Lan</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y. Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Z. P.</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>Y. M.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Chiu</surname>
<given-names>C. F</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>J. G.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Capsaicin induces apoptosis in SCC-4 human tongue cancer cells through mitochondria-dependent and-independent pathways</article-title>. <source>Environ Toxicol</source>. <comment>[Epub ahead of print] doi: 10.1002/tox.20646</comment>.</citation>
</ref>
<ref id="bibr76-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ip</surname>
<given-names>S. W.</given-names>
</name>
<name>
<surname>Lan</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>H. F.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Lien</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Chiu</surname>
<given-names>C. F.</given-names>
</name>
<name>
<surname>Wood</surname>
<given-names>W. G.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>J. G.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Capsaicin mediates apoptosis in human nasopharyngeal carcinoma NPC-TW 039 cells through mitochondrial depolarization and endoplasmic reticulum stress</article-title>. <source>Hum Exp Toxicol</source>. <comment>[Epub ahead of print]. doi: 10.1177/0960327111417269</comment>.</citation>
</ref>
<ref id="bibr77-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ito</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nakazato</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yamato</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Miyakawa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hozumi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Segawa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kizaki</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Induction of apoptosis in leukemic cells by homovanillic acid derivative, capsaicin, through oxidative stress: Implication of phosphorylation of p53 at Ser-15 residue by reactive oxygen species</article-title>. <source>Cancer Res</source> <volume>64</volume>, <fpage>1071</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr78-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacobsson</surname>
<given-names>S. O.</given-names>
</name>
<name>
<surname>Wallin</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Fowler</surname>
<given-names>C. J.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors</article-title>. <source>J Pharmacol Exp Ther</source> <volume>299</volume>, <fpage>951</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr79-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jang</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y. S.</given-names>
</name>
<name>
<surname>Bae</surname>
<given-names>J. H.</given-names>
</name>
</person-group> (<year>1991</year>). <article-title>Different modifying responses of capsaicin in a wide-spectrum initiation model of F344 rat</article-title>. <source>J Korean Med Sci</source> <volume>6</volume>, <fpage>31</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr80-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jang</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Yun</surname>
<given-names>T. K.</given-names>
</name>
</person-group> (<year>1989</year>). <article-title>Inhibitory effect of capsaicin on mouse lung tumordevelopment</article-title>. <source>In Vivo</source> <volume>3</volume>, <fpage>49</fpage>–<lpage>53</lpage>.</citation>
</ref>
<ref id="bibr81-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Gorenstein</surname>
<given-names>N. M.</given-names>
</name>
<name>
<surname>Morré</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Morré</surname>
<given-names>D. J.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Molecular cloning and characterization of a candidate human growth-related and time-keeping constitutive cell surface hydroquinone (NADH) oxidase. Molecular cloning and characterization of a candidate human growth-related and time-keeping constitutive cell surface hydroquinone (NADH) oxidase</article-title>. <source>Biochemistry</source> <volume>47</volume>, <fpage>14028</fpage>–<lpage>38</lpage>.</citation>
</ref>
<ref id="bibr82-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnson</surname>
<given-names>W.</given-names>
<suffix>Jr</suffix>
</name>
</person-group>, (<year>2007</year>). <article-title>Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin</article-title>. <source>Int J Toxicol</source> <volume>26</volume>, <fpage>3</fpage>–<lpage>106</lpage>.</citation>
</ref>
<ref id="bibr83-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joung</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H. G.</given-names>
</name>
<name>
<surname>Somparn</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>Y. S.</given-names>
</name>
<name>
<surname>Na</surname>
<given-names>H. K.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Cha</surname>
<given-names>Y. N.</given-names>
</name>
<name>
<surname>Surh</surname>
<given-names>Y. J.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Capsaicin induces heme oxygenase-1 expression in HepG2 cells via activation of PI3K-Nrf2 signaling: NAD(P)H: quinone oxidoreductase as a potential target</article-title>. <source>Antioxid Redox Signal</source> <volume>9</volume>, <fpage>2087</fpage>–<lpage>98</lpage>.</citation>
</ref>
<ref id="bibr84-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jun</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C. K.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>H. I.</given-names>
</name>
<name>
<surname>Surh</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>O. H.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Capsaicin induced apoptosis of B16-F10 melanoma cells through down-regulation of Bcl-2</article-title>. <source>Food Chem Toxicol</source> <volume>45</volume>, <fpage>708</fpage>–<lpage>15</lpage>.</citation>
</ref>
<ref id="bibr85-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jung</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Capsaicin-induced apoptosis in SK-Hep-1 hepatocarcinoma cells involves Bcl-2 downregulation and caspase-3 activation</article-title>. <source>Cancer Lett</source> <volume>165</volume>, <fpage>139</fpage>–<lpage>45</lpage>.</citation>
</ref>
<ref id="bibr86-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamata</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Roles of Nox1 and other Nox isoforms in cancer development</article-title>. <source>Cancer Sci</source> <volume>100</volume>, <fpage>1382</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr87-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Soh</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Surh</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H. R.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Roles of JNK-1 and p38 in selective induction of apoptosis by capsaicin in <italic>ras</italic>-transformed human breast epithelial cells</article-title>. <source>Int J Cancer</source> <volume>103</volume>, <fpage>475</fpage>–<lpage>82</lpage>.</citation>
</ref>
<ref id="bibr88-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>I. S.</given-names>
</name>
<name>
<surname>Kawada</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Capsaicin, a spicy component of hot peppers, modulates adipokine gene expression and protein release from obese-mouse adipose tissues and isolated adipocytes, and suppresses the inflammatory responses of adipose tissue macrophages</article-title>. <source>FEBS Lett</source> <volume>581</volume>, <fpage>4389</fpage>–<lpage>96</lpage>.</citation>
</ref>
<ref id="bibr89-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>W. H.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M. O.</given-names>
</name>
<name>
<surname>Kawada</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>I. S.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Capsaicin, a spicy component of hot pepper, induces apoptosis by activation of the peroxisome proliferator-activated receptor gamma in HT-29 human colon cancer cells</article-title>. <source>J Med Food</source> <volume>7</volume>, <fpage>267</fpage>–<lpage>73</lpage>.</citation>
</ref>
<ref id="bibr90-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>Y. S.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y. S.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>A phospholipase C-dependent intracellular Ca<sup>2+</sup> release pathway mediates the capsaicin-induced apoptosis in HepG2 human hepatoma cells</article-title>. <source>Arch Pharm Res</source> <volume>28</volume>, <fpage>73</fpage>–<lpage>80</lpage>.</citation>
</ref>
<ref id="bibr91-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Pyo</surname>
<given-names>J. O.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>B. S.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>I. S.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Capsaicin can alter the expression of tumor forming-related genes which might be followed by induction of apoptosis of a Korean stomach cancer cell line, SNU-1</article-title>. <source>Cancer Lett</source> <volume>120</volume>, <fpage>235</fpage>–<lpage>41</lpage>.</citation>
</ref>
<ref id="bibr92-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>B. S.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>I. S.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Effects of capsaicin on induction of c-jun proto-oncogene expression in Fisher-344 rats by N-methyl-N'-nitro-N-nitrosoguanidine</article-title>. <source>Cancer Lett</source> <volume>142</volume>, <fpage>155</fpage>–<lpage>60</lpage>.</citation>
</ref>
<ref id="bibr93-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>E. H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S. U.</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>T. K.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>K. S.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Capsaicin sensitizes malignant glioma cells to TRAIL-mediated apoptosis via DR5 upregulation and survivin downregulation</article-title>. <source>Carcinogenesis</source> <volume>31</volume>, <fpage>367</fpage>–<lpage>75</lpage>.</citation>
</ref>
<ref id="bibr94-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Trudel</surname>
<given-names>L. J.</given-names>
</name>
<name>
<surname>Wogan</surname>
<given-names>G. N.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Apoptosis induced by capsaicin and resveratrol in colon carcinoma cells requires nitric oxide production and caspase activation</article-title>. <source>Anticancer Res</source> <volume>29</volume>, <fpage>3733</fpage>–<lpage>40</lpage>.</citation>
</ref>
<ref id="bibr95-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Capsaicin-induced apoptosis of H-<italic>ras</italic>-transformed human breast epithelial cells is Rac-dependent via ROS generation</article-title>. <source>Arch Pharm Res</source> <volume>27</volume>, <fpage>845</fpage>–<lpage>49</lpage>.</citation>
</ref>
<ref id="bibr96-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>Y. M.</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname>Kwak</surname>
<given-names>D. W.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y. K.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>O. J.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Involvement of AMPK signaling cascade in capsaicin-induced apoptosis of HT-29 colon cancer cells</article-title>. <source>Ann NY Acad Sci</source> <volume>1095</volume>, <fpage>496</fpage>–<lpage>503</lpage>.</citation>
</ref>
<ref id="bibr97-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>LaHann</surname>
<given-names>T. R.</given-names>
</name>
</person-group> (<year>1986</year>). <article-title>Effect of capsaicin on croton oil and TPA induced tumorigenesis and inflammation</article-title>. <source>Proc West Pharmacol Soc</source> <volume>29</volume>, <fpage>145</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr98-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lawson</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gannett</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>1989</year>). <article-title>The mutagenicity of capsaicin and dihydrocapsaicin in V79 cells</article-title>. <source>Cancer Lett</source> <volume>49</volume>, <fpage>109</fpage>–<lpage>13</lpage>.</citation>
</ref>
<ref id="bibr99-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>I. O.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>K. H.</given-names>
</name>
<name>
<surname>Pyo</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y. C.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Anti-inflammatory effect of capsaicin in <italic>Helicobacter</italic> pylori-infected gastric epithelial cells</article-title>. <source>Helicobacter</source> <volume>12</volume>, <fpage>510</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr100-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>J. K.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>K. Y.</given-names>
</name>
<name>
<surname>Ahn</surname>
<given-names>Y. O.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Dietary factors and stomach cancer: A case-control study in Korea</article-title>. <source>Int J Epidemiol</source> <volume>24</volume>, <fpage>33</fpage>–<lpage>41</lpage>.</citation>
</ref>
<ref id="bibr101-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J. A.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Capsaicin-induced apoptosis and reduced release of reactive oxygen species in MBT-2 murine bladder tumor cells</article-title>. <source>Arch Pharm Res</source> <volume>27</volume>, <fpage>1147</fpage>–<lpage>53</lpage>.</citation>
</ref>
<ref id="bibr102-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Kee</surname>
<given-names>K. H.</given-names>
</name>
<name>
<surname>Suh</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>S. H.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Capsaicin-induced apoptosis is regulated by endoplasmic reticulum stress-and calpain-mediated mitochondrial cell death pathways</article-title>. <source>Toxicology</source> <volume>264</volume>, <fpage>205</fpage>–<lpage>14</lpage>.</citation>
</ref>
<ref id="bibr103-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Krisanapun</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Baek</surname>
<given-names>S. J.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>NSAID-activated gene-1 as a molecular target for capsaicin-induced apoptosis through a novel molecular mechanism involving GSK3β, C/EBPβ and ATF3</article-title>. <source>Carcinogenesis</source> <volume>31</volume>, <fpage>719</fpage>–<lpage>28</lpage>.</citation>
</ref>
<ref id="bibr104-0192623312444471">
<citation citation-type="web">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Richardson</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Dashwood</surname>
<given-names>R. H.</given-names>
</name>
<name>
<surname>Baek</surname>
<given-names>S. J.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Capsaicin represses transcriptional activity of β-catenin in human colorectal cancer cells</article-title>. <source>J Nutr Biochem</source>. <comment>[Epub ahead of print]</comment>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org.laneproxy.stanford.edu/10.1016/j.jnutbio.2011.03.009">http://dx.doi.org.laneproxy.stanford.edu/10.1016/j.jnutbio.2011.03.009</ext-link>.</citation>
</ref>
<ref id="bibr105-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>Y. S</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>Y. S.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Nicolova</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J. A.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Involvement of NADPH oxidase-mediated generation of reactive oxygen species in the apototic cell death by capsaicin in HepG2 human hepatoma cells</article-title>. <source>Free Radic Res</source> <volume>38</volume>, <fpage>405</fpage>–<lpage>12</lpage>.</citation>
</ref>
<ref id="bibr106-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>Y. S.</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>D. Q.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>Y. S.</given-names>
</name>
<name>
<surname>Huh</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J. A.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Redox status-dependent regulation of cyclooxygenases mediates the capsaicin-induced apoptosis in human neuroblastoma cells</article-title>. <source>J Environ Pathol Toxicol Oncol</source> <volume>21</volume>, <fpage>113</fpage>–<lpage>20</lpage>.</citation>
</ref>
<ref id="bibr107-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>Y. S.</given-names>
</name>
<name>
<surname>Nam</surname>
<given-names>D. H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J. A.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Induction of apoptosis by capsaicin in A172 human glioblastoma cells</article-title>. <source>Cancer Lett</source> <volume>161</volume>, <fpage>121</fpage>–<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr108-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lehen'kyi</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Prevarskaya</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Oncogenic TRP channels</article-title>. <source>Adv Exp Med Biol</source> <volume>704</volume>, <fpage>929</fpage>–<lpage>45</lpage>.</citation>
</ref>
<ref id="bibr109-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lo</surname>
<given-names>Y. C.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y. C.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>I. C.</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>F. C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H. W.</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>D. C.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Capsaicin-induced cell death in a human gastric adenocarcinoma cell line</article-title>. <source>World J Gastroenterol</source> <volume>11</volume>, <fpage>6254</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr110-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>López-Carrillo</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hernández Avila</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dubrow</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>Chili pepper consumption and gastric cancer in Mexico: A case-control study</article-title>. <source>Am J Epidemiol</source> <volume>139</volume>, <fpage>263</fpage>–<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr111-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>López-Carrillo</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>López-Cervantes</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Robles-Diaz</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ramirez-Espitia</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mohar-Betancourt</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Menses-Garcia</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>López-Vidal</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Blair</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Capsaicin consumption, <italic>Helicobactor pylori</italic> positivity and gastric cancer in Mexico</article-title>. <source>Int J Cancer</source> <volume>106</volume>, <fpage>277</fpage>–<lpage>82</lpage>.</citation>
</ref>
<ref id="bibr112-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>H. F.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y. L.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y. Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>K. C.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>J. G.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Antitumor activity of capsaicin on human colon cancer cells <italic>in vitro</italic> and colo 205 tumor xenografts <italic>in vivo</italic>
</article-title>. <source>J Agric Food Chem</source> <volume>58</volume>, <fpage>12999</fpage>–<lpage>3005</lpage>.</citation>
</ref>
<ref id="bibr113-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luqman</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Meena</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Marler</surname>
<given-names>L. E.</given-names>
</name>
<name>
<surname>Kondratyuk</surname>
<given-names>T. P.</given-names>
</name>
<name>
<surname>Pezzuto</surname>
<given-names>J. M.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Suppression of tumor necrosis factor-α-induced nuclear factor κB activation and aromatase activity by capsaicin and its analog capsazepine</article-title>. <source>J Med Food</source> <volume>14</volume>, <fpage>1344</fpage>–<lpage>51</lpage>.</citation>
</ref>
<ref id="bibr114-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luqman</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pezzuto</surname>
<given-names>J. M.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>NFκB: A promising target for natural products in cancer chemoprevention</article-title>. <source>Phytother Res</source> <volume>24</volume>, <fpage>949</fpage>–<lpage>63</lpage>.</citation>
</ref>
<ref id="bibr115-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macho</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Blázquez</surname>
<given-names>M. V.</given-names>
</name>
<name>
<surname>Navas</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Muñoz</surname>
<given-names>E</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Induction of apoptosis by vanilloid compounds does not require de novo gene transcription and activator protein 1 activity</article-title>. <source>Cell Growth Differ</source> <volume>9</volume>, <fpage>277</fpage>–<lpage>86</lpage>.</citation>
</ref>
<ref id="bibr116-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macho</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Calzado</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Muñoz-Blanco</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gómez-Díaz</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gajate</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mollinedo</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Navas</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Muñoz</surname>
<given-names>E</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Selective induction of apoptosis by capsaicin in transformed cells: The role of reactive oxygen species and calcium</article-title>. <source>Cell Death Differ</source> <volume>6</volume>, <fpage>155</fpage>–<lpage>65</lpage>.</citation>
</ref>
<ref id="bibr117-0192623312444471">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Madan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Usuki</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Burton</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Ogllvie</surname>
<given-names>B. W.</given-names>
</name>
<name>
<surname>Parkinson</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title><italic>In vitro</italic> approaches for studying the inhibition of drug-metabolizing enzymes and identifying the drug-metabolizing enzymes responsible for the metabolism of drugs</article-title>. In <source>Drug-Drug Interactions</source> (<person-group person-group-type="editor">
<name>
<surname>Rodrigues</surname>
<given-names>A. D.</given-names>
</name>
</person-group>, ed.), pp <fpage>217</fpage>–<lpage>94</lpage>. <publisher-name>Marcel Dekker, Inc</publisher-name>., <publisher-loc>New York, NY</publisher-loc>.</citation>
</ref>
<ref id="bibr118-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maity</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jana</surname>
<given-names>N. R.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Capsaicin induces apoptosis through ubiquitin-proteasome system dysfunction</article-title>. <source>J Cell Biochem</source> <volume>109</volume>, <fpage>933</fpage>–<lpage>42</lpage>.</citation>
</ref>
<ref id="bibr119-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marques</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>N. G.</given-names>
</name>
<name>
<surname>Chaveca</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Rueff</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Micronuclei and sister chromatid exchanges induced by capsaicin in human lymphocytes</article-title>. <source>Mutat Res</source> <volume>517</volume>, <fpage>39</fpage>–<lpage>46</lpage>.</citation>
</ref>
<ref id="bibr120-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCormack</surname>
<given-names>P. L.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Capsaicin dermal patch: In non-diabetic peripheral neuropathic pain</article-title>. <source>Drugs</source> <volume>70</volume>, <fpage>1831</fpage>–<lpage>42</lpage>.</citation>
</ref>
<ref id="bibr121-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGregor</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Riach</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Edwards</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Reynolds</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>West</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Willington</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>1988</year>). <article-title>Reactivity of catcholamines and related substances in the mouse lymphoma L5178Y cell assay for mutagens</article-title>. <source>Environ Mol Mutagen</source> <volume>11</volume>, <fpage>523</fpage>–<lpage>44</lpage>.</citation>
</ref>
<ref id="bibr122-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Teel</surname>
<given-names>R. W.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>Effects of compounds of plant origin on the mutagenicity and metabolism of the tobacco-specific nitrosamine NKK</article-title>. <source>Phytother Res</source> <volume>8</volume>, <fpage>342</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr123-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Min</surname>
<given-names>J. K.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>K. Y.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>E. C.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y. M.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S. W.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>O. H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>K. W.</given-names>
</name>
<name>
<surname>Gho</surname>
<given-names>Y. S.</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>Y. G.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Capsaicin inhibits <italic>in vitro</italic> and <italic>in vivo</italic> angiogenesis</article-title>. <source>Cancer Res</source> <volume>64</volume>, <fpage>644</fpage>–<lpage>51</lpage>.</citation>
</ref>
<ref id="bibr124-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mori</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lehmann</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>O'Kelly</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kumagai</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Desmond</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Pervan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>McBride</surname>
<given-names>W. H.</given-names>
</name>
<name>
<surname>Kizaki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Koeffler</surname>
<given-names>H. P.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells</article-title>. <source>Cancer Res</source> <volume>66</volume>, <fpage>3222</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr125-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morré</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Chueh</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Morré</surname>
<given-names>D. M.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture</article-title>. <source>Proc Natl Acad Sci USA</source> <volume>92</volume>, <fpage>1831</fpage>–<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr126-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morré</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Geilen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>L. Y.</given-names>
</name>
<name>
<surname>de Cabo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Krasagakis</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Orfanos</surname>
<given-names>C. E.</given-names>
</name>
<name>
<surname>Morré</surname>
<given-names>D. M.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Capsaicin inhibits plasma membrane NADH oxidase and growth of human and mouse melanoma lines</article-title>. <source>Eur J Cancer</source> <volume>32A</volume>, <fpage>1995</fpage>–<lpage>2003</lpage>.</citation>
</ref>
<ref id="bibr127-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morré</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Caldwell</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mayorga</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>L. Y.</given-names>
</name>
<name>
<surname>Morré</surname>
<given-names>D. M.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>NADH oxidase activity from sera altered by capsaicin is widely distributed among cancer patients</article-title>. <source>Arch Biochem Biophys</source> <volume>342</volume>, <fpage>224</fpage>–<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr128-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morré</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Hostetler</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Weston</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Morré</surname>
<given-names>D. M.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Cancer type-specific tNOX isoforms: A putative family of redox protein splice variants with cancer diagnostic and prognostic potential</article-title>. <source>Biofactors</source> <volume>34</volume>, <fpage>201</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr130-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morré</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Sweeting</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Morré</surname>
<given-names>D. J.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Aqueous two-phase partition and detergent precipitation of a drug-responsive NADH oxidase from the HeLa cell surface</article-title>. <source>J Chromatogr B Biomed Sci Appl</source> <volume>711</volume>, <fpage>173</fpage>–<lpage>84</lpage>.</citation>
</ref>
<ref id="bibr131-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mueller</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kikuchi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Probst</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Schechtman</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Shimada</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sofuni</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tweats</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>ICH-harmonised guidances on genotoxicity testing of pharmaceuticals: Evolution, reasoning and impact</article-title>. <source>Mutat Res</source> <volume>436</volume>, <fpage>195</fpage>–<lpage>225</lpage>.</citation>
</ref>
<ref id="bibr132-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muralidhara</surname>
<given-names>N. K.</given-names>
</name>
</person-group> (<year>1988</year>). <article-title>Non-mutagenicity of capsaicin in albino mice</article-title>. <source>Food Chem Toxicol</source> <volume>26</volume>, <fpage>955</fpage>–<lpage>58</lpage>.</citation>
</ref>
<ref id="bibr133-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagabhushan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bhide</surname>
<given-names>S. V.</given-names>
</name>
</person-group> (<year>1985</year>). <article-title>Mutagenicity of chili extract and capsaicin in short-term tests</article-title>. <source>Environ Mutagen</source> <volume>7</volume>, <fpage>881</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr134-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Obach</surname>
<given-names>R. S.</given-names>
</name>
<name>
<surname>Kalgutkar</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Soglia</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>S. X.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Can <italic>in vitro</italic> metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose</article-title>. <source>Chem Res Toxicol</source> <volume>21</volume>, <fpage>1814</fpage>–<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr135-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oyagbemi</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Saba</surname>
<given-names>A. B.</given-names>
</name>
<name>
<surname>Azeez</surname>
<given-names>O. I.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Capsaicin: A novel chemopreventive molecule and its underlying molecular mechanisms of action</article-title>. <source>Indian J Cancer</source> <volume>47</volume>, <fpage>53</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr136-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ozçelik</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kartal</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Orhan</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Cytotoxicity, antiviral and antimicrobial activities of alkaloids, flavonoids, and phenolic acids</article-title>. <source>Pharm Biol</source> <volume>49</volume>, <fpage>396</fpage>–<lpage>402</lpage>.</citation>
</ref>
<ref id="bibr137-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parhi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mondal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>P. M.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Novel penetration enhancers for skin applications: A review</article-title>. <source>Curr Drug Deliv</source>. <volume>9</volume>, <fpage>219</fpage>–<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr138-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>B. K.</given-names>
</name>
<name>
<surname>Boobi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Goldring</surname>
<given-names>C. E. P.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kenna</surname>
<given-names>J. G.</given-names>
</name>
<name>
<surname>Lambert</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Laverty</surname>
<given-names>H. G.</given-names>
</name>
<name>
<surname>Naisbitt</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nicoll-Griffith</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Obach</surname>
<given-names>R. S.</given-names>
</name>
<name>
<surname>Routledge</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Tweedie</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Vermeulen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>D. P.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>I. D.</given-names>
</name>
<name>
<surname>Baillie</surname>
<given-names>T. A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Managing the challenge of chemically reactive metabolites in drug development</article-title>. <source>Nature Reviews</source> <volume>10</volume>, <fpage>292</fpage>–<lpage>306</lpage>.</citation>
</ref>
<ref id="bibr139-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>K. K.</given-names>
</name>
<name>
<surname>Chun</surname>
<given-names>K. S.</given-names>
</name>
<name>
<surname>Yook</surname>
<given-names>J. I.</given-names>
</name>
<name>
<surname>Surh</surname>
<given-names>Y. J.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Lack of tumor promoting activity of capsaicin, a principal pungent ingredient of red pepper, in mouse skin carcinogenesis</article-title>. <source>Anticancer Res</source> <volume>18</volume>, <fpage>4201</fpage>–<lpage>05</lpage>.</citation>
</ref>
<ref id="bibr140-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>K. K.</given-names>
</name>
<name>
<surname>Surh</surname>
<given-names>Y. J.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Effects of capsaicin on chemically-induced two-stage mouse skin carcinogenesis</article-title>. <source>Cancer Lett</source> <volume>114</volume>, <fpage>183</fpage>–<lpage>84</lpage>.</citation>
</ref>
<ref id="bibr141-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patel</surname>
<given-names>P. S.</given-names>
</name>
<name>
<surname>Varney</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Dave</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>R. K.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Regulation of constitutive and induced NF κB activation in malignant melanoma cells by capsaicin modulates interleukin-8 production and cell proliferation</article-title>. <source>J Interferon Cytokine Res</source> <volume>22</volume>, <fpage>427</fpage>–<lpage>35</lpage>.</citation>
</ref>
<ref id="bibr142-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patel</surname>
<given-names>P. S.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Varney</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>R. K.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Capsaicin regulates vascular endothelial cell growth factor expression by modulation of hypoxia inducing factor-1α in human malignant melanoma cells</article-title>. <source>J Cancer Res Clin Oncol</source> <volume>128</volume>, <fpage>461</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr143-0192623312444471">
<citation citation-type="web">
<collab collab-type="author">Pesticide Action Network Pesticides Database</collab>. (<year>2009</year>). <article-title>California pesticide use: Pesticide use in chili peppers in 2009</article-title>. <ext-link ext-link-type="uri" xlink:href="http://www.pesticideinfo.org/DS.jsp?sk=8050">http://www.pesticideinfo.org/DS.jsp?sk=8050</ext-link>.</citation>
</ref>
<ref id="bibr144-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pramanik</surname>
<given-names>K. C.</given-names>
</name>
<name>
<surname>Boreddy</surname>
<given-names>S. R.</given-names>
</name>
<name>
<surname>Srivastava</surname>
<given-names>S. K.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Role of mitochondrial electron transport chain complexes in capsaicin mediated oxidative stress leading to apoptosis in pancreatic cancer cells</article-title>. <source>PLoS One</source> <volume>6</volume>, <fpage>e20151</fpage>.</citation>
</ref>
<ref id="bibr145-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Proudlock</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Longstaff</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Examination of the potential genotoxicity of pure capsaicin in bacterial mutation, chromosome aberration, and rodent micronucleus tests</article-title>. <source>Environ Mol Mutagen</source> <volume>44</volume>, <fpage>441</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr146-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qiao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Tsubouchi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Haneda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Murakami</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yoshino</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Involvement of peroxynitrite in capsaicin-induced apoptosis of C6 glioma cells</article-title>. <source>Neurosci Res</source> <volume>51</volume>, <fpage>175</fpage>–<lpage>83</lpage>.</citation>
</ref>
<ref id="bibr147-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reilly</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Ehlhardt</surname>
<given-names>W. J.</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Kulanthaivel</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mutlib</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>Espina</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Moody</surname>
<given-names>D. E.</given-names>
</name>
<name>
<surname>Crouch</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Yost</surname>
<given-names>G. S.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Metabolism of capsaicin by cytochrome P450 produces novel dehydrogenated metabolites and decreases cytotoxicity to lung and liver cells</article-title>. <source>Chem Res Toxicol</source> <volume>16</volume>, <fpage>336</fpage>–<lpage>49</lpage>.</citation>
</ref>
<ref id="bibr148-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reilly</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Yost</surname>
<given-names>G. S.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Metabolism of capsaicinoids by P450 enzymes: A review of recent findings on reaction mechanisms, bio-activation, and detoxification processes</article-title>. <source>Drug Metab Rev</source> <volume>38</volume>, <fpage>685</fpage>–<lpage>706</lpage>.</citation>
</ref>
<ref id="bibr149-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richeux</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Cascante</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ennamany</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Saboureau</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Creppy</surname>
<given-names>E. E.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Cytotoxicity and genotoxicity of capsaicin in human neuroblastoma cells SHSY-5Y</article-title>. <source>Arch Toxicol</source> <volume>73</volume>, <fpage>403</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr150-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richter</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Engl</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Friesenegger</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tricker</surname>
<given-names>A. R.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Biotransformation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in lung tissue from mouse, rat, hamster, and man</article-title>. <source>Chem Res Toxicol</source> <volume>22</volume>, <fpage>1008</fpage>–<lpage>17</lpage>.</citation>
</ref>
<ref id="bibr151-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roy</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chakraborty</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Siddiqi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bhattacharya</surname>
<given-names>R. K.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Induction of apoptosis in tumor cells by natural phenolic compounds</article-title>. <source>Asian Pac J Cancer Prev</source> <volume>3</volume>, <fpage>61</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr152-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sánchez</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Malagarie-Cazenave</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Olea</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Vara</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Chiloeches</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Díaz-Laviada</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Apoptosis induced by capsaicin in prostate PC-3 cells involves ceramide accumulation, neutral sphingomyelinase, and JNK activation</article-title>. <source>Apoptosis</source> <volume>12</volume>, <fpage>2013</fpage>–<lpage>24</lpage>.</citation>
</ref>
<ref id="bibr153-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sánchez</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Martínez-Botas</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Malagarie-Cazenave</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Olea</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Vara</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lasunción</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Díaz-Laviada</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Induction of the endoplasmic reticulum stress protein GADD153/CHOP by capsaicin in prostate PC-3 cells: A microarray study</article-title>. <source>Biochem Biophys Res Commun</source> <volume>372</volume>, <fpage>785</fpage>–<lpage>91</lpage>.</citation>
</ref>
<ref id="bibr154-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sánchez</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Sánchez</surname>
<given-names>M. G.</given-names>
</name>
<name>
<surname>Malagarie-Cazenave</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Olea</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Díaz-Laviada</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Induction of apoptosis in prostate tumor PC-3 cells and inhibition of xenograft prostate tumor growth by the vanilloid capsaicin</article-title>. <source>Apoptosis</source> <volume>11</volume>, <fpage>89</fpage>–<lpage>99</lpage>.</citation>
</ref>
<ref id="bibr155-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sánchez</surname>
<given-names>M. G.</given-names>
</name>
<name>
<surname>Sanchez</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Collado</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Malagarie-Cazenave</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Olea</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Carmena</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Prieto</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Diaz-Laviada</surname>
<given-names>I. I.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue</article-title>. <source>Eur J Pharmacol</source> <volume>515</volume>, <fpage>20</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr156-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Satoh</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Miyoshi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sakamoto</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Iwamura</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Comparison of the inhibitory action of synthetic capsaicin analogues with various NADH-ubiquinone oxidoreductases. Comparison of the inhibitory action of synthetic capsaicin analogues with various NADH-ubiquinone oxidoreductases</article-title>. <source>Biochim Biophys Acta</source> <year>1273</year>, <fpage>21</fpage>–<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr157-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Serra</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Calvo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cavada</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Báez</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Endoh</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tajima</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Association of chili pepper consumption, low socioeconomic status and longstanding gallstones with gallbladder cancer in a Chilean population</article-title>. <source>Int J Cancer</source> <volume>102</volume>, <fpage>407</fpage>–<lpage>11</lpage>.</citation>
</ref>
<ref id="bibr158-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shimomura</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kawada</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>1989</year>). <article-title>Capsaicin and its analogs inhibit the activity of NADH-coenzyme Q oxidoreductase of the mitochondrial respiratory chain</article-title>. <source>Arch Biochem Biophys</source> <volume>270</volume>, <fpage>573</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr159-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shin</surname>
<given-names>D. H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>O. H.</given-names>
</name>
<name>
<surname>Jun</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>M. K.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Inhibitory effect of capsaicin on B16-F10 melanoma cell migration via the phosphatidylinositol 3-kinase/Akt/Rac1 signal pathway</article-title>. <source>Exp Mol Med</source> <volume>40</volume>, <fpage>486</fpage>–<lpage>94</lpage>.</citation>
</ref>
<ref id="bibr160-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siddiqi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Fazili</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Spiegelhalder</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Preussmann</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>1992</year>). <article-title>Increased exposure to dietary amines and nitrate in a population at high risk of oesophageal and gastric cancer in Kashmir (India)</article-title>. <source>Carcinogenesis</source> <volume>13</volume>, <fpage>1331</fpage>–<lpage>35</lpage>.</citation>
</ref>
<ref id="bibr161-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siddiqi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tricker</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Preussmann</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>1988</year>). <article-title>The occurrence of preformed N-nitroso compounds in food samples from a high risk area of esophageal cancer in Kashmir, India</article-title>. <source>Cancer Lett</source> <volume>39</volume>, <fpage>37</fpage>–<lpage>43</lpage>.</citation>
</ref>
<ref id="bibr162-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Asad</surname>
<given-names>S. F.</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>N. U.</given-names>
</name>
<name>
<surname>Hadi</surname>
<given-names>S. M.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Oxidative DNA damage by capsaicin and dihydrocapsaicin in the presence of Cu(II)</article-title>. <source>Cancer Lett</source> <volume>169</volume>, <fpage>139</fpage>–<lpage>46</lpage>.</citation>
</ref>
<ref id="bibr163-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>S. S.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Preclinical pharmacokinetics: An approach towards safer and efficacious drugs</article-title>. <source>Curr Drug Metab</source> <volume>7</volume>, <fpage>165</fpage>–<lpage>82</lpage>.</citation>
</ref>
<ref id="bibr164-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Surh</surname>
<given-names>Y. J.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>More than spice: Capsaicin in hot chili peppers makes tumor cells commit suicide</article-title>. <source>J Natl Cancer Inst</source> <volume>94</volume>, <fpage>1263</fpage>–<lpage>65</lpage>.</citation>
</ref>
<ref id="bibr165-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Surh</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Ahn</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>K. C.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>Sohn</surname>
<given-names>Y. W.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S. S.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Metabolism of capsaicinoids: Evidence for aliphatic hydroxylation and its pharmacological implications</article-title>. <source>Life Sci</source> <volume>56</volume>, <fpage>PL305</fpage>–<lpage>11</lpage>.</citation>
</ref>
<ref id="bibr166-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Surh</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>R. C.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>K. K.</given-names>
</name>
<name>
<surname>Mayne</surname>
<given-names>S. T.</given-names>
</name>
<name>
<surname>Liem</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>J. A.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Chemoprotective effects of capsaicin and diallyl sulfide against mutagenesis or tumorigenesis by vinyl carbamate and <italic>N</italic>-nitrosodimethylamine</article-title>. <source>Carcinogenesis</source> <volume>16</volume>, <fpage>2467</fpage>–<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr167-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Surh</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S. S.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Capsaicin a double-edged sword: Toxicity, metabolism, and chemopreventive potential</article-title>. <source>Life Sci</source> <volume>56</volume>, <fpage>1845</fpage>–<lpage>55</lpage>.</citation>
</ref>
<ref id="bibr168-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takahata</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Monobe</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tada</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Growth inhibition of capsaicin on HeLa cells is not mediated by intracellular calcium mobilization</article-title>. <source>Life Sci</source> <volume>64</volume>, <fpage>PL165</fpage>–<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr169-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tanaka</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kohno</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sakata</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hirose</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sugie</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Modifying effects of dietary capsaicin and rotenone on 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis</article-title>. <source>Carcinogenesis</source> <volume>23</volume>, <fpage>1361</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr170-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teel</surname>
<given-names>R. W.</given-names>
</name>
<name>
<surname>Huynh</surname>
<given-names>H. T.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Lack of the inhibitory effect of intragastrically administered capsaicin on NNK-induced lung tumor formation in the A.J mouse</article-title>. <source>In Vivo</source> <volume>13</volume>, <fpage>231</fpage>–<lpage>4</lpage>.</citation>
</ref>
<ref id="bibr171-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thoennissen</surname>
<given-names>N. H.</given-names>
</name>
<name>
<surname>O'Kelly</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Iwanski</surname>
<given-names>G. B.</given-names>
</name>
<name>
<surname>La</surname>
<given-names>D. T.</given-names>
</name>
<name>
<surname>Abbassi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Leiter</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Karlan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Mehta</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Koeffler</surname>
<given-names>H. P.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway</article-title>. <source>Oncogene</source> <volume>29</volume>, <fpage>285</fpage>–<lpage>96</lpage>.</citation>
</ref>
<ref id="bibr172-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Toth</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gannett</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>1992</year>). <article-title>Carcinogenicity of lifelong administration of capsaicin of hot pepper in mice</article-title>. <source>In Vivo</source> <volume>6</volume>, <fpage>59</fpage>–<lpage>63</lpage>.</citation>
</ref>
<ref id="bibr173-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Toth</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Nagel</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Patil</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>1980</year>). <article-title>Tumorigenesis by N-n-propyl-N-formylhydrazine in mice</article-title>. <source>Br J Cancer</source> <volume>42</volume>, <fpage>922</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr174-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Toth</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Rogan</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Walke</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>1984</year>). <article-title>Tumorigenicity and mutagenicity studies with capsaicin of hot peppers</article-title>. <source>Anticancer Res</source> <volume>4</volume>, <fpage>117</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr175-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tricker</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Siddiqi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Preussmann</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>1988</year>). <article-title>Occurrence of volatile <italic>N</italic>-nitrosamines in dried chillies</article-title>. <source>Cancer Lett</source> <volume>38</volume>, <fpage>271</fpage>–<lpage>3</lpage>.</citation>
</ref>
<ref id="bibr176-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsou</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>H. F.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>L. T.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y. S.</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>J. G.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Involvement of Bax, Bcl-2, Ca<sup>2+</sup> and caspase-3 in capsaicin-induced apoptosis of human leukemia HL-60 cells</article-title>. <source>Anticancer Res</source> <volume>26</volume>, <fpage>1965</fpage>–<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr177-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsuchiya</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Terao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Okano</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Oyama</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ikegami</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Mutagenicity and mutagens of the red chili pepper as gallbladder cancer risk factor in chilean women</article-title>. <source>Asian Pac J Cancer Prev</source> <volume>12</volume>, <fpage>471</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr178-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tuoya</surname>
<given-names>B. N.</given-names>
</name>
<name>
<surname>Shimoishi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Murata</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tada</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Koseki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Takahata</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Apoptosis induction by dohevanil, a DHA substitutive analog of capsaicin, in MCF-7 cells</article-title>. <source>Life Sci</source> <volume>78</volume>, <fpage>1515</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr179-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turgut</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Newby</surname>
<given-names>B. M.</given-names>
</name>
<name>
<surname>Cutright</surname>
<given-names>T. J.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Determination of optimal water solubility of capsaicin for its usage as a non-toxic antifoulant</article-title>. <source>Environ Sci Pollut Res Int</source> <volume>11</volume>, <fpage>7</fpage>–<lpage>10</lpage>.</citation>
</ref>
<ref id="bibr180-0192623312444471">
<citation citation-type="web">
<collab collab-type="author">US FDA</collab>. (<year>2006</year>). <article-title>Guidance for Industry: <italic>In Vivo</italic> Drug Metabolism/Drug Interaction Studies—Study Design, Data Analysis, and Recommendations for Dosing and Labeling</article-title>. <ext-link ext-link-type="uri" xlink:href="http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm072119.pdf">http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm072119.pdf</ext-link>.</citation>
</ref>
<ref id="bibr181-0192623312444471">
<citation citation-type="web">
<collab collab-type="author">US FDA</collab>. (<year>2009</year>). <article-title>Summary Basis for Regulatory Action: Qutenza</article-title>. <ext-link ext-link-type="uri" xlink:href="http://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022395s000Sumr.pdf">http://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022395s000Sumr.pdf</ext-link>.</citation>
</ref>
<ref id="bibr182-0192623312444471">
<citation citation-type="web">
<collab collab-type="author">US FDA</collab>. (<year>2011</year>). <article-title>Inspections, Compliance, Enforcement, and Criminal Investigations: Millennium Bioceutics 2/17/11</article-title>. <ext-link ext-link-type="uri" xlink:href="http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm244906.htm">http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm244906.htm</ext-link>.</citation>
</ref>
<ref id="bibr183-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valenzano</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Current perspectives on the therapeutic utility of VR1 antagonists</article-title>. <source>Curr Med Chem</source> <volume>11</volume>, <fpage>3185</fpage>–<lpage>202</lpage>.</citation>
</ref>
<ref id="bibr184-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Villaseñor</surname>
<given-names>I. M.</given-names>
</name>
<name>
<surname>de Ocampo</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bremner</surname>
<given-names>J. B.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>Effect of natural capsaicin on bone marrow cells of mice</article-title>. <source>Philipp J Sci</source> <volume>122</volume>, <fpage>397</fpage>–<lpage>402</lpage>.</citation>
</ref>
<ref id="bibr185-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vinitketkumnuen</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Sasagawa</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Matsushima</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>1991</year>). <article-title>Mutagenicity study of chili and its pungent principles, capsaicin and dihydrocapsaicin</article-title>. <source>Mutat Res</source> <volume>252</volume>, <fpage>115</fpage> <comment>(abstract 81).</comment>
</citation>
</ref>
<ref id="bibr186-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vriens</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Janssens</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Prenen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nilius</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wondergem</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>TRPV channels and modulation by hepatocyte growth factor/scatter factor in human hepatoblastoma (HepG2) cells</article-title>. <source>Cell Calcium</source> <volume>36</volume>, <fpage>19</fpage>–<lpage>28</lpage>.</citation>
</ref>
<ref id="bibr187-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Chuang</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>Y. C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y. H.</given-names>
</name>
<name>
<surname>Chueh</surname>
<given-names>P. J.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Down-regulation of tumor-associated NADH Oxidase, tNOX (ENOX2), enhances capsaicin-induced inhibition of gastric cancer cell growth</article-title>. <source>Cell Biochem Biophys</source> <volume>61</volume>, <fpage>355</fpage>–<lpage>66</lpage>.</citation>
</ref>
<ref id="bibr188-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Chueh</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>S. P.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>K. N.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Effect of capsaicin on tNOX (ENOX2) protein expression in stomach cancer cells</article-title>. <source>Biofactors</source> <volume>34</volume>, <fpage>209</fpage>–<lpage>17</lpage>.</citation>
</ref>
<ref id="bibr189-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>S. T.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Y. T.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>H. L.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>J. G.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Capsaicin induced cell cycle arrest and apoptosis in human esophagus epidermoid carcinoma CE 81T/VGH cells through the elevation of intracellular reactive oxygen species and Ca<sup>2+</sup> productions and caspase-3 activation</article-title>. <source>Mutat Res</source> <volume>601</volume>, <fpage>71</fpage>–<lpage>82</lpage>.</citation>
</ref>
<ref id="bibr190-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Z. H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X. H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H. P.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>L. Q.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>X. M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S. W.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Capsaicin mediates cell death in bladder cancer T24 cells through reactive oxygen species production and mitochondrial depolarization</article-title>. <source>Urology</source> <volume>75</volume>, <fpage>735</fpage>–<lpage>41</lpage>.</citation>
</ref>
<ref id="bibr191-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshitani</surname>
<given-names>S. I.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kohno</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Takashima</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Chemoprevention of azoxymethane-induced rat colon carcinogenesis by dietary capsaicin and rotenone</article-title>. <source>Int J Oncol</source> <volume>19</volume>, <fpage>929</fpage>–<lpage>39</lpage>.</citation>
</ref>
<ref id="bibr192-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nagasaki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Morikawa</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Capsaicin inhibits growth of adult T-cell leukemia cells</article-title>. <source>Leuk Res</source> <volume>27</volume>, <fpage>275</fpage>–<lpage>83</lpage>.</citation>
</ref>
<ref id="bibr193-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Humphreys</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Sahu</surname>
<given-names>R. P.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Srivastava</surname>
<given-names>S. K.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title><italic>In vitro</italic> and <italic>in vivo</italic> induction of apoptosis by capsaicin in pancreatic cancer cells is mediated through ROS generation and mitochondrial death pathway</article-title>. <source>Apoptosis</source> <volume>13</volume>, <fpage>1465</fpage>–<lpage>78</lpage>.</citation>
</ref>
<ref id="bibr194-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Strother</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Teel</surname>
<given-names>R. W.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>Inhibition of liver microsomal cytochrome P450 activity and metabolism of the tobacco-specific nitrosamine NNK by capsaicin and ellagic acid</article-title>. <source>Anticancer Res</source> <volume>13</volume>, <fpage>2341</fpage>–<lpage>46</lpage>.</citation>
</ref>
<ref id="bibr195-0192623312444471">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ziglioli</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Frattini</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Maestroni</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Dinale</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ciufifeda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cortellini</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Vanilloid-mediated apoptosis in prostate cancer cells through a TRPV-1 dependent and a TRPV-1-independent mechanism</article-title>. <source>Acta Biomed</source> <volume>80</volume>, <fpage>13</fpage>–<lpage>20</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>